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 Abstract 
This thesis contributes to the understanding of the effectiveness of 
marketing strategy making processes. It examines how such 
effectiveness is contingent upon the internal and external 
environments in which the process operates and, therefore, how the 
requisite process is contingent upon its organisational and market 
context.  
It builds on the fields of strategy content and strategy process and of 
organisational effectiveness, organisational culture and organisation 
theory. It tests and develops Burrell and Morgan’s congruency 
hypotheses as an explanation of the effectiveness of marketing 
strategy making processes. That work postulates that effectiveness 
results when the process is congruent with both its internal 
environment (i.e. microcongruent) and external environment 
(i.e. macrocongruent) 
This work takes a pragmatist epistemological perspective. The 
methodology is qualitative, using multiple-informant case studies. 
The congruency hypotheses are operationalised using a model and 
constructs based on the extant literature. The work is restricted to 
the medical products market in order to optimise insight and 
understanding. 
The findings support the congruency hypotheses. Strong strategy is 
associated with simultaneous macrocongruence and 
microcongruence. Further, a mechanism for the hypotheses is 
identified. Interactions between the strategy process and 
organisational structure, systems and habits provide an underlying 
mechanism of microcongruence. Failure or success of the process to 
manage market complexity and turbulence provide an underlying 
mechanism of macrocongruence. 
This work contributes to theory, confirming the congruency 
hypotheses, extending them into marketing strategy making and 
making a new contribution concerning the mechanism of 
congruency. To methodology, this work confirms the use of case 
studies, extends it to consider simultaneously internal and external 
environments and makes a new contribution concerning the 
construct of strategy quality. To practice, the work confirms the value 
of planning in complex markets, extends the concept of a “requisite” 
process and contributes new ideas for the deliberate management of 
marketing strategy making processes.  
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 1 An Overview of this Thesis 
This work, in seeking to address a real and pressing management 
problem, necessarily draws upon a broad range of existing 
knowledge. To aid understanding of this work, it is summarised in 
this section and in Figure 1 (Page9). 
This work is intended to contribute to the domain concerning the 
effectiveness of strategic marketing planning. Its roots lie in the 
seminal work of McDonald (McDonald 1982). In that work the author, 
whilst advocating the use of strategic marketing planning, took care 
to qualify the applicability of that set of techniques. In particular, he 
referred to the necessity of a “requisite” marketing planning process, 
indicating that the process must be appropriate to its organisational 
and market context. He contrasted this with the inappropriate use of 
one model of strategic marketing planning in all contexts.  
This work can therefore be seen as an attempt to better understand 
what requisite means and to apply that understanding to the 
improvement of marketing strategy development processes within 
commercial organisations. In particular, the work explores how 
different types of marketing strategy making process are more or less 
appropriate to differing internal and external environments.  
This work attempts to build its contribution from the synthesis of 
three well established bodies of literature: 
a) The strategy content literature, which seeks to define the 
content of marketing strategy and differentiate between strong 
and weak strategies. 
b) The strategy process literature, which seeks to understand the 
mixture of explicit and implicit processes that lead to the 
marketing strategy. 
c) The organisation theory literature, and particularly the 
contingency theory school, which attempts to explain the 
effectiveness of management processes in terms of their fit with 
the environment in which they operate. 
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 Figure 1: Overview of the Thesis 
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 Those three bodies of literature yield three broad conclusions, upon 
which this work is based. 
a) Strong marketing strategies have recognisable characteristics 
that differentiate them from weaker strategies and this 
differentiation can be used to measure strategy quality 
independently of context. These characteristics fall into three 
groupings: market definition, fit with internal conditions and fit 
with external conditions. These conclusions come from a broad 
body of prior work, but particularly that of Drucker, Ansoff, 
Andrews, Chandler, Porter and Ruekert. 
b) Marketing strategy arises from a complex hybrid process and 
the precise nature of the hybrid is characteristic to each 
organisation. This hybrid has components of rational planning, 
visionary command and incremental processes. This 
conclusion comes from another extensive body of literature, 
but especially that of Chaffee, Hart, Mintzberg, Bailey and 
Johnson, and McDonald. 
c) The effectiveness of the process (measured in terms of resultant 
strategy quality) is a function of the congruence between the 
process and both its internal and external environments. This 
conclusion comes from three related streams of literature. The 
first considers the actual usage of strategic marketing planning 
and the barriers to it. The second considers contingency theory 
including the work of Thompson, Lawrence and Lorsch, and 
Burrell and Morgan. The third considers external contingent 
effects on strategic planning, including the work of Harris, 
Mintzberg, Eisenhardt and Frederickson. 
This work builds upon those three broad conclusions by developing a 
putative model to explain the effectiveness of hybrid marketing 
strategy making processes in the context of differing internal and 
external contexts. The research objectives were to test and develop 
this combined congruency model as an explanation of the 
effectiveness of strategic marketing planning. 
The contribution of this work lies in three areas. 
 
The Effectiveness of Marketing Strategy Making Processes in Medical Markets 
 (2003)  Page 10 
 Theoretically, the findings confirm and extend the combined 
congruency model. Further, they make a new contribution to this 
area of theory by elucidating the nature of congruence with the 
internal and external environments. 
Methodologically, this work confirms the applicability of multiple 
informant case studies in marketing strategy process research. It 
extends methodology to consider simultaneously both internal and 
external contingent effects on strategy process. Further, it makes a 
new contribution to methodology in its operationalisation of the 
construct of marketing strategy quality. 
In terms of practice, this work confirms the effectiveness of rational 
planning in complex markets. It extends ideas about the nature of 
“requisite” marketing strategy making processes. Further, it provides 
practitioner guidelines for the deliberate design of marketing strategy 
making processes. 
The research design of this work is based on a pragmatist paradigm 
using qualitative, semi-structured interviews and content analysis by 
a matrix analysis. The field work included fifty interviews with 
managers closely involved with the marketing strategy development 
process. The managers came from eighteen companies of varying 
sizes across different sectors of the medical products industry. 
The conclusions of the work are that the combined congruency model 
is supported in this context and that marketing strategy quality does 
depend on achieving both congruence with the external environment 
(macrocongruence) and with the internal environment 
(microcongruence). Additionally, the work identifies characteristics of 
macrocongruence and microcongruence. In the former case, it 
suggests optimal strategy process hybrids for particular conditions of 
market complexity and turbulence. In the latter, it suggests 
characteristics of organisational culture that support or hinder 
particular hybrids of marketing strategy market process. Finally, the 
work suggests possible connections between the combined 
congruency model and the concept of strategic drift. 
The work therefore makes its intended contribution to knowledge, as 
well as suggesting practical implications for practitioners. 
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 2 Literature Review 
2.1 An Overview of this Literature Review 
This literature review is broad in its scope and an overview is 
appropriate to frame the following detailed and complicated critique 
of many different strands of literature. This work reviews critically 
literature that seeks to answer four questions: 
• How effective is marketing strategy making? (Section 2.2) 
• What is the intended outcome of marketing strategy making 
processes? (Section 2.3) 
• How do organisations make marketing strategy? (Section 2.4)  
• What mediates marketing strategy making processes? 
(Section 2.5)  
Whilst there are, as always, contradictions in the literature, this work 
contends that each of these four questions can be answered with a 
useful degree of consensus by the literature. In short, these 
consensus answers can be summarised as: 
• How effective is marketing strategy making?  
This question has only been significantly answered for rational 
planning, one form of marketing strategy making. Such formal 
processes are seen to contribute to organisational effectiveness, 
although they are not the panacea some advocates suggest. 
• What is the intended outcome of marketing strategy making 
processes?  
The literature contains a useful level of agreement on this 
subject. Marketing strategies are defined as that set of 
management decisions about which customers to target and 
what value propositions to offer them. Further, the literature 
contains a functional set of properties that differentiate strong 
marketing strategies from weaker ones. These properties 
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 suggest a better measure of the effectiveness of marketing 
strategy making processes than traditional measures of 
organisational effectiveness. 
• How do organisations make marketing strategy?  
Organisations make marketing strategy by a hybrid process of 
rational, visionary and incremental processes. Each 
organisation would appear to have a characteristic hybrid 
strategy making process, although some clustering allows 
approximate taxonomies of strategy making processes. 
• What mediates marketing strategy making processes?  
This literature suggests that rational strategic marketing 
planning is not a good description of much practice. Further, it 
suggests that the effectiveness those processes used, is 
mediated by both the external (market) environment and the 
internal (organisational culture) environment. In the external 
environment, market turbulence and market complexity appear 
to be the most significant factors. In the internal environment, 
systems, structure and other cultural artefacts influence the 
effectiveness of marketing strategy making. 
A synthesis of this literature therefore suggests that hybrid marketing 
strategy making processes lead to marketing strategies, the content 
and properties of which are a function of the processes and their fit 
with the external and internal environments in which they operates. 
The following sections support this overview and lead to the 
development of a model and propositions that this research attempts 
to assess. 
2.2 The Effectiveness of Marketing Strategy 
Making Processes  
Researchers investigating the effectiveness of marketing strategy 
making processes have concentrated almost exclusively on the 
success of rational, formal, strategic marketing planning processes. 
As will be discussed later, this is a significant weakness in the 
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 literature, as strategic marketing planning is not a good description 
of practice. However, the assessment of normative approaches is a 
useful and necessary starting point for this work. 
Researchers’ efforts to prove or disprove the effectiveness of 
normative, rational, planning methods have a history almost as long 
as planning itself. An examination of this long history reveals three 
phases of opinion amongst researchers attempting to correlate 
planning with organisational effectiveness. 
The first phase adopted a strongly positivist approach to the problem. 
The prototype of this work was the much cited work by Thune and 
House who found that: 
“Formal planners significantly outperform informal planners with 
respect to five economic measures.” (Thune & House 1970) 
This work was later extended by Herold (Herold 1972). Using five 
pairs of formal and informal planners, this work demonstrated that 
formal planners did perform better than non-planners over a seven 
year period against both sales and profit criteria. This work is, of 
course, unsophisticated by modern standards, but was subsequently 
confirmed and extended by a large number of studies. This further 
work, using similar comparisons of formal versus informal planners 
supported these conclusions (see, for instance, Eastlack & McDonald 
1970, Karger & Malik 1975, Wood & LaForge 1979, Armstrong 1982, 
Bracker & Pearson 1986, Pearce II, Robbins, & Robinson 1987). 
These works show a gradual increase in methodological 
sophistication and, whilst claiming only association and not 
correlation between planning and effectiveness, do provide 
substantial if qualified evidence for this association. This phase of 
work is perhaps best summarised by Pearce et al who, in a study of 
ninety-seven companies, found 
“a strong positive correlation between the degree of planning 
formality and firm performance. Additionally, interactive analysis 
disclosed that this relationship pervaded the various grand strategies; 
the implication being that formalized strategic planning  was 
consistently a positive factor associated with high levels of 
performance.” (Pearce II, Robbins, & Robinson1987) 
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 This phase of research therefore firmly concluded that planning 
formality was positively correlated with organisational effectiveness. 
Even at this stage, however, there were indications that this 
correlation was not universally true and anomalies were observed in 
service industries (Rue & Fulmer 1973) and in the impact of planning 
on growth rates (Sheehan 1975). 
The second phase of this work can be seen as something of a reaction 
against the absolute positivism of the first phase. Researchers, both 
in original work and in meta-analysis of prior work, contrasted the 
complexity of the problem to the relative simplicity of the early work. 
In particular, two main strands of criticism emerged.  
Firstly, the planning/performance link is highly contingent upon a 
multitude of other factors and the methodologies employed were not 
sufficiently rigorous to allow for this complexity. Such criticisms were 
made by a number of researchers (see for instance Shrader, Taylor, & 
Dalton D R 1984, Rhyne 1986, Pearce II, Freeman, & Robinson 1987, 
Keats & Hitt 1988) but were summarised by Greenley in a paper 
towards the end of this episode in the literature: 
“Many differences were found among the methodologies of these 
studies, while the rigour of each study is seemingly limited. 
Consequently their results cannot be legitimately combined, and 
therefore it cannot be concluded that an association is evident”  
(Greenley 1994). 
Secondly, the construct of organisational effectiveness was itself 
much more complex than even a comprehensive set of financial 
measures might allow for (Cameron 1986, see for instance 
Chakravarthy 1986, Venkatraman & Ramanujam 1986, Lewin & 
Minton 1986). Cameron characterised this discussion with the 
assertion that organisational effectiveness was “paradoxical, a 
multidimensional construct, relating to many domains of activity and 
reflecting multiple constituency ideas”  (Cameron1986). 
After considering both the highly contingent nature of organisational 
effectiveness and its complexity as a construct, this phase of research 
therefore concluded that the planning/performance link was in fact 
unproved. Further, it suggested that such a simple correlation would 
never be possible. Instead, the consensus of this work was that, at 
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 best, planning is only effective within a certain set of contingent 
conditions and that effectiveness itself is a complex construct, 
dependent upon the organisation’s goals and situation. 
The third and most recent phase of this work suggests a position 
somewhere between the unbridled positivism of the first and the 
inconclusive relativism of the second. Partly, this work paralleled the 
development of ideas about determining organisational performance 
(see, for example, Lewin & Minton1986, Kaplan & Norton 1992, 
Drucker 1993b, Neely, Gregory, & Platts 1995, Neely 1999). Further, 
it reflected more sophisticated work that attempted to allow for the 
many contingent factors of effectiveness. Examples of this greater 
methodological sophistication are shown by a number of authors (see 
for example Lysonski & Percottich 1992, Herbig & Milewicz 1995, 
Pelham & Wilson 1996, Greenley & Foxall 1997, Pelham 1999). 
Despite different approaches, their overall conclusions contain a  
high degree of agreement and a best summarised by  the most recent 
piece of work in this field: 
“Strategic marketing formalization also associates with improved 
market and financial performance. These findings hold when 
controlling for a range of contextual variables including firm size, 
industry growth rate and uncertainty in demand.”  
(Claycomb, Germain, & Droge 2000) 
This latter collection of work therefore considers the 
performance/planning link within the limits of environmental 
contingencies and the context of organisationally specific objectives. 
In this way, it addresses, to a large degree, the criticisms discussed 
above.  Within those parameters, a consensus is apparent amongst 
researchers on this topic. This consensus is of a “small but 
significant correlation between planning and performance”  (Schwenk 
& Shrader 1993), that “substantive external contingencies have little 
impact” (Miller & Cardinal 1994) and that “more sophisticated 
methodologies have produced stronger links than earlier work”  
(Priem, Rasheed, & Kotulic 1995). Furthermore, this work contends 
that the advantages of strategic planning are not only financial but lie 
also in less tangible “process” benefits (Greenley1994, Appiah-Adu, 
Morgan, & Katsikeas 1996). 
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 The long history of research into the effectiveness of planning, 
therefore, seems to have reached a balanced and qualified conclusion 
to the positive. However, this body of literature is open to two 
criticisms in the context of this thesis. Firstly, it concerns itself 
entirely with the effectiveness of rational planning processes. As will 
be argued later, strategy process researchers suggest that strategy 
making is, in reality, more complex than this, and that a purely 
rational strategic marketing planning process is, in practice, notable 
for its rarity. Hence the extant literature, by considering only 
planning, simplifies strategy making into one dimension (normally 
expressed as rationality or formality) and gives only one perspective. 
Secondly, the work in this area seeks to correlate strategy making 
with organisational effectiveness, usually operationalised as financial 
performance, whilst attempting to control for other mediating factors 
(such as market conditions) via the methodology. This limits the 
insight gained from the research. Other researchers advocate the 
construction of intermediate variables lying between strategy process 
and financial outcome (Rajagopalan, Rasheed, & Datta 1993) as a 
means of improving insight. 
These shortcomings in the literature suggest that current knowledge 
about the effectiveness of strategy making processes is limited in two 
ways. Firstly, our current knowledge is limited to a qualified 
association between planning and performance, and not to the more 
direct output of strategy process (i.e. strategy content). Secondly, our 
current knowledge is almost entirely based upon the one dimension 
of strategy making, the degree of rational planning.  Little or no 
knowledge exists concerning the effectiveness (by any measure) of 
non-planning strategy making processes, except that inferred by the 
studies of planning effectiveness.  
These two limitations mean that our extant knowledge cannot answer 
the question: “what is the best process for making marketing 
strategy?” This suggests that researchers need to design research 
more carefully to measure the direct outputs of hybrid marketing 
strategy making processes, rather than the correlation between 
formal planning and organisational performance. This in turn 
prompts a consideration of the extant literature concerning the direct 
outputs of marketing strategy making and the nature of the strategy 
making process. Other authors have noted that the content of the 
 
The Effectiveness of Marketing Strategy Making Processes in Medical Markets 
 (2003)  Page 17 
 strategy produced by any strategy making process is distinct from the 
process that creates it (Chakravarthy & Doz 1992) and these two 
areas are therefore considered separately in the next two sections. 
2.3 The Content and Properties of Marketing 
Strategies 
The direct outputs of marketing strategy making processes are 
marketing strategies. Whilst definitions of marketing strategy vary in 
detail amongst authors, the literature seems to hold a strong 
consensus about the content of marketing strategy. At its simplest, 
marketing strategy is agreed to have two necessary components: a 
definition of the target “market”, and a statement of the “product” or 
“value proposition” aimed at that target. These two components have 
been variously but consistently expressed in the literature. For 
instance Drucker, in his seminal book “Management: Tasks, 
Responsibilities, Practices” argues that: 
“One has to decide in which segment of the market, with what 
product, what services, what values, one should be the leader”  
(Drucker 1974, page 96). 
Echoing this, Mintzberg and Markides characterise marketing 
strategy as the answer to three questions: 
“Whom should I target as customers and who should I not? What 
should I offer these customers and what should I not? How can I do 
this in the most efficient way?” (Mintzberg 2000). 
This dual-component, target plus proposition, view of marketing 
strategy is sufficient to differentiate marketing strategy from 
strategies relating to other, non-marketing, functions such as 
research and development or manufacturing, and from other non-
strategy aspects of marketing management such as tactical actions. 
However, it provides little guidance as to the quality of a marketing 
strategy. Even a weak marketing strategy can be stated in terms that 
contain definitions of market and product. The literature concerning 
marketing strategy content is noticeably lacking in providing 
indications of desirable marketing strategy properties.  
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 Fortunately, the marketing strategy literature is complemented in 
this respect by the broader strategic management literature. Careful 
consideration suggests that there is much overlap between the two 
and that distinctions are largely a matter of semantics. In the 
strategic management literature, there is an observable consensus 
about the ideal properties of a good strategy. Different authors 
emphasise different aspects of strategy, but a consolidation of this 
work identifies nine different criteria by which to assess strategy and, 
therefore, predict effectiveness. These nine properties of an effective 
strategy and, by extension, marketing strategy are summarised in 
 (page 20). Table 1
This literature concerning strategy properties and content has a long 
history and is very broadly based. It fails to prove strong correlations 
between the properties of strategy and organisational results but this 
is not surprising, given the difficulty of this discussed earlier. On the 
other hand, the strength of the consensus amongst the leading 
authors, and the lack of serious disagreement, supports the view that 
this list of properties might form the basis for the measurement of 
marketing strategy strength or quality. Such a variable may also be a 
better (that is, more direct) measure of strategy making process 
effectiveness than measures of organisational effectiveness such as 
financial performance. Such a marketing strategy content variable 
would be independent of context and closely associated with 
marketing strategy making process, both of which are advantages 
over the use of financial or other higher organisational effectiveness 
measures. The literature concerning strategy content and properties 
therefore suggests a way to correct one of the two shortcomings in 
the marketing planning effectiveness literature (that is, the use of 
financial performance measures) identified in Section 2.2. The second 
shortcoming, that concerning the consideration of only planning, and 
not non-planning, strategy making processes is addressed in the next 
section. 
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 Table 1: The Nine Properties of an Effective Marketing Strategy 
Strategy property  References 
 
Market definition 
Effective strategies direct resource allocation across 
markets by making explicit those markets that will receive 
resources and those that will not. 
 
“domain” (Hofer & Schendel 1986)  
“identifiable” (Andrews 1987) 
“product market scope” (Ansoff 1965) 
“decision on concentration” (Drucker1974) 
“market positioning” (Greenley 1984) 
“market definition” (Piercy 1997) 
 
Definition of intended competitive advantage 
Effective strategies direct resource allocation across 
internal functions by making explicit the nature of intended 
competitive advantage. 
 
“competitive advantages” (Hofer & Schendel1986) 
“advantage” (Rumelt 1997) 
“competitive advantages” (Ansoff1965) 
“decision on concentration” (Drucker1974) 
“product positioning” (Greenley1984) 
“the value proposition” (Piercy1997) 
“market discipline” (Treacy & Wiersema 1995) 
 
Internal consistency and synergy 
Effective strategies enable efficiency by minimising internal 
conflicts between areas of activity and optimising synergy 
between areas of activity. 
 
“synergy” (Hofer & Schendel1986)  
“consistency” (Rumelt1997) 
“synergy parenting” (Gould & Campbell 2000) 
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 Strategy property  References 
 
Degree of uniqueness 
Effective strategies minimise the effects of competition by 
focusing resources and activity in a way that is significantly 
different from that of competitors. 
 
“unique” (Andrews1987) 
“rests on unique activities” (Porter 1996) 
“as different as legitimately possible” (Deephouse 
1999) 
 
Fit with the external environment 
Effective strategies leverage relative organisational 
strengths against relevant market opportunities and either 
negate or correct relative organisational weaknesses 
against likely market threats. 
 
“resource deployments” (Hofer & Schendel1986) 
 “fully exploits opportunities” (Andrews1987)  
“consonance” (Rumelt1997)     
“suitability” (Lynch 1997b) 
“synergy” (Ansoff1965) 
 
Consistency with the organisation’s objectives 
Effective strategies define a target market that is 
sufficiently large, and a value proposition that is 
sufficiently strong, relative to the competition, to win a 
market share that is in accordance with the organisation’s 
objectives.  
 
“appropriate to the values of the key managers” 
and “appropriate to the desired level of 
contribution to society” (Andrews1987) 
“consistency” and “attractiveness” Lynch 1997a) 
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 Strategy property  References 
 
Acceptability of risk level 
Effective strategies involve a level of risk that is within the 
organisation’s limits of acceptability. 
 
“level of risk feasible” (Andrews1987) 
“Acceptability” (Lynch1997a) 
 
Feasibility within the organisation’s resources 
Effective strategies are executable within the resources 
available to the organisation. 
 
“consistent with competencies and resources” 
(Andrews1987) 
“feasible” (Rumelt1997) 
“feasibility” (Lynch1997a) 
 
Provision of a level of guidance to tactical activity 
Effective strategies facilitate their own implementation by 
providing clear guidance as to what tactical activity is 
necessary for and appropriate to the execution of the 
strategy. 
 
“stimulate organisational activity” and “internally 
consistent” (Andrews1987) 
“growth vector” (Ansoff1965) 
“marketing mix” (Greenley1984) 
“the key relationships” (Piercy1997) 
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 2.4 The Nature of Strategy Making Processes  
Much of the strategy process literature, in both strategic marketing 
planning and the broader strategic management field, reflects the 
singular perspectives of individual researchers on strategy 
development. This single-perspective literature argues for the 
consideration of strategy development as, for instance, a rational, 
planned process or an incremental process. An admirable summary 
of this work is contained in the work of Bailey et al, as summarised 
in Table 2 (page 24). 
These single-perspective schools of thought are also considered by 
Mintzberg (Mintzberg, Ahlstrand, & Lampel 1998), who perceived 
strategy process as essentially a hybrid process and rationalised the 
single perspective views as not incorrect but simply one perspective 
on a very complex phenomenon. To quote Mintzberg: 
“Strategy formation is judgmental designing, intuitive visioning and 
emergent learning” (Mintzberg, Ahlstrand, & Lampel1998, page 372)  
Mintzberg’s work suggests that such single perspective studies 
clearly elucidate the contribution that each dimension, such as 
planning or incrementalism, makes to strategy development. However 
in doing so, they understate the complex nature of the multiple 
simultaneous processes that constitute strategy making in practice. 
Building on single perspective schools, other attempts to identify 
typologies or taxonomies of strategy development processes in 
practice reflect a multiple perspective view of strategy development 
processes. These show an evolution in sophistication based upon 
recognising and incorporating the various schools of thought. Hence 
there are structures suggesting three (Chaffee 1985), four 
(Shrivastava & Grant 1985, Hart 1991), five (Bourgeois & Brodwin 
1984, Hart 1992) and six (Bailey & Johnson 1994) modes of strategy 
development. Each of these pieces of work identifies a number of 
typologies of strategy development, each of which can be seen as 
hybrids, containing a blend of the single-perspective dimensions in 
varying ratios. Whilst differing in terminology and complexity, this 
stream of research presents a coherent theme of strategy making as a 
hybrid process. These attempts to identify a taxonomy of strategy 
development processes are summarised in Table 3 (page 25). 
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 Table 2: Key Dimensions of Strategy Development 
(Adapted from Bailey, Johnson, & Daniels 2000)  
Dominant dimension of strategy development Example references 
Command, strategy deriving mainly from a key 
individual or top management team. 
Bennis & Nanus 1985, Shrivastava & Grant1985, 
Westley & Mintzberg 1989, Kotter 1990 
Planning, strategy deriving mainly from a logical, 
sequential, deliberate set of procedures. 
Ansoff1965, Mintzberg 1978, Steiner 1969, Argenti 
1980, Rowe et al. 1989 
Incremental, strategy deriving mainly from “successive 
limited comparisons of alternative actions”. 
Lindblom 1959, Mintzberg, Raisinghani, & Theoret 
1976, Quinn 1980, Johnson 1988 
Political, strategy deriving mainly from negotiated 
settlements between powerful sub-units of the 
organisation. 
Cyert & March 1963, Pettigrew 1973, Hinings et al. 
1974, Hickson et al. 1986, Anderson 1982 
Cultural, strategy deriving mainly from the “taken for 
granted” frames of reference shared in the organisation. 
Weick 1985, Deal & Kennedy 1982, Schein 1984, 
Johnson 1987 
Enforced Choice, strategies deriving mainly from the 
external forces and constraints acting on the 
organisation. 
Aldrich 1979, DiMaggio P & Powell W 1983, Hannan 
& Freeman 1984 
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 Table 3: The Evolution of Attempts to Identify a Taxonomy of Strategy Development Processes 
Proposed taxonomy Reference 
Linear, adaptive, interpretative  Chaffee1985 
Managerial autocracy, systemic bureaucracy, adaptive 
planning, political expediency  
Shrivastava & Grant1985 
Rational, transactional, symbolic, generative Hart1991 
Command, rational, transactional, symbolic, 
generative 
Hart1992 
Commander, change, collaborative, cultural, crescive Bourgeois & Brodwin1984 
Planning, logical incremental, planning command, 
muddling through, externally dependent, political 
cultural command  
Bailey & Johnson1994 
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 This evolution of academic thought indicates that strategy making is 
complex, involving multiple processes. Further, it suggests that each 
organisation, although broadly complying with one or another 
typology of strategy making process, has a unique process consisting 
of a singular combination of the various influences that go to make 
up the overall process. Taken as a whole, this literature underlines 
the shortcomings of much the effectiveness literature considered in 
Section 2.2. That work, which measures complex hybrid strategy 
making in terms of only one dimension (degree of planning used) is 
unlikely to provide an explanation of marketing strategy process 
effectiveness. 
Whilst much of the strategy process literature relates to strategy 
making in general, a helpfully rationalised model of this hybrid 
strategy making process has been proposed for strategic marketing 
planning in particular (McDonald 1996). This model (see Figure 2, 
page 27) envisages marketing strategy development as a blend of 
rational planning, visionary and incremental processes, analogous to 
the manner in which the three primary colours mix: 
“It can be hypothesized that in a manner similar to that in which the 
three primary colours can, in various proportions, combine to form 
all other colours, so might all shades and hues of planning 
approaches be possible according to proportions of the components 
(logical rational models, pragmatic incremental models, subjective 
visionary models)” (McDonald1996) 
Hence the strategy process literature would appear to offer an answer 
to the second shortcoming of the strategic marketing planning 
effectiveness literature. Rather than characterise the nature of a 
marketing strategy making process in only one dimension, that of 
planning, a multiple dimension approach may be possible. 
Comparison of hybrid marketing strategy making process type to the 
properties of the resultant strategy might provide a better explanation 
of the effectiveness of marketing strategy making processes. However, 
such an explanation is still likely to be incomplete, incorporating as it 
does only the process and its outputs. A more valuable 
understanding is likely to include the context in which the process 
functions to create the strategy. That context, both organisational 
and external, is considered in Section 2.5.    
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 Figure 2: The Three Contributing Processes of Marketing Strategy Making (Adapted from McDonald 1996) 
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 2.5 Mediators of Marketing Strategy Making 
Process Effectiveness 
As with studies of marketing strategy process effectiveness, most of 
the work which investigates mediating effects focuses upon 
normative, rational planning processes. As described later, some of 
the strategic management literature considers non-rational 
processes, but even this literature is based upon comparison with 
established prescriptive planning processes. 
The published work in this area falls broadly into four categories:  
• the extent to which strategic marketing planning is used  
• the internal (organisational) mediators of marketing strategy 
making processes 
• the external (market) mediators of marketing strategy making 
processes 
• the theoretical basis by which the combined effects of internal 
and external mediators might be explained. 
The following sections attempt to critically assess the literature in 
each of those four areas.  
2.5.1 The Observed Application of Strategic Marketing 
Planning 
A significant sub-set of the literature concerning the effectiveness of 
strategic marketing planning is that work which examines the actual 
level of application of these formal, rational processes. 
Early studies of the degree to which companies adopted marketing as 
a strategic management process were encouraging. Hise, for 
examples, found that: 
“1. To a large extent, both large and medium manufacturing firms 
have adopted the marketing concept. 
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 2. The greatest degree of acceptance is found in the customer 
orientation of marketing programmes and in the organisational 
structure of the marketing department, particularly in the status 
provided the chief marketing executive. 
3. Large firms are more fully committed to the marketing concept 
than medium ones. Although the difference is only slight as to some 
factors, a distinct pattern does exist.” (Hise 1965) 
McNamara suggested that adoption was diffusing from consumer to 
industrial companies: 
“The empirical evidence in this study clearly supports the hypothesis 
that consumer goods companies have tended to adopt and implement 
the marketing concept to a greater degree than industrial goods 
companies. Thus the existing fundamental differences between 
industrial goods and consumer goods businesses may explain the lag 
in the development of the concept in capital goods companies.”  
(McNamara 1972) 
These studies suggested that marketing was becoming central to 
business planning, although there were clear variations across 
industry sectors, company sizes and functional areas. Even among 
these earlier studies, however, there were indications that, whilst 
many firms espoused the values of marketing, their actual behaviour 
contradicted this (see for example, Ames 1970 and Bell & Emory 
1971). The literature in this area gradually moved towards the 
conclusion that strategic marketing planning was widely claimed but 
much less practised (Martin 1979, see for example Zeithaml, 
Parasuraman, & Berry 1985, Martin 1987, Hooley, West, & Lynch 
1990, McDonald1996). The aggregate view amongst researchers 
considering this area is consistent with Martin’s view that: 
“Corporate planning as advocated by the theorists is not practised in 
any developed form by large corporations.” (Martin1979) 
Further work went on to describe the realities of marketing planning, 
as compared to the espoused activity.  This work described how 
rational marketing planning was subverted by less rational decision 
making processes (see for instance Walker & Ruekert 1987, Carson & 
Cromie 1989, Currens, Folkes, & Steckel 1992,  McColl-Kennedy & 
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 Keil 1990, Mowen & Gaeth 1992, Abratt & Bendixen 1993). The 
consensus amongst these authors as to the deviation of actual 
marketing planning from the prescribed and espoused is notable. 
Less clear is the mechanism underlying this deviation, although one 
piece of research does attempt to suggest a mechanism in 
behavioural terms: 
“In summary, we argue that the evaluation stage of the decision 
process consists of the marketing manager making judgements 
involving prediction and valuation. In any decision making situation 
such decisions may be systematically biased through the application 
of heuristics.” (Mowen & Gaeth1992) 
The related but more broadly based literature concerning strategic 
decision making reinforces the conclusion that rational planning, 
whatever its merits or otherwise as a prescription, is a “poor 
description of reality” (Eisenhardt & Zbaracki 1992, Rajagopalan, 
Rasheed, & Datta1993). This conclusion has been fully supported by 
exploratory fieldwork for this study (Smith 1999), which shows that 
marketing practitioners in healthcare companies are generally 
unqualified and make little use of the tools of strategic marketing 
planning. Contrasting this, some researchers (Glaister & Falshaw 
1999) have recently suggested that strategic marketing planning is a 
thriving and popular process in many companies: 
“We have found a reasonable and increasing level of the use of several 
older and simpler planning techniques, with apparently little use of 
older more sophisticated or new techniques. Despite this relatively 
unsophisticated approach to strategic planning, there is generally a 
very positive attitude expressed by respondents to its benefits for 
their organisations.” (Glaister & Falshaw1999) 
However, this work, based on self-administered postal surveys, is 
open to significant criticism as to its internal validity. 
Some of the work in this area is open to the criticism that it is overly 
concerned with semantics. It could easily be argued that a strategic 
marketing plan that does not use the terminology and structure of 
the accepted texts is still a strategic marketing plan. However, studies 
of the use of the most important tools in strategic marketing planning 
 
The Effectiveness of Marketing Strategy Making Processes in Medical Markets 
 (2003)  Page 30 
 reinforce the impression that it is often honoured in name and 
abused in practice.  
The first example of these lies in the use of segmentation, which is 
fundamental to strategic marketing planning. Strategically, 
segmentation is meant to be both customer driven and reflected in 
organisational structure. The reality (Jenkins & McDonald 1997) is 
that most companies rely on customer categorisation bolted on to the 
customer contact part of the company. The second example concerns 
SWOT analysis, the central technique for aligning the internal and 
external environments and, therefore, defining the key issues to be 
addressed. Examination of practice (Piercy & Giles 1989) reveals that, 
although widely quoted, the technique is usually reduced to a 
“subjective listing exercise” (Piercy1997), identifying none of the key 
issues that are the intended output of the technique. The abuse of 
these two fundamental tools suggests that the lack of commitment to 
prescriptive strategic marketing planning processes is a real 
phenomenon and not just a matter of semantics. 
Further evidence of the real, and not just semantic, lack of use of the 
tools of strategic marketing planning is provided by a body of 
literature reviewed by Greenley and Bayus, who conclude: 
“Except for a small number of sophisticated decision makers, few 
companies seem to use these techniques which are advocated in the 
prescriptive literature” (Greenley & Bayus 1994). 
Greenley and Bayus’ review of the observed use of marketing 
planning techniques is summarised in Table 4 (page 32) , taken from 
this work.  
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 Table 4: The Observed Use of Marketing Planning Techniques (from Greenley & Bayus1994) 
Study Country Focus Outline of results 
Buzzell & Wiersema 1981 USA Strategic Planning Limited use of formal planning methods 
McColl-Kennedy & Keil1990 Australia Marketing Planning Awareness and usage of methods - low 
Greenley 1985 UK Marketing Planning Only 24% use portfolio analysis; half use PLC analysis 
Haspeslagh P 1982 USA Strategic Planning Only 45% use portfolio analysis regularly 
Hopkins 1981 USA Marketing Planning A quarter use portfolio analysis, only 13% use PLC 
analysis 
Hooley, West, & Lynch 1981 UK Marketing Planning Half use SWOT analysis, one-third use PLC, only a few use 
portfolio, PIMS, perceptual mapping and conjoint analysis 
Reid & Hinckley 1989 UK/Hong 
Kong 
Strategic Planning Little awareness of PIMS, portfolio and PLC analysis 
Ross & Silverblatt 1987 USA Strategic Planning Half use portfolio analysis regularly, and a quarter use 
PIMS regularly 
Verhage & Waarts 1988 Netherlands Strategic Planning 15% use portfolio analysis, 27% use PLC with 62% using 
SWOT 
Wittink and Cattin 1989 USA Marketing Planning  Limited use of conjoint analysis by MR consultants 
Wood and LaForge 1986 USA Strategic Planning Portfolio analysis used by 67% of sample 
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 Critical assessment of this body of literature, therefore, concludes 
that the prescriptive rational model of strategic marketing planning is 
not an accurate description of what occurs in many organisations. 
Further, the literature supports the observation that planning is 
replaced or supplemented by non-rational processes. However, the 
literature concerning the actual use of rational planning does not 
explain this low level of use. This is an important gap, especially in 
the context of the proven contribution to effectiveness made by 
planning, as discussed in Section 2.2.  
The lack of use of planning is highly significant to this study of 
strategy making effectiveness, and reinforces the hybrid process 
picture suggested by the strategy process literature (see Figure 2, 
page 27). Taken alongside the effectiveness literature in Section 2.2, 
it suggests another idea. If rational processes contribute to 
effectiveness but are not used, this suggests that they are limited in 
their utility rather than their effectiveness. This is a critical 
distinction. Taken together, the literature suggests that strategic 
marketing planning can work, but that organisations find it too 
difficult to use in practice. This is entirely consistent with a related 
stream of work calling for improvements in the marketing strategy 
process (Bonoma 1985b, Hutt, Reingen, & Ronchetto 1988, Kohli & 
Jaworski 1990, Menon, Bharadwaj, & Howell 1996, Marketing 
Science Institute 1998, Varadarajan 1999). This stream of work calls 
in particular for the development of marketing strategy making 
processes so as to be more appropriate to the context in which they 
operate, pointing out that marketing is more “context dependent” 
than other disciplines and that its “law-like generalisations” only still 
apply if the context has not changed (Sheth & Sisodia 1999). This 
sentiment is also echoed in the work that considers the antecedents 
and consequences of marketing strategy making: 
“Because environmental turbulence demonstrated a significant 
association with learning and market performance and moderated the 
relationship between situational analysis and performance, further 
research should examine other moderators and controls, such as 
market characteristics, as well as other dimensions of the 
environment, such as environmental munificence and complexity.” 
(Menon et al. 1999) 
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 Hence that part of the literature which considers the application of 
marketing planning supports two assertions: that marketing planning 
is not extensively used despite its contribution to effectiveness; the 
reasons for this seem to lie in the difficulty of application in the 
context of internal and external conditions. This suggests that future 
research consider not simply the processes of marketing strategy 
making and the content of the resultant strategy, but also the 
internal and external contexts in which the process operates.  The 
extant literature concerning the relationship between marketing 
strategy making processes and their internal and external contexts is 
therefore considered in Sections 2.5.2 and 2.5.3 respectively. 
2.5.2 Internal Mediators of the Effectiveness of 
Marketing Strategy Making Processes 
Examples of and reasons for the failures of organisations to 
implement strategic marketing planning are well documented (Wong, 
Saunders, & Doyle 1989, McDonald 1989). Broadly, these have been 
categorised as either “cognitive” or “cultural”  barriers 
(McDonald1996). A more expansive classification of these barriers is 
given by one review work (McDonald & Wilson 1999). As well as 
culture, these authors cite management roles, management cognition 
(i.e. knowledge of marketing techniques), systems and procedures, 
resource allocation and data availability as moderators of rational 
planning use. Other researchers expand this work to include barriers 
across the organisation as a whole (Stampfl 1983, Ruekert & Walker 
1987). These last two researchers, in an attempt to develop a general 
framework from social systems theory and resource dependence 
models, conclude: 
“Much of the horizontal interaction among departments is informal. 
Consequently, it is outside the prescribed structures of the 
organisation chart, the substantive content of the marketing plan and 
the formal authority of the marketing and other functional managers. 
However, despite the informal nature of such interactions, their 
critical role in the successful implementation of marketing strategies 
is widely recognised.” (Ruekert & Walker1987) 
Researchers looking at how strategy making varies between 
organisations reinforce this conclusion. Investigations of strategic 
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 planning in SMEs, for instance, point to lack of resources and 
knowledge as barriers to rational planning (Lindsay & Rue 1980, 
Pearce II, Robbins, & Robinson1987, McKiernan & Morris 1994). 
Systems, procedures and structures are also linked to the degree to 
which strategic planning can be used. In some organisational 
structures “formal planning may cause internal contradictions and 
endanger and organisation’s viability”  (Bishop & Bresser 1983). 
Ruekert, using different terminology but covering the same point, 
went further in saying:  
“The degree to which an organisation can increase its market 
orientation is inextricably linked to the organisational structures, 
systems and processes created to sustain them” (Ruekert 1992).  
However, other authors building on this work suggest that these 
tangible reasons reflect fundamental differences in small firms’ beliefs 
about themselves (Liu 1995) and other cultural factors (Lancaster & 
Waddelow 1998).  
More recently, empirical work examining the interaction between  
management control systems and strategy making has demonstrated 
that lower and middle management control systems have an 
important influence on strategy making: 
“Findings suggest that belief systems influence managers initiation or 
“triggering” decisions, the use of administrative controls affects the 
location of strategic initiatives and may lead to the polarization of 
roles, and simultaneous emphasis on a range of key performance 
indicators can create a bias towards one set of measures and against 
another.” (Marginson 2002)  
Marginson’s work suggests a connection between beliefs and systems 
that is echoed by other researchers. Whilst tangible factors such as 
systems or structures are acknowledged to effect strategy making,  
authors building on this work suggest that these tangible reasons 
reflect “fundamental differences in small firms’ beliefs about 
themselves” (Liu1995) and other cultural factors (Lancaster & 
Waddelow1998).  
Consistent with this theme of strategy process hindrance by 
organisational cultural factors is that stream of work concerned with 
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 strategy making from the perspective of organisational discourse. 
This work, based on social systems theory, depicts the strategy 
process as “a technological and appropriative social practice” (Hendry 
2000) and strategic episodes as “the effective locus of strategic 
practice and the interaction between strategic and operating 
routines” (Hendry & Seidl 2003). Using the social discourse 
perspective, some researchers have suggested that failures of 
organisational strategy making can be attributed to cultural factors, 
in particular: 
“We argue the failure in organisational strategising can be 
understood as resulting from the interplay of certain elements of 
organisational discourse and specific kinds of political behaviour.” 
(Maitlis & Lawrence 2003)  
Thus two streams of literature suggest different ways in which 
internal factors mediate the performance of marketing strategy 
making processes. The earlier work suggests tangible factor such as 
systems and structures: the latter work suggests less tangible factors 
associated with organisational discourse. However, these views need 
not be mutually exclusive and can indeed be seen as two aspects of 
one phenomenon if they are both, as is discussed next, regarded as 
artefacts of organisational culture.   
The influence of organisational culture on marketing planning is the 
subject of a comprehensive stream of work by one author, Harris, 
and his colleagues. Investigating the interaction between culture and 
strategic marketing planning, he supports the idea that the cultural 
context is critical to the initiation and implementation of marketing 
planning (Harris 1996; Harris 1999b; Harris 1999a; Harris 1999c; 
Harris 2000; Harris & Ogbonna 1999b; Harris & Ogbonna 1999a; 
Harris & Ogbonna 2001). This prolific body of work considers many 
different aspects of the culture/marketing planning interaction but is 
perhaps best summarised in the conclusions concerning one 
company: 
“The study finds that six entrenched values appear to have impeded 
the initiation of planning within the company. These are: 
reactiveness, management activities and practice, 
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 compartmentalisation, short-term cost orientation, internal focus and 
stability.” (Harris1999b) 
Thus, it is argued,  various streams of work, each looking at internal 
mediators of planning performance,  converge on the underlying 
significance of culture. The connection between tangible barriers to 
planning and the firm’s beliefs, values and culture suggests that 
culture is a fundamental root cause for the ineffective implementation 
of strategic marketing planning. If tangible barriers, such as lack of 
resources and extant systems, are simply manifestations of 
organisational culture, then there is really only one internal barrier to 
strategic marketing planning, namely organisational culture. This 
tentative conclusion, based on the empirical observation of failures in 
strategic marketing planning, is reinforced by the organisational 
culture literature, as discussed in the following paragraph. 
The literature concerned with organisational culture consists of two 
very different philosophical traditions. The first, essentially positivist, 
stems from the earlier body of literature on organisational climate, 
(Tagiuri & Litwin 1968, Denison 1996) and is strongly quantitative in 
its approach (see for instance Denison 1984; Denison 1990, 
Denison1990, Kotter & Heskett 1992, Denison & Mishra 1995). The 
second, essentially phenomenological, has its origins in anthropology 
(Pettigrew 1979, Martin 1992) and claims sharp epistemological 
divisions with the quantitative approach. Despite this philosophical 
schism, there exists a core of agreement about the nature and 
significance of organisational culture. Both positivists and 
phenomenologists see culture as being “a means by which the 
organisation aligns itself to the external environment” (Smirchich 
1983) and “regulates internal transactions” (Wilkins & Ouchi 1983). 
Similarly, both schools see organisational culture as multi-layered (as 
explicated by Schein1984; Schein 1991).  
A second point of consensus exists between the positivist and 
phenomenological schools of organisational culture. This is that 
culture is, as Drucker puts it, “persistent and pervasive” (Drucker 
1993a). Studies of organisational culture support the belief that the 
phenomenon is very difficult to manage (see for instance Fitzgerald 
1988, Ogbonna 1993, Legge 1994). Legge holds the view that “the 
empirical evidence supports the difficulty of cultural change”  whilst 
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 Ogbonna (op cit) argues that much perceived cultural change is in 
fact “resigned behavioural compliance”, and not cultural change at 
all.  
Where cultural change is achieved, it is usually the result not of 
dramatic change, but of managing the “natural dynamic flux of 
culture” via the use of symbolism (Hatch 1999). Even if 
organisational culture were open to easy manipulation, this risks 
lessening any positive aspects of the extant organisational culture 
(Lorsch 1986, Drucker1993a), decreasing organisational efficiency by 
increasing the intangible costs of internal transactions (Wilkins & 
Ouchi1983) and other unintended consequences of cultural 
intervention (Harris & Ogbonna 2002). 
Synthesising the culture and planning mediators’ literature suggests 
both a cause and mechanism for marketing strategy process 
effectiveness. Strategic marketing planning, acting as an explicit 
process of alignment between the organisation and the market, 
necessarily interacts with organisational culture, an implicit process 
of alignment. Either positive or negative interaction might be 
expected. This interaction is seen via systems, structures and other 
cultural artefacts, but has its roots in the cultural assumptions that 
underlie those artefacts. Attempts to change organisational culture to 
support the marketing strategy making process are problematic. This 
suggests that the strategy process effectiveness might be linked to, 
and achieved by, adaptation of the process to the culture. 
This concept of fit between marketing strategy making process and 
culture is well supported by other researchers. Some researchers 
either implicitly or explicitly recognise planning and culture as two 
parallel and interacting processes for internal/external alignment (see 
for instance Deshpande & Webster 1989, Saker & Speed 1992, 
Cespedes & Piercy 1996) and call for “a culture driven contingency 
approach” (Saker & Speed1992). This is consistent with studies in the 
organisational behaviour literature, which also correlate fit between 
organisational culture and  planning process to organisational 
effectiveness: 
"All other things being equal, the greater the total degree of 
congruence between the various components (of an organisation) the 
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 more effective will be organisational behaviour at multiple levels" 
(Nadler & Tushman 1980) 
And  
“For better or worse a corporate culture has a major impact on a 
company’s ability to carry out objectives and plans, especially when 
the company is changing strategic direction.”  (Schwartz & Davis 
1981) 
Similarly, the idea of culturally congruent planning is consistent with 
theories that management skills are culturally specific (Hofstede 
1984) and that strategy formulation must recognise behavioural as 
well as mechanical aspects of organisational processes (Pearce II & 
Randolph 1980). Other researchers, from different perspectives, have 
pointed to the observed importance of organisational culture to 
strategy formation and implementation (Schwartz & Davis1981, 
Peters & Waterman 1982, Deal & Kennedy1982), without referring 
specifically to the alignment function of both the phenomenon and 
the management process. More specifically, the existence of 
appropriate organisational values as a pre-requisite to marketing 
effectiveness has been identified (Dunn, Norburn, & Birley 1994, 
Dobni & Luffman 2000), and is at the root of the marketing 
orientation literature. This last body of work suggests clear 
association between marketing orientation and performance (see for 
instance, Greenley 1995, Jaworski & Kohli 1996, Pitt, Caruana, & 
Berthon 1996, Jaworski & Kohli1996; Lukas & Ferrel 2000; Pitt, 
Caruana, & Berthon1996; Slater & Narver 2000; Wood, Bhuhian, & 
Keicker 2000).  The general tenor of this work is that market 
orientation is associated with superior performance. However, 
proponents of marketing orientation have addressed neither the 
methodological criticisms implied by the organisational effectiveness 
literature nor the potential difficulties and risks of cultural 
intervention (Harris & Ogbonna2002). Finally, the concept that 
marketing strategy process is affected by the level of market 
orientation is supported by the work showing that both rational and 
incremental processes operate in market oriented companies 
(Tadepalli & Avila 1999). 
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 Hence, a very broad body of literature supports the idea that the 
effectiveness of marketing strategy making processes is related to 
their fit with the organisational context, at the root of which is 
pervasive and persistent organisational culture. This concept is not 
new. It was one of the conclusions of one of the earliest PhDs in 
strategic marketing planning (McDonald1982). A mismatch between 
culture and process would suggest at least a partial explanation for 
the limited adoption of a known contributor to organisational 
success. However, this consideration of internal factors is not likely to 
be a complete explanation of marketing strategy making process 
effectiveness. To be so would imply that external market factors are of 
no importance. The importance of external market factors in 
mediating marketing strategy making processes is discussed in 
Section 2.5.3. 
2.5.3 External Mediators of the Effectiveness of 
Marketing Strategy Making Processes 
Both the marketing strategy literature and the broader strategic 
management literature point to the need to consider external 
mediators and their impact on the effectiveness of strategy making 
processes. From the many possible dimensions of the market 
environment, two broad themes emerge as being especially relevant.  
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Firstly, the impact of market turbulence. Planning is noted to have 
dysfunctional effects in uncertain and inefficient markets (Bishop & 
Bresser1983). Similarly, research in high-velocity environments 
indicates that “planning formality may be negatively associated with 
performance” (Eisenhardt 1989b, but see also Eisenhardt 1999, 
Eisenhardt & Sull 2001). Secondly, the significance of market 
complexity. This is supported by work showing the relationship 
between planning comprehensiveness and effectiveness (Fredrickson 
1984, Fredrickson & Mitchell 1984, Pelham1999). Many of the 
arguments concerning the impact of external context on marketing 
planning processes have been consolidated by Speed and his co-
workers (Speed 1994, Pulendran & Speed 1996) who contend that 
“external context affects decision character, decision process and 
decision outcome”. Supporting the importance of external factors 
from a slightly different perspective, is work correlating planning to 
effectiveness in hostile environments and for “mechanistic” cultures, 
 whilst advocating emergent processes in benign environments and 
“organic” structures (Slevin & Covin 1997). 
This stream of work suggests, therefore, that the effectiveness of 
strategy development processes is mediated by external market 
contingencies. Further, it suggests that market turbulence and 
market complexity are the two most significant external mediators of 
strategy process effectiveness. The consensus around this is 
indicated by the fact that this was the common ground in the debate 
between Mintzberg and Ansoff (Mintzberg 1990, Ansoff 1991). This 
stream of work also gives some indication about the nature of 
appropriate fit, or congruence, between strategy making processes 
and market conditions; complexity is seen to favour rational planning 
whilst turbulence is seen to favour less rational approaches. 
However, this is the limit of the conclusions that can be drawn from 
this work, which retains three important weaknesses.  
Firstly, the work relating strategy process to effectiveness remains 
wedded to the measurement of organisational, rather than strategy 
process, outputs, and thus fails to answer the criticisms associated 
with this approach, as discussed earlier. Secondly, the empirical 
work does not allow for simultaneous internal and external mediation 
of the strategy making process, hence failing to distinguish between 
the effects of internal and external mediators. Thirdly, the work 
comes, almost entirely, from the perspective of proving or refuting the 
effectiveness of rational planning. It therefore tends to characterise 
strategy making processes along a simple planning/non-planning 
dimension. As the earlier section concerning hybrid strategy 
processes suggests (Section 2.4), this is a simplistic approach to 
understanding actual marketing strategy making processes. The 
literature on external mediators of strategy making process 
effectiveness, therefore, suggests external mediation occurs and 
indicates dimensions of process/market fit, but leaves unanswered 
important questions about the effectiveness of different strategy 
process hybrids in differing market conditions. 
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 2.6 Theoretical Bases for Marketing Strategy 
Process Effectiveness 
The prior work summarised and criticised in Sections 2.1 to 2.5 
suggests that both internal cultural factors and external market 
factors impact upon the effectiveness of marketing strategy making 
processes. This clearly suggests that a contingency approach might 
be useful in understanding and explaining the effectiveness of 
marketing strategy making processes. 
Contingency theory is, of course, a very broad approach covering 
numerous bodies of literature. Thompson (Thompson 1967) usefully 
describes the origins of the contingency approach as being the 
intersection of various streams of organisation theory including 
general systems theory, open systems theory and behavioural theory. 
Theoretical and practical contributions are seen to be derived from 
contingency theory through: 
• Identifying important contingency variables that distinguish 
between contexts 
• Grouping similar contexts based on these contingency 
approaches and 
• Determining the most effective internal organisational designs 
or responses in each major group 
and the approach has been used “both implicitly and explicitly in 
much marketing research” (Zeithaml, Varadarajan, & Zeithaml 1988). 
Relevant to this work, contingency approaches are seen as 
particularly useful in strategy research because they improve on the 
generalisability of single in-depth case studies whilst providing 
greater depth than large sample, statistically based work which 
deemphasises contextual differences (Harrigan 1983, Hambrick 
1983). 
Much of the research on strategic marketing planning effectiveness 
and mediating variables, criticised above, adopts the contingency 
approach. However, this body of work appears to have two significant 
flaws when applied to understanding marketing strategy making 
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 processes in the context of the extant knowledge reviewed above. 
Firstly, the work concerns itself with contingent dimensions of either 
the internal or the external environment in which marketing operates. 
This is at variance with the empirical findings discussed above that 
suggest that both internal and external contingencies impact on the 
effectiveness of marketing strategy making processes. Secondly, it 
considers only one dimension of strategy process, that of its 
rationality or formality. This does not make sufficient allowance for 
the complexity of hybrid marketing strategy making processes. 
However, one stream of that work does suggest some ways in which 
the theory of marketing strategy process might be developed. One of 
the early seminal works in the contingency tradition of organisational 
theory developed from the concept of the organisation as an open 
system, with interaction between its different sub-components 
(Lawrence & Lorsch 1967). Based on this concept, the authors 
developed concepts of functional differentiation, specialisation and 
integration as bases of organisational effectiveness. Building on the 
work of Lawrence and Lorsch, other researchers from a sociological 
perspective developed the theory that management processes are 
most effective when they are congruent with both their micro-
environment and macro-environment: 
“Contingency theory postulates that the effectiveness of the 
organisation in coping with the demands of its environment is 
contingent upon the elements of the various sub-systems which 
comprise the organisation being designed in accordance with the 
demands of the environment (or, more accurately, the sub-
environments) with which they interact; this implies that that the 
elements of the different sub-systems must be congruent in terms of 
the characteristics along each of the basic dimensions by which they 
are defined. We call this the congruency hypothesis”. (Burrell & 
Morgan 1979, and additionally discussed in Morgan 1986) 
Interestingly, Burrell and Morgan reinforce the conclusions of the 
preceding parts of this literature review by making specific reference 
to market complexity and turbulence and to organisational culture as 
important dimensions of the external and internal environments. 
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 This idea of effectiveness being a function of congruency,  described 
by Burrell and Morgan as the congruency hypothesis, represents a 
significant step forward in thinking from earlier, simpler work. 
Significantly, by including all of the sub-environments in which the 
organisational sub-systems operate, the congruency hypotheses 
incorporate the simultaneous importance of both internal and external 
contingencies to the effectiveness of any management process. The 
congruency hypotheses, when applied specifically to the process of 
marketing strategy making, suggest a potential explanation for the 
effectiveness or otherwise of any strategy making process; namely, 
that the effectiveness of a marketing strategy making process is 
contingent upon its congruence with both the external market 
environment (macrocongruence) and the internal environment 
(microcongruence). Using both Burrell and Morgan’s own ideas and 
those derived from the literature review, market complexity, 
turbulence and organisational culture seem to converge as the factors 
important to achieving congruence and therefore effectiveness. 
In their favour, the congruency hypotheses allow for both the 
organisational and market contingencies suggested by the literature 
already discussed. Against this, they do not, specifically, suggest the 
dimensions of the internal or external environment of most 
importance to strategy making effectiveness. Nor do they specify the 
nature of success for that process. Nor does the literature contain 
empirical applications of Burrell and Morgan’s hypotheses. However, 
taken together with the preceding literature review, contingency 
theory, and specifically the congruency hypotheses of Burrell and 
Morgan, suggests a theoretical basis upon which an explanation of 
marketing strategy making effectiveness may be developed. This 
explanation and its concomitant research questions and hypotheses, 
will be developed in Section 3. 
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 3 Research Questions & Design 
3.1 Gaps in the Extant Literature 
The preceding literature review identifies both points of consensus 
and a number of gaps in the literature. Taken together, these suggest 
a number of useful areas to research:  
a) The literature concerning the use and effectiveness of 
marketing strategy making processes suggests that normative 
rational planning processes do contribute to organisational 
effectiveness but that they are not a good description of 
practice in many companies. This suggests the need to improve 
the utility of marketing strategy making process and raises the 
question of how to do this. 
b) The literature concerning mediating contingencies upon 
strategy making suggests that both external and internal 
contingencies are significant. The congruency hypotheses 
suggest that fit between the strategy process and both market 
conditions (macrocongruence) and internal, organisational 
culture conditions (microcongruence) are necessary for effective 
marketing strategy making and, hence, suggest a theoretical 
explanation of the effectiveness of marketing strategy making 
processes. However, this theory has not been specifically tested 
in the area of marketing strategy making process, suggesting a 
research question concerning the applicability of the 
congruency hypotheses in this particular area. 
c) The strategy process literature is coherent in its view that 
strategy making is a hybrid process. Some elements of that 
literature discuss the failing of rational processes and the 
possible merits of non-rational processes, but the state of 
knowledge in this area is incomplete and not specifically 
extended to marketing strategy making. This raises questions 
as to the relative effectiveness of different hybrids of marketing 
strategy making process. 
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 d) The strategy content literature is consistent in its view of what 
are the contents and properties of a strong marketing strategy. 
However, little work exists relating those properties to the 
process or environment from which they arise. This raises 
questions about how the nature of the resultant strategy is 
related to the strategy making process and the internal and 
external environments. 
e) The literature concerning internal contingences upon strategy 
making processes points to organisational culture as the 
underpinning factor and points out not only the incongruity 
between many cultures and rational planning, but also the 
difficulty of changing organisational culture. This literature has 
relatively little to say on the relationship between non-rational 
strategy making processes and culture. This gap suggests a 
useful area of investigation concerning the adaptation of 
strategy making processes to work with organisational culture. 
f) The literature concerning external contingencies suggests that 
market complexity and market turbulence are both important 
mediators of strategy process effectiveness. This literature 
suggests the adaptation of rational processes to fit market 
conditions. However, this work is not tested in the area of 
marketing strategy making and has not been controlled for the 
possibility of simultaneous internal mediating effects such as 
culture. Each of these gaps suggests possible areas for 
research. 
Hence the preceding literature review suggests a variety of areas in 
which our knowledge of the effectiveness of strategy making 
processes is incomplete and to which a useful contribution might be 
made. 
3.2 A Putative Model for the Effectiveness of 
Marketing Strategy Making Processes 
The preceding literature review suggests that there are a number of 
areas in the literature in which the consensus is strong enough to 
suggest accepted extant knowledge upon which a putative model 
might be built. These are: 
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 • That the content of a marketing strategy can be defined and 
that the properties of a strong marketing strategy can be 
differentiated from those of a weak marketing strategy. Hence 
the construct of context-independent marketing strategy 
quality can be developed from the literature. This is supported 
by the literature discussed in Section 2.2 (page 49). 
• That the process of marketing strategy making is hybrid with 
multiple dimensions and therefore more complex than 
suggested by simple measures of planning formality. Hence the 
construct of hybrid marketing strategy making process can be 
developed from the literature. This is supported by the 
literature discussed in Section 2.4 (page 23). 
• That the relationship between the nature of the hybrid 
marketing strategy making process employed and the 
properties of the resultant strategy are mediated by external 
market factors. Hence an externally mediated model of the 
relationship between strategy process and strategy properties is 
suggested by the literature. This is supported by the literature 
discussed in Section 2.5.3 (page 40). 
• That the relationship between the nature of the hybrid 
marketing strategy making process employed and the 
properties of the resultant strategy are mediated by internal, 
cultural factors. Hence an internally mediated model of the 
relationship between strategy process and strategy properties is 
suggested by the literature. This is supported by the literature 
discussed in Section 2.5.2 (page 34). 
• That the effectiveness of the organisational sub-system of 
marketing strategy making is dependent upon its congruency 
with both its internal and external sub-environments.  Hence a 
model of the relationship between strategy process and strategy 
properties that is both internally and externally mediated is 
suggested by the literature. This is supported by the literature 
discussed in Section 2.6 (page 42). 
• Taken together, these areas of extant knowledge can be taken 
to form a putative model to explain the relationship between 
the hybrid marketing strategy making process employed and 
the properties of the resultant marketing strategy. Such a 
model is illustrated in Figure 3 (page 49). 
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 Figure 3: Combined Congruency Model 
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As indicated above, the literature review suggests likely dimensions 
that might help to operationalise each of the constructs involved in 
this model. 
• Strategy quality can be seen as the degree or otherwise to 
which the marketing strategy has the properties of a strong 
strategy identified in the extant literature (see  on page 
20). Note, however that, although the literature would suggest 
that, whilst an accurate characterisation of strategy quality 
requires the assessment of all nine characteristics, it may be 
possible and more pragmatic to characterise strategy quality in 
terms of a smaller number of the more easily assessed 
characteristics. 
Table 1
• Strategy process can be characterised along three dimensions, 
namely the proportion of rational, command and incremental 
processes that go to make up the hybrid (see Figure 2 in 
Section 2.4, page 27). The literature may support other sets of 
dimensions of strategy process, but this trivariate 
measurement would seem to balance the practicality of single 
dimension measurement (such as planning formality, used in 
much early work) and the insight of multiple dimension 
measurement (such as Bailey and Johnson’s work). 
• External environment, whilst undoubtedly a complex construct 
can, in part, be characterised along the two dimensions most 
frequently cited as impacting on strategy process effectiveness, 
namely market complexity and market turbulence. The nature 
of each of these two constructs can be characterised by 
reference to the literature specifically concerning complexity 
and turbulence. Hence complexity can be characterised as the 
number of different entities involved in each of the components 
of the market environment (segments, competitors, channels, 
proposition complexity etc). Similarly, market turbulence can 
be characterised as the rate of change in these components 
and the macro-environment. 
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• Internal environment, whilst also a complex construct, can in 
part be characterised as those artefacts of organisational 
 culture most frequently cited as impacting on strategy process 
effectiveness, namely structures, systems and organisational 
habits. 
• Macrocongruence can be characterised as the degree to which 
the strategy making process manages the external 
environment, in particular, the degree to which the process 
manages market complexity or turbulence. Conversely, 
macroincongruence can be seen as the degree to which the 
strategy making process fails to manage market complexity or 
turbulence. 
• Microcongruence can be characterised as the degree to which 
the strategy making process is supported by the internal 
environment, in particular, the degree to which the process is 
supported by cultural artefacts such as systems and structures 
and other organisational habits. Conversely, 
microincongruence can be seen as the degree to which the 
strategy making process is hindered by those artefacts. 
This model then, imperfectly characterised as it is, formed the basis 
of the research questions and hypotheses to follow and was the basis 
for operationalising the research. 
3.3 Research Questions & Propositions 
Clearly, it is beyond the scope of a single PhD to answer fully all of 
the research issues raised in Section 3.1. Instead, this research 
focuses upon one primary research question, namely: 
Do the congruency hypotheses of Burrell and Morgan apply in 
the context of marketing strategy making processes?  
This question can be operationalised via the following proposition:   
Proposition P1: 
The degree to which an organisation’s marketing strategy exhibits the 
properties associated with a strong strategy is proportional to the 
extent to which microcongruence (between strategy process and 
internal environment) and macrocongruence (between strategy 
process and market environment) are exhibited. 
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 If supported by the research, this first proposition would provide 
support for the applicability of the congruency hypotheses in this 
context. However, it would not provide conclusive proof of the 
hypotheses in this context. As with all research, the issue of 
verification and falsification arises, as described by Popper 
(summarised in Easterby-Smith, Thorpe, & Lowe 1995). 
For purposes of theory testing, therefore, it is also useful to consider 
alternatives to this proposition that would, if supported, disprove or 
modify the congruency hypotheses. These would include: 
Proposition P2: 
The degree to which an organisation’s marketing strategy exhibits the 
properties associated with a strong strategy is unrelated to the degree 
to which either microcongruence (between strategy process and 
internal environment) or macrocongruence (between strategy process 
and market environment) is exhibited. 
This second proposition would be consistent with the views of those, 
such as prescriptive planners, who hold that one single type of 
strategy making process produces the strongest strategy. 
Another alternative proposition would hold: 
Proposition P3: 
The degree to which an organisation’s marketing strategy exhibits the 
properties associated with a strong strategy is related to the degree to 
which microcongruence (between strategy process and internal 
environment) is exhibited but not to the degree to which 
macrocongruence (between strategy process and market 
environment) is exhibited. 
This third proposition would be consistent with the views of those 
who see organisational culture as the dominant, perhaps overriding, 
factor in determining the effectiveness of marketing strategy making 
processes.  
Conversely, a fourth proposition by which to test the theory that both 
types of congruence are necessary would be: 
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 Proposition P4: 
The degree to which an organisation’s marketing strategy exhibits the 
properties associated with a strong strategy is related to the degree to 
which macrocongruence (between strategy process and market 
environment) is exhibited, but not the degree to which 
microcongruence (between strategy process and internal 
environment) is exhibited. 
This fourth hypothesis would be consistent with the views of those 
who see external market contingencies as the dominant, perhaps 
overriding, factor in determining the effectiveness of marketing 
strategy making processes. These propositions will therefore form the 
basis of the subsequent sections of this thesis and the philosophical 
and methodological considerations that follow in Section 4. 
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 4 Philosophical Considerations and 
Methodological Design 
The aim of this section is to explicate the factors considered in the 
design of this research and, whilst recognising any limitations in the 
methods used, justify the methodology as appropriate and valid. 
Accordingly, this section has four sub-divisions: philosophical 
considerations, methodological design considerations, method 
description and an assessment of the validity of the method. 
4.1 Philosophical Considerations 
Clearly, there are many possible methodological approaches to 
answering the research questions posed above (Section 3.3). Further, 
each will have its merits and none will be impossible to criticise. The 
choice of an appropriate methodology is therefore as problematic as it 
is important. However, the starting point for this choice lies in the 
selection of a philosophical paradigm upon which the work will been 
based. To quote Easton, “Consistency within a methodological 
paradigm is what is required” (Easton 2002). 
As befitting to the concept of a PhD as “learning how to do research”, 
a broad range of possible paradigms has been evaluated for their 
appropriateness to the particular context of this research. These 
alternative paradigms are summarised in Table 5 (page 56), adapted 
from the work of other researchers. The design of any piece of 
research has its origins in the philosophical position adopted, 
consciously or otherwise, by the researcher. In particular, the 
research design reflects the ontological and epistemological 
assumptions from which the research design begins. Blaikie (Blaikie 
1993) defines the two closely related concepts of ontology and 
epistemology in the following ways:  
Ontology: The claims or assumptions that a particular approach to 
social enquiry makes about the nature of social reality; claims about 
what exists, what it looks like, what units make it up and how these 
units interact with one another.  
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 Epistemology: The claims or assumptions made about the ways in 
which it is possible to gain knowledge of this reality, whatever it is 
understood to be; claims about what exists may be known.  
There is, of course, a huge range of ontological and epistemological 
positions available to any researcher. They are most frequently 
represented by a continuum between positivist/objectivist and the 
constructivist/subjectivist, as summarised in  (page 56), 
adapted from the work of other researchers (Guba & Lincoln 1994, 
Guba & Lincoln1994, Perry, Alizadeh, & Riege 1997). 
Table 5
Research into marketing and strategy making processes has adopted 
a variety of these paradigms. Much has come from a positivistic 
tradition, which Easterby-Smith attributes to the origins of the 
disciplines in economics and cognate fields (Easterby-Smith, Thorpe, 
& Lowe1995). More recently, however, the dominance of positivism 
has receded. For instance, Hirschman (Hirschman 1986) has argued 
that many of the constructs in marketing research are intangible and 
socially constructed (e.g. beliefs, behaviours, perceptions and values) 
and hence that positivistic approaches are less appropriate. This has 
been echoed by calls to make marketing research more interpretive in 
its approach (Gummesson 2000) 
In order to assess the appropriateness of each paradigm to this 
research, each has been evaluated against three factors that are 
characteristic of the research questions and theoretical models 
discussed in Section 3.3 (page 51). 
a) The work attempts to contribute to knowledge in a manner that 
is to some degree generalisable across business contexts. This 
suggests an approach towards the positivist end of the 
ontological spectrum.  
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 Table 5: Basic Belief Systems of Alternative Enquiry Paradigms 
Paradigm 
Item     Positivism Realism Critical theory Constructivism
Ontology naïve realism: 
reality is real and 
apprehensible 
critical realism: 
reality is “real” but only 
imperfectly and probabilistically 
apprehensible and so 
triangulation from many sources 
is required to try to know it 
 
historical realism: 
“virtual” reality shaped by 
social, economic, ethnic, 
political, cultural, and 
gender values, crystallised 
over time 
critical relativism: 
multiple local and 
specific “constructed” 
realities 
Epistemology objectivist: 
findings true 
modified objectivist: 
findings probably true 
subjectivist: 
value mediated findings 
subjectivist: 
created findings 
Methodology experiments/ 
surveys: 
verification of 
hypotheses: chiefly 
quantitative 
methods 
case studies /convergent 
interviewing: 
triangulation, interpretation of 
research issues by qualitative 
and quantitative methods such 
as structural equation modelling 
dialogic/dialectical: 
researcher is a 
“transformative intellectual” 
who changes the social world 
within which participants live  
hermeneutical / 
dialectical: 
researcher is a 
“passionate participant” 
within the world being 
investigated 
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 b) The work attempts to understand relationships between several 
complex and not fully characterised variables. This suggests an 
approach towards the relativist end of the ontological 
spectrum. 
c) The work utilises a priori theory, but one which is incompletely 
characterised in this context. This suggests a mixed ontology. 
Initial consideration of these three characteristics against each 
paradigm suggests that neither purely positivist nor purely relativist 
positions would be appropriate to this work. This is entirely 
consistent with the views of other researchers in similar fields. These 
workers have criticised much management research for failing to 
grasp the complexity of the real world (Pettigrew 1987), and stated 
that “both extremes are unnecessary and untenable” (Parkhe 1993). 
Some workers have suggested a rapprochement between the two 
ontological extremes and a blend of methodological approaches 
(Borch & Arthur 1995) whilst others have claimed the issue to be 
more fundamental than a choice of methodology, arguing for a realist 
ontological perspective that lies between positivism and critical theory 
(see, for instance, Tsoukas 1989, Perry, Reige, & Brown 1998). This 
latter work justifies a realism paradigm for research into networks on 
the grounds that it can simultaneously allow for both testing and 
development of theory and can delve into the complexities of the 
situation. However, many of the arguments the authors cite are 
equally applicable to this research into marketing strategy making. 
For instance, they refer to constructs that are difficult to measure 
and which are not the only considerations, making positivism 
inappropriate. The same authors (via Hunt 1991a) point to the 
existence of clearly tangible phenomena such as economic 
conditions. These considerations suggest that a realist approach 
would be an appropriate paradigm in the context of the three 
characteristics of this research into marketing strategy making. 
Robson (Robson 1993, partly after House 1991) suggests that a 
realist view of science has seven characteristics: 
1. There is no unquestionable foundation of science, no “facts” that 
are beyond dispute. Knowledge is a social and historical product. 
“Facts” are theory-laden.  
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 2. The task of science is to invent theories to explain the real world, 
and to test those theories by rational criteria. 
3. Explanation is concerned with how mechanisms produce events. 
The guiding metaphors are of structures and mechanisms in 
favour of realism (Easton2002). However, this work goes on to 
point out that realism is reality rather than phenomena and 
events.  
4. A law is a characteristic pattern of activity or tendency of a 
mechanism. Laws are statements about things that are “really” 
happening, the ongoing ways of acting of independently existing 
things, which may not be a single, homogeneous ontology (via 
reference to Hunt 1991b) and that critical realism is a better 
articulated form of the paradigm. Easton uses this better 
articulation, and the widespread use of critical realism expressed 
at the level of events. 
5. The real world is not only very complex but also stratified into 
different layers. Social reality incorporates individual, group and 
institutional and societal levels.  
6. The concept of causation is one in which entities act as a function 
of their basic structure.  
7. Explanation is showing how some event has occurred in a 
particular case. Events are to explained even when they cannot be 
predicted.  
Robson goes on, however, to point out that realism shares “a helpful 
compatibility” with another epistemology, pragmatism. Similarly, 
others have pointed to shared assumptions between pragmatism and 
realism (Tsang & Kwan 1999, Cherryholmes 1992,  Mir & Watson 
2000, Mir & Watson 2001, Kwan & Tsang 2001). 
Finally, closer consideration of critical realism is made possible by 
its characterisation under eight signposts (Sayer 1992). 
Pragmatism is an epistemological position that is rarely adopted in 
marketing research, explicitly at least. It therefore merits some 
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 explanation and background. It has its origins in the work of 
Peirce (Peirce 1966) who summarised the basic principal as: 
“Consider what effects, which might conceivably have practical 
bearings, we conceive the object of our concept to have. Then, our 
conception of these effects is the whole of our conception of the 
object.”  
The place of pragmatism in the objectivist/subjectivist spectrum is 
more clearly made by Hill (Hill 1987) who says:  
“The pragmatic philosophy holds that all reality has practical 
consequences and that, therefore, the best way to know and to 
understand reality is through the inductive analysis of practical 
consequences. According to this philosophy, the reality and truth 
of any proposition, belief or idea can be correctly specified and 
accurately evaluated only in terms of its practical consequences. 
Conversely, if any proposition, belief or idea has no practical 
consequences, therefore it is not real and, therefore, cannot be 
true.” 
The epistemology of the pragmatist position was developed by 
James (James W 1925). According this epistemology, truth: 
“possesses two essential characteristics or properties: verifiability 
and usefulness. Verifiability means that the proposition, belief or 
ideas can be corroborated or contradicted by reality. If the 
proposition, belief or idea agrees with reality, it can be regarded as 
true; but if it disagrees with reality it must be regarded as false. 
Agreement, in this context, means that the expected or anticipated 
practical consequences of a proposition, belief or idea are 
consistent with the real world, but this is a static concept of truth. 
A pragmatist would add a dynamic dimension to the concept of 
truth by asking the questions: If this proposition, belief or idea is 
true, how will it affect the actual experiences of everyday life? 
Would it help a person to integrate the various aspects of his 
experience into a coherent whole? Would it be useful to a person 
in solving everyday problems? A pragmatic truth must not only be 
verifiable, but also useful in at least two respects. Firstly, a 
pragmatically true concept must be useful in integrating 
experience, which tends to be random and disorganised, into a 
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 coherent whole. Second, a pragmatic truth must be useful to the 
people in applying their experience to the practical problems 
which plague their lives.”  
As seems to be the case with any epistemology, there is no 
agreement or consensus amongst researchers as to the 
appropriateness of pragmatism. However, its use has been well 
argued in contrast to scientific realism (Cherryholmes1992), in the 
field of educational research (Howe 1988), in ethics (Wicks & 
Freeman 1998), in action research in sociology (Oquist P 1987) 
and in social economics (Hill1987). The literature searches for this 
work found no discussion of the pragmatic epistemology in 
marketing strategy making, although a recent published debate 
(Durend 2003, Powell 2003) illustrates both the belief in and 
scepticism about pragmatism in the strategy field. 
After consideration of the various philosophical positions, 
therefore, and with the inevitable influence of the researcher’s own 
beliefs and the academic environment in which he works, a 
pragmatist position has been adopted for this research. The 
implications of this for research design are discussed in the 
following section.  
4.2 Methodological Design Considerations 
The starting point for the design of the methodology in this work was 
the chosen ontological position (pragmatist) and its epistemological 
corollaries. From the many possible methodological options, the 
realist perspective effectively excludes some strongly positivist 
quantitative methods (such as self-administered questionnaires) and 
some typically constructivist qualitative methods (for instance long 
term “immersion” in single cases). Whilst it is recognised that, even 
within the critical realist approach, it is possible to apply a number of 
qualitative methods, case study interviews and archival analysis were 
“shortlisted” as the two most appropriate, and possibly 
complementary, methods. However, archival analysis was relegated to 
a possible supportive evidence option in the light of previous 
researchers’ experience. In the field of strategy process research, 
archival measures had been found to have limited ability to measure 
internal processes (Bailey et al 2000) and in any case to be scarce 
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 and inconsistent (Schwenk 1985) and to fail in recording more recent 
events (Boyd et al 1993). It was therefore felt that structured case 
study interviews were most appropriate to this work. This conclusion 
is well supported in a review of the area (Perry, Reige, & Brown1998) 
which gives four justifications of the case study method, in addition 
to its consistency with realist ontological assumptions. Two of these 
justifications are especially relevant to this work. The first 
justification is the capacity of case study methodology to incorporate 
some degree of both theory testing and theory building. This work, 
whilst testing the congruency hypotheses of Burrell and Morgan, 
necessarily requires a degree of development of the constructs of 
strategy quality, macrocongruence and microcongruence. The second 
justification is the degree to which case study method can delve into 
the depth of the matter and explore generative processes. Perry et al 
quote Stake as saying “previously unknown relationships … can be 
expected to emerge from case studies leading to a rethinking of the 
phenomenon being studied” (Stake 1981, p47). In the field of strategy 
process research, using case studies to develop theory has also been 
specifically advocated (Eisenhardt 1989a). 
For these reasons then, a case study approach was selected as the 
most useful for this work. In particular, a mostly confirmatory (rather 
than exploratory) case study approach was deemed appropriate in 
order to make best use of the prior theory and literature base. This 
decision made, the chief consideration was, therefore, to ensure the 
rigour of the method employed. 
Numerous authors have contributed to the debate concerning the use 
of case studies in marketing and strategy research. Throughout this 
work, the theme emerges of the need for careful design to achieve 
validity and remove bias. Obviously, the two seminal works in this 
area (Yin 1989, Miles & Huberman 1994) form the foundation for the 
design of the methodology and both works have been used 
extensively to design both data gathering and data analysis.  
Usefully, however, the research design has also considered recent 
debate concerning the use of case studies to test theories (Johnston, 
Leach, & Liu 1999, Hillebrand, Kok, & Biemans 2001). This work 
builds on that of Yin and of Miles and Huberman, but also considers 
issues of independent verification (based on the work of 
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 Hirschman1986) and establishing causal linkages. Both of these 
additional issues are problematic for this work. The first is practically 
impossible in the scope of a PhD. The second is rather contrary to the 
critical realist ontology, which eschews causal linkages in favour of 
causal or generative powers. However, both have been considered, if 
not totally accommodated, in the design of this research. 
Independent verification, if not practically possible, might be 
facilitated for future researchers by making the method transparent 
and the results verifiable. Independent verification was also, to some 
degree, accommodated by the use of an independent but marketing 
qualified transcriber, allowing verbal emphasis to be objectively 
recorded. In place of causal linkages, the nature of generative 
mechanisms or causal powers has been considered in the design of 
the research. Additional contributing ideas for the design of the 
research were taken from other authors in the area of case study 
research generally and marketing in particular (Harrigan1983, 
Bonoma 1985a, McDonald 1985, Mostyn 1985, Orlikowski & Baroudi 
1991). 
The recommendations of Yin, Miles and Huberman and the other 
authors (especially Robson1993) mentioned above were used to 
create a set of guidelines for the design of the research. This was not 
straightforward, as the authors’ recommendations were each based 
on a particular ontological position and therefore sometimes 
conflicted with one another. Not withstanding that, it was felt useful 
to begin the research design with a set of broad specifications by 
which the method might be designed and evaluated. These 
specifications are presented below in  (page 63). Note, 
however, that they were intended to guide this particular research 
and are not proposed as generic tests for any case study. They are 
thought to be applicable however to this confirmatory, theory based 
study into marketing strategy making processes.   
Table 6
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 Table 6: Research Design Considerations 
Element of 
research design 
Consideration 
Unit of analysis  This must be appropriate to the study and, in 
particular, must select those individuals with a first-
hand knowledge of the phenomenon under 
investigation. 
Sampling  The sample must be appropriate to the study in terms 
of relevance to the phenomenon under investigation; 
however, the sample must be suitably varied, so as to 
allow some claim of generalisability (or theory 
modification) to be supported. 
Question areas The question areas should be derived from the 
informing theory and prior knowledge to allow 
appropriate testing and falsification.  
Question order and 
structure 
Questions should be ordered and structured from the 
general to the particular, allowing the gradual 
development of the respondents’ trust and 
explanation. 
Causal links or 
underlying 
mechanisms 
Questions should be structured to test not only the 
hypotheses but also to seek out causal powers within 
the phenomena.  
Questioning 
technique 
In order to optimise consistency across interviews, 
questioning should follow a structured document as 
much as possible. In order to reduce interviewer-
induced bias, questions should be open, and free 
from value-laden terms. 
Analytical coding The analytical coding should be consistent with the 
questionnaire structure and therefore with the 
informing theory from which the questionnaire was 
derived. 
Results collation 
and display 
The results should be collated and displayed within 
and across cases both to test hypotheses and suggest 
underlying mechanisms. 
Analysis 
transparency 
All elements of the research design should be 
constructed and explained in such a way as to make 
the method both transparent and reproducible by an 
independent researcher.  
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4.3 Method Description 
The method used in this work is described in detail below. It is 
intended that the description is sufficiently detailed to allow other 
researchers to critique, replicate and improve upon this work. 
However, it is appropriate to begin with an overview. 
The method involved the structured interviewing of three executives 
in each of fifteen medical companies (in fact, fifty interviews were 
eventually completed in eighteen companies). Each executive was 
selected as being closely involved in the organisation’s marketing 
strategy making process. The interviews were guided by a structured 
questionnaire, the structure and construction of which was based 
upon the theory suggested by the literature review. The 
independently transcribed interviews were then analysed, using a 
template matrix derived from the theory to be tested. Construct 
operationalisation was based on the reviewed literature, using 
deliberately ordered open and directed questions in order both to test 
and develop theory. Although the method was fixed, the interview 
structure was tested and modified before use and the analysis 
template was applied, revised and re-applied during the interviews. 
Unit of Analysis  
The unit of analysis was taken as the marketing strategy making 
team. Since this was not always well defined, and access to entire 
teams was problematic, respondent companies were asked to provide 
interviews with three managers “closely involved with the 
development of the strategic marketing plan”. Typically, this involved 
an SBU head (or Sales and Marketing Director), a marketing manager 
and a sales manager. This triumvirate was designated as the unit of 
analysis in order to avoid problems of single-respondent research 
(see, for instance, Bowman & Ambrosini 1997 and Van Bruggen, 
Lilien, & Kacker 2002). A copy of the recruitment correspondence is 
shown in Appendix 1 (page 244). 
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 Sampling 
Sampling was deliberate, although necessarily influenced to some 
degree by access constraints. The medical products industry was 
chosen as the arena for the research, primarily in order to facilitate a 
good understanding of the context and deep structure of the 
interviews. The researcher had more than twenty years experience in 
this sector and therefore was conversant with the industry jargon 
and market structure. This proved to be important at a number of 
levels. Firstly, it facilitated relatively fast and effective elucidation of 
the facts of the case, without spending a great deal of time on 
understanding jargon. Secondly, it encouraged the interviewees to 
speak openly to a “peer” who understood their situation. Finally, it 
meant that supplementary probing could be much more effective, 
when based on a knowledge of the underlying market structure and 
technology. Examples of this included being able to probe for 
complexity and turbulence associated with recent health service 
reforms, and clarifying real differences in propositions between 
competitors. A secondary but important reason for this sector choice 
was that it offered a large variety of case types, beneficial for proving 
or falsifying theory. Although all companies in the sector sold to the 
same or similar customer groups (i.e. healthcare providers such as 
hospitals), the sector was very fragmented. Each of the main sub-
sectors (pharmaceuticals, in-vitro-diagnostics, medical consumables 
and medical equipment) was largely distinct from the others, 
reducing the risk of homogeneity in either sector culture or market 
conditions. A tertiary reason for selecting this sector was the 
pragmatic one of access, in which the researcher’s industry 
knowledge and contacts were able to provide suitable samples. In 
total, fifty interviews were completed across eighteen companies. A 
descriptive, anonymous, list of participating companies is given in 
 (page 76). Table 7
Sources of Data 
Although it was originally hoped to collect both interview transcripts 
and documentary evidence, the latter source was not used. Primarily, 
this was because case companies strongly resisted providing it. 
Corporate confidentiality policies played some part in this reticence, 
but the primary reason was the sensitivity of the individual. It rapidly 
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 became clear that granting a verbal, even taped, interview was within 
the remit of all managers but that release of printed material 
inevitably required much higher authority. Sensitivity to this often 
threatened the entire case access and, interestingly, many 
respondents stated that the written plans were largely financial 
control documents and revealed little about the marketing strategy. 
Hence the transcribed interviews (and the accompanying notes) were 
the only sources of data used. This approach to data sources, whilst 
potentially foregoing some of the benefits of multiple sources, allowed 
extensive and usually very honest access to the case companies and 
the respondents. 
Questionnaire Design 
Questionnaire design began with Yin’s recommendation to make 
explicit the questions that spring from the research, before 
attempting to frame them into a structured form and word them 
deliberately. The questions derived from the literature gaps, extant 
knowledge and theory and hypotheses were:  
• What is the content of the marketing strategy of the 
organisation? 
• What is the marketing strategy making process of the 
organisation? 
• What external market conditions exist? 
• What internal cultural conditions exist? 
• What evidence of macrocongruence (or macroincongruence) is 
there? 
• What evidence of microcongruence (or microincongruence) is 
there? 
• Are there any other notable aspects of the case that have not 
been detected by the questioning? 
These questions were then developed into a semi-structured interview 
guide as shown in Appendix 2 (Page 245). The ordering and wording 
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 of the questions was developed using various texts on the subject (see 
for instance Foddy 1993) to ensure effective questioning. The 
development of the questionnaire then involved an initial script, 
based on the explicit questions, which was then pre-tested on 
numerous non-respondent marketing managers. This resulted in 
minor changes to question wording and order and more significant 
changes to the construct operationalisation. 
The operationalisation of the constructs (strategy quality, 
macrocongruence and microcongruence) was based on the literature 
reviewed above. During the course of pre-testing, the sub-elements of 
each construct were revised to aid understanding and clarity, but 
open questions created to capture all factors. During this testing 
phase, the following points emerged as necessary improvements to 
the questionnaire: 
1. What is the content of the marketing strategy of the organisation? 
It was found necessary to define marketing strategy explicitly as 
“that set of management decisions about which customers to 
focus upon and what to offer them”, and to differentiate that 
carefully from purely promotional strategy. Further, it was clear 
that the extensive list of properties that distinguish strong 
marketing strategies from weak was too long, and in some cases 
not understood by the respondents. Hence four key areas of 
strategy content were selected, based on their importance 
(assessed from their use in the literature) and the ability of the 
respondents to discuss them. These were: 
• Target market definition; the homogeneity in terms of benefits 
sought or buying behaviour. 
• Proposition differentiation; the degree to which propositions 
were aligned to the specific needs of the target market. 
• SWOT alignment; the degree to which the choice of targets and 
propositions was intended to leverage the relative strengths 
and minimise the relative weaknesses of the organisation. 
• Strategy uniqueness; the degree to which target markets and 
value propositions differed from those of the competition. 
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 • What is the strategy making process of the organisation? 
The initial drafts of the interview guide used the three element 
concept of strategy making process derived from McDonald 
(McDonald1996). This seemed to work well and the final version of 
the interview guide used the concepts of rational planning, 
visionary command and incremental processes to guide the 
questioning. 
2. What external market conditions exist and what evidence of 
macrocongruence (or macroincongruence) is there? 
In initial interviews, the breadth of this question was found to be 
useful in eliciting a response. However, it was found necessary to 
follow initial broad questions with subsequent more directed 
questions in order help respondents understand the questions. 
The directed questions were based on two aspects of market 
conditions, market complexity and market turbulence, suggested 
by the literature. 
3. What internal cultural conditions exist and what evidence of 
microcongruence (or microincongruence) is there? 
It was found that after the initial open questions, it was necessary 
to probe for microcongruence specifically in relation to rational 
planning, visionary command and incremental processes. This 
was found to be useful in eliciting informative responses regarding 
microcongruence (and microincongruence). 
4. Are there any other notable aspects of the case that have not been 
detected by the questioning? 
This “catch-all” question was used to capture anything not 
previously uncovered and was found to elicit useful responses. 
The testing phase suggested it was useful to remind the 
respondent of the scope of the interview and ask for additional 
comments on any part of it. 
The results of the testing phase were used to amend early drafts of 
the interview guide. The final version of the interview guide is 
shown in Appendix 2 (page 245). 
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 Transcription and Analysis of Interviews 
Each interview was tape recorded and transcribed. Transcription was 
carried out by a qualified, independent marketer in order to better 
capture specialist terms and avoid interpretation bias by the 
researcher during transcription. These transcripts formed the raw 
material for subsequent analysis. 
Note that, after initial experimentation, the decision was made not to 
use a specialised qualitative data analysis software package such as 
NUD:IST or NVIVO. This decision was informed by a consideration of 
the literature discussing this choice (see, for example, Robson1993, 
Fielding & Lee 1998, Cresswell 1998, Catterall & Maclaran 1998), but 
also on the basis of those initial experiments. It was felt that the 
advantages the software (e.g. convenience, consistency of approach) 
were outweighed by the disadvantages (e.g. inflexibility). Further, the 
researcher felt that the use of software would reduce the sensitivity of 
the analysis and place, to some extent, process before task. Hence a 
decision was made only to use Microsoft Word and its standard 
capabilities for adding comments and highlights. 
Data reduction was carried out in five stages to minimise loss of 
detail and texture of the interviews: 
a) Each interview transcript was heavily annotated using hand-
written notes made at the time of the interview, whilst 
re-listening to the original interview tape. At this stage, every 
individual question and answer was annotated to explain its 
purpose (for questions) and interpretation by the researcher 
(for answers). 
b) Each annotated interview was then coded using a coding 
matrix derived from the interview guide. Hence each 
meaningful statement was allocated an individual code and a 
mark. The mark corresponded to the degree to which the 
statement supported or refuted a statement in the analysis 
matrix. Typically, thirty to fifty statements were derived from 
each interview. This coding  analysis of each interview was 
recorded on an interviewee-specific coding form (See 
 (page 247). Qualitative comments were also included on this 
sheet. The development of the analysis template went through 
Appendix 
3
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 various stages as each case was analysed. Foremost among 
these were the sub-division (i.e. increasing numbers of 
categories) of case situations so that the data reduction did not 
lead to loss of insight. Similarly, the grading of the responses 
was developed from three points (agree, neutral, disagree) to 
five points (including moderated agreement and disagreement). 
c) For each respondent company, the coding forms for all 
interviewees were collated and summated.  The combined 
results for each case were recorded on a coding form identical 
to that used for individual interviewees. The values arising from 
this collation and summation were used as the basis for the 
assessments of variables in the research. Hence a semi-
quantitative assessment of strategy quality, strategy process, 
market turbulence and complexity, macrocongruence and 
microcongruence was made.  
d) A summary of all cases was recorded in a summary of results 
table, to enable easier cross-case comparison. The finalised 
version, showing the results deduced from the coding analysis, 
is shown in Table 11 (page 104). 
e) For each respondent company, a narrative description of the 
case was created using both the results of the matrix analysis 
and the qualitative comments made during the interview 
analysis. 
As the above description shows, data was gathered, reduced and 
analysed in a manner both to optimise insight and reduce bias. An 
assessment of the method validity is given in Section 4.4. 
4.4 Assessment of Method Validity  
The concept of method validity is problematic from any 
epistemological position. For instance, the critical realist assumption 
is that all methods are fallible (Robson 1993) and that “a realist 
conception of validity … sees the validity of an account as inherent, 
not in the procedures used to produce and validate it, but in its 
relationship to those things that it is intended to be an account of” 
(Maxwell & Delaney 1999, quoted in Robson 1993). The pragmatist 
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 position, as discussed earlier (Section 4.1) adopts a similar position. 
Notwithstanding the assumption of ultimate fallibility, Robson 
summarises the work of various authors to provide a list of 
assessment criteria against which the potential trustworthiness of a 
piece of research might be assessed. This comprehensive framework 
was used to assess the reliability, construct validity, internal validity 
and external validity of this research, as discussed below. 
Reliability 
The four main sources of lack of reliability are error and bias in both 
the participant and the observer. This study allows for these as 
follows:  
• Participant error: In this study, the most likely sources of 
participant error were misunderstanding of the question or 
being ignorant of the answer. To avoid the former, the interview 
question wording was repeatedly tested on non-participants 
with similar backgrounds to the participants. As a result, 
misleading terms were changed and additional explanation 
added where necessary. To avoid the latter, the case study 
companies were carefully briefed regarding the type of 
interviewee required, defined as “three members of the 
marketing strategy making team closely involved with the 
strategy making process, typically a Marketing Director, 
Marketing Manager and Sales Manager”. At the start of the 
interview, interviewee role and involvement in the marketing 
strategy making process were confirmed. Finally, the interview 
questions were layered so that simple, possibly erroneous, 
initial answers were tested subsequently by supplementary 
questions. 
• Participant bias: In this study, the mostly likely sources of 
participant bias were from participant perceptions about the 
“correct” answer to give. To avoid this, the nature of the 
research was not explained to the participants prior to the 
interview, other than that it was “examining the effectiveness of 
marketing strategy making processes in medical markets”. 
Interestingly, there was relatively little espousal of prescriptive 
methods, arguably the most likely sign of participant bias. 
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 Additionally, the interview guide was developed to avoid value-
laden terms or indications of interviewer position. Finally, the 
interview questions were layered so that simple, possibly 
biased, initial answers were subsequently tested by 
supplementary questions. 
• Observer error: In this study, the most likely source of observer 
error was misunderstanding of terminology or other specialised 
factors in the medical sector, for example, the important 
distinction between primary and secondary care or between the 
different components of the regulatory process. As already 
discussed, the choice of medical sector was made to reduce 
this error. Further, supplementary questions were used to 
clarify any terms that were not clear. Finally, the interview 
technique was developed to include summary questions 
specifically designed to check the interviewer’s understanding 
with the respondent. 
• Observer bias: In this study, the mostly likely sources of 
observer bias were existing views of the interviewer influencing 
questioning, transcription or analysis. To avoid this, the 
sample deliberately avoided market sub-sectors in which the 
observer had direct experience or an interest. Additionally, the 
transcription was carried out by an independent, qualified 
marketer and the observer’s analysis tested, at a gross level, 
against the interpretations of that marketer. Finally, multiple 
levels of questions were used to counter the possibility of bias. 
Construct Validity 
Ensuring construct validity in case study research is naturally 
problematic. In this work, three constructs were employed (strategy 
quality, macrocongruence and microcongruence) that might have 
been expected to be unfamiliar to participants and therefore at risk of 
misunderstanding and invalid assessment. Partly, this risk was offset 
by the use of multiple informants. However, the most important 
technique used to ensure construct validity was to embed the 
supplementary questions firmly in the large body of existing 
knowledge concerning the three constructs. Techniques subsequent 
to the research, such as key informant feedback, were considered but 
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 abandoned after poor results, arising from access problems, in pre-
pilot work. 
Internal Validity 
The issue of internal validity or causality is, of course, closely related 
to the epistemological perspective. From the pragmatic perspective of 
this work, internal validity refers to the operation of underlying 
mechanisms by which macrocongruence and microcongruence 
influence strategy quality. In particular, internal validity refers to the 
plausibility of those mechanisms compared to any other possible 
influences on strategy quality. To ensure internal validity in this 
work, the analysis looked for both the hypothesised underlying 
mechanisms of macrocongruence and microcongruence (for instance, 
process failing to cope with market complexity, market turbulence or 
cultural factors) whilst adding open questions to uncover other 
possible factors. Non-hypothesised influences on strategy quality 
were considered in the context of the work of other researchers (for 
instance, Cook & Campbell 1979) who have catalogued possible 
threats to internal validity. In addition, the sample size and diversity 
were seen as defences against these threats to internal validity. 
External Validity 
The external validity or generalisability of this study was to some 
degree compromised by the deliberate sampling and analysis 
methods used to optimise internal validity. However, the study was 
considered against the four commonly recognised threats to external 
validity (LeCompte & Goetz 1982). In this context, neither the 
selection, setting, history nor construct effects would suggest that the 
results would not be generalisable beyond the sample, or to similar 
organisational settings. 
In short, then, the research design was based upon the 
recommendations of the various respected texts in the field of 
qualitative case study research and augmented with arguments from 
the literature more specific to this work (i.e. a contingency approach 
to theory testing in strategy process from a pragmatist perspective). 
The methods developed from those recommendations were then 
examined for reliability, and for construct, internal and external 
validity using the concepts developed by other researchers. 
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 The preceding explanation of the methods employed recognises the 
views of those (Shipman 1988) who ask: “Is there sufficient detail on 
the way the evidence is produced for the credibility of the research to 
be assessed?” It is intended that this section meets that criterion. 
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 5 Presentation of Results 
This section describes the findings of this work. It contains an 
overview of the respondent companies and individuals, the findings 
in terms of each variable examined, and the findings concerning the 
observed relationships between those variables. Finally, it gives a 
more detailed description of the cases both in the form of a cross-
comparison summary, Table 11 (page 104) and short qualitative 
descriptions of each case in Section 5.5 (page 122). 
This section concludes with a discussion of the structures emergent 
from this work. Note, however, that this section does not attempt to 
discuss the meaning of the findings; that is contained in Section 6 
(page 202). 
5.1 An Overview of the Respondent Companies 
and Individuals 
 
In total, eighteen companies agreed to take part in the research. Of 
these, two were able to supply only one respondent and two supplied 
two respondents. With four respondents from one company and three 
from the remaining fourteen, the total sample was fifty respondents. 
An overview of the responding companies and cases is given in 
 (page 76). 
Table 
7
As the table shows, the sample met the selection criteria of 
companies whose customers were clinicians or related professionals, 
whilst being varied in product type, industry sub-sector and size. The 
individual respondents all met the criteria of being closely involved in 
the marketing strategy making process of their organisation. In both 
respects, therefore, the sample was appropriate to the study of 
marketing strategy making in medical markets. 
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 Table 7: Respondent Overview 
Cas
e  
Company description Respondents 
A The UK subsidiary of a global in-vitro diagnostics company, 
specialising in one type of technology 
Marketing & Sales Director, Sales Manager, Marketing 
Manager 
B The UK Headquarters of a global medical device company, part of a 
larger conglomerate 
Commercial Director, Sales Manager, Marketing 
Manager 
C The UK Headquarters of a mostly UK medical disposables company Managing Director, Sales Director, Marketing Director 
D The UK Sales and Marketing subsidiary of a global pharmaceutical 
company, specialising in one therapeutic area 
General Manager, Sales Director, Marketing Director 
E The Global Headquarters of a first rank pharmaceutical company, 
with many therapeutic areas 
Sales Director, Marketing Director, Business 
Development Director 
F The UK Sales and Marketing subsidiary of a first rank 
pharmaceutical company, with many therapeutic areas 
General Manager, Sales Director, Director of Strategic 
Planning, Financial Controller 
G The UK Headquarters of a first rank pharmaceutical company, with 
many therapeutic areas 
Business Information Director 
H The UK Headquarters of a small medical equipment company, part 
of a larger multinational group with global interests 
Marketing Director, International Sales Manager, UK 
Sales and Service Manager. 
I The UK Headquarters of a medium sized medical equipment 
company, part of a larger multinational group with global interests 
Managing Director, Marketing Director, Sales Director 
J The UK Sales and Marketing subsidiary of a first rank 
pharmaceutical company, with many therapeutic areas 
General Manager of Hospital Division, Group Product 
Manager 
K The UK Headquarters of a first rank medical disposables company 
with global interests 
Marketing Manager, Internal Product Manager, UK 
Product Manager 
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 Cas
e  
Company description Respondents 
L The UK Sales and Marketing subsidiary of a first rank medical 
devices company 
General Manager, Sales Manager, Marketing Manager 
M The UK Sales and Marketing subsidiary of a second tier global 
pharmaceutical company 
General Manager, Marketing Manager, Sales Manager 
N The UK Sales and Marketing subsidiary of a first rank medical 
devices and pharmaceutical company 
General Manager, Business Development Manager, 
Marketing Manager 
O The UK Headquarters of a small medical equipment company Managing Director, Sales and Marketing Director, 
Marketing Manager 
P The UK Sales and Marketing subsidiary of a first rank 
pharmaceutical company, with many therapeutic areas 
Marketing Director 
Q The UK Sales and Marketing subsidiary of a second tier 
pharmaceutical company, with many therapeutic areas 
Marketing Director, Sales Manager, Medical Director 
R The UK Sales and Marketing subsidiary of a second rank medical 
devices and pharmaceutical company 
Sales and Marketing Director, Sales Manager, Medical 
Affairs Manager 
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 5.2 Findings for Each Variable 
This section presents the results for the variables under 
consideration by way of a preamble to presenting their inter-
relationships in Section 5.3 (page 100). 
5.2.1 Strategy Quality 
A reasonably clear division was found between those cases that met 
the conditions of a strong strategy and those that did not. 
Comparison of the cases revealed distinct differences between 
companies in the four areas of strategy quality used for evaluation, 
with only two companies having moderate strategies.  The findings for 
strategy properties are summarised in  (page 80), a 
comparison of strategy properties. 
Table 8
Note that these characteristics are broadly in line with the properties 
suggested in the strategy content literature, but with some important 
degrees of difference. Hence, the findings of this work support but 
add interesting depth to the generalised assertions of that literature. 
These results suggest that the general principals of strategy quality 
suggested by the literature are supported by this work but that they 
are moderated by the constraints of the industry setting. That is: 
• Target market definition is rarely seen to consist of multiple 
homogeneous, distinct motivator-based segments as found in, 
for instance, consumer markets. Instead, strong strategies bear 
an initial resemblance to weaker strategies in their target 
definition. However, closer examination reveals tighter target 
definition both in product terms (for instance, sub-sets of 
product categories) and, importantly, by motivators. Strong 
strategies were notable for their use of “intangible” behavioural 
and attitudinal factors in defining their target markets. Weaker 
strategies were notable for failing to target at any level of detail 
below product or job-title category. The literature implies that 
such targets are neither homogeneous nor distinct, and the 
respondents’ own comments supported heterogeneity amongst 
product-defined target groups. Hence, the target market 
definition of even the strongest marketing strategies observed 
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 did not fully match the idealised descriptions in that multiple, 
distinct and homogenous segments were not seen. Instead, 
strong strategies were characterised by initial product market 
definitions then augmented by motivator based segmentation, 
usually resulting in only one or two target segments. This 
limited degree of market segmentation would seem to be 
associated with the limited options for organisational flexibility 
or agility open to the companies. These limitations seemed, in 
turn, associated with regulatory constraints and long 
development lead times. There remained, however, a clear 
difference in target market definition between strong and weak 
strategies. The latter used similar product market definitions 
but failed to overlay motivator based segmentation on top of 
that. Hence, despite not meeting the idealised target market 
definition of the literature, the target market definition property 
of marketing strategy strength would still appear to be a useful 
differentiator of strong and weak strategies.  
• Value proposition differentiation is not seen to be as distinct as 
the literature would ideally have it. In particular, the core 
products (for instance, therapeutic agent, device or instrument) 
offered to different target groups were not seen to be highly 
differentiated. This would appear to be a result of product 
technical complexity and the associated “fixed” nature of the 
product. Such inflexibility is often amplified by  regulatory 
constraints adding to both the costs and time of product 
variation. Similarly, pricing flexibility was limited by 
contractual and legal controls. In many market sectors, pricing 
of medical products is regulated by the government or else 
limited by the consolidated nature of the customer base. 
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 Table 8: A Comparison of Strategy Properties 
Strategy properties 
examined, in terms of 
idealised description from 
the literature 
Characteristics of strong 
strategies found in this study 
Characteristics of 
moderate strategies 
found in this study 
Characteristics of 
weak strategies 
found in this study 
The target market(s) are 
defined as groups of 
customers that are 
broadly homogeneous in 
their needs. 
Target markets are defined by a 
tight product definition, but with 
additional focussing according to 
behaviour and attitudes.  
Target markets are 
defined by product, but 
systematic targeting of 
resource is according to 
sales potential.  
Target markets are 
defined by a 
product definition 
and no sub-
targeting is visible 
within that. 
The value proposition(s) 
are tailored to the 
specific needs of the 
target(s), across the 
breadth of the marketing 
mix.  
A core product proposition is 
clearly “tiered” by levels of 
augmented product such as 
service and support. 
Alternatively, target customers 
are allowed to “tailor” 
propositions individually. There 
is clear evidence of alliances or 
other means of enabling the 
augmented product.  
There is crude 
“rationing” of a fairly 
standard service and 
support offer according 
to potential, usually 
carried out at sales 
team level. 
The proposition is 
largely standard 
across the customer 
base, with minimal 
tailoring of price at 
sales team level.  
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 Strategy properties 
examined, in terms of 
idealised description from 
the literature 
Characteristics of strong 
strategies found in this study 
Characteristics of 
moderate strategies 
found in this study 
Characteristics of 
weak strategies 
found in this study 
The choice of target(s) 
and proposition(s) allows 
leverage of organisational 
strengths and 
minimisation of 
organisational 
weaknesses.  
There is tightly defined focus, 
based on a combination of 
tangible and “cultural” 
strengths, combined with de 
facto avoidance of less attractive 
segments.  
“Accidental” alignment 
is caused by the de facto 
selection by customers 
in the context of 
differentiated 
competitors.  
There is poor 
appreciation of 
relative strengths 
and weaknesses, 
with alignment only 
at sales level.  
The choice of target(s) 
and proposition(s) is 
significantly different 
from that of the 
competition. 
Initial targeting is similar to that 
of the competition, but with sub-
targeting on different 
motivational criteria. There are 
similar core product 
propositions but with distinctly 
different augmented products.  
Very similar explicit 
targeting and 
propositions to the 
competition is improved 
by targeting and 
proposition refinement, 
within narrow limits, at 
sales team level.  
Target description is 
identical to that of 
the competition and 
there is little 
proposition 
differentiation; often 
driven by “market 
follower” or 
benchmarking 
activity. 
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 Instead of the segment-specific propositions suggested by the 
literature, strong strategies differentiated themselves in the 
nature of their augmented product with components of service 
and support. The best examples allowed for customer-specific 
proposition tailoring of an extensive augmented product 
including logistics management, financial management tools 
and training/educational packages. Examples of this included 
the uses of strategic alliances with third parties to enable such 
augmented propositions. At the other extreme, whilst weaker 
strategies included elements of service and support, they were 
only marginally differentiated between customers or target 
groups. Most frequently, this limited differentiation of the 
augmented product involved effectively rationing support on 
the grounds of business potential. This marked difference 
between proposition tailoring and service level rationing 
provided a useful distinction between strong and weak 
strategies. Hence, although the level of proposition variation 
between target segments was not as comprehensive as that 
suggested by the literature, value proposition differentiation 
between segments was seen and represented a useful point of 
distinction between strong and weak strategies.  
• Alignment of relative strengths and weaknesses to external 
opportunities and threats was apparent in this work but was 
again less clear cut than suggested by the literature. It would 
appear that the capacity for SWOT alignment is limited by the 
tightly product-defined nature of much of the targeting.  That 
is, the use of product-based criteria as the initial targeting 
basis precluded, to some extent, the alignment strengths to 
opportunities and weaknesses to threats suggested in the 
literature. Hence, SWOT alignment was less active, more 
passive, than expected, but still clearly visible. The best 
examples of SWOT alignment combined active focus and 
passive de-focussing. By this is meant that targets were 
selected and propositions defined to make best use of both 
tangible advantages (e.g. product features) and intangible, often 
culturally based, strengths (e.g. management skills, knowledge 
of sector economics). By contrast, the minimising of relative 
weaknesses was not done by actively withdrawing from certain 
customer groupings, but by the creation of a value proposition 
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 which effectively alienated those groups. For example, the 
proposition comprised a combination of price, performance and 
service that was seen by cost-sensitive segments as 
unattractive. In cases of weaker strategy, the notable feature 
was ignorance of relative weaknesses (e.g. economies of scale, 
sales team size, support infrastructure) and a distorting 
subjectivity concerning the strength of product design or, 
commonly, customer relationships. This combination of 
ignorance and subjectiveness distinguished strategies with 
poor SWOT alignment. Hence differences between SWOT 
alignment are a useful differentiator between strong and weak 
strategies.  
• Strategy uniqueness was also limited by practical constraints 
but remained a tangible difference between stronger and 
weaker strategies. The literature suggests that strong strategies 
both target different customers and offer different propositions 
when compared to competitors. In practice, the degree to which 
this happens is limited by the size of the market and its 
product-defined constraints. At first it appeared that even 
strong strategies defined the same targets as their competitors’ 
strategies. However, closer examination revealed a sub-
targeting, usually based on intangible motivators, that was 
distinctly different from competitors’ strategies. In terms of the 
value proposition, the uniqueness of strong strategies was 
clearer. The value proposition was usually distinct and this 
differentiation was achieved, rarely, in the core product and, 
more usually, in the augmented service and support element. 
Hence the level of strategy uniqueness was confirmed as a 
valuable measure of strategy quality. 
Hence this part of the data analysis provided the study with two 
useful contributions. Firstly, it provided clearly differentiated 
examples of strong, weak and moderate strategies. Secondly, it 
provided contextual depth to the literature concerning the ideal 
properties of strong strategies. 
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 5.2.2 Strategy Process 
Using McDonald’s model of a three-component hybrid marketing 
strategy making process (see Section 2.4, page 23 and Figure 2, page 
27), this work sought to understand the strategy process adopted in 
each case. The results imply that the model is a useful description of 
practice and an effective device for elucidating discussion on the 
subject. 
An uneven distribution of hybrid marketing strategy making process 
types was uncovered within the sample, but a sufficient variety of 
types was studied from which to draw conclusions. In order of 
frequency of occurrence within this sample, the following hybrid 
types were noted. 
• Command and Incrementalism hybrids 
A majority of the cases exhibited hybrid marketing strategy 
making processes that consisted of a core command process 
supplemented by an incremental process, with little or no 
indication of formal planning processes beyond budgeting 
procedures. Typically, this process involved a command 
process originated by a global headquarters in which the 
market was defined, the bulk of the proposition established 
and both objectives and resource limits set. In such cases, the 
marketing strategy was often a consequence of the research 
and development process outputs, although some limited 
feedback was always present. In some cases, this command 
process included, or was claimed to include, a rational 
planning element executed at headquarters. However, little 
evidence of strategic marketing planning being transmitted to 
subsidiaries was seen in these cases. The subsidiaries’ part in 
marketing strategy making was an incremental process in 
which the political, experimental and cultural strands of 
incrementalism were most commonly observed. Formal test 
marketing was not observed and explicit feedback and 
monitoring processes were rare. However, some testing of 
promotional efforts was noted. 
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 • Command and Planning hybrids 
A small but significant minority of cases exhibited marketing 
strategy making processes that consisted of a core command 
process supplemented by a rational planning process, with a 
significant degree of incrementalism as a minor strand. These 
appeared to be examples of command and incremental 
processes into which rational planning had been introduced to 
supplant the incremental process. As with command and 
incremental processes, such processes typically involved a 
command process originated by a global headquarters by which 
the market was defined, the bulk of the proposition established 
and both objectives and resource limits set. Noticeably, 
however, interaction between central and local or subsidiary 
processes was more obvious than in the command and 
incremental hybrid. In these cases, there was evidence that the 
command process was also based on some degree of rational 
planning. Such processes were characterised by use of 
planning techniques (e.g. portfolio management), and clear 
connectivity between central and local objectives. Incremental 
processes remained of the cultural and political type with little 
mention of market testing or other deliberate incrementalism. 
• Command, Planning and Incrementalism hybrids 
A small sub-set of companies exhibited a fairly even hybrid of 
all three processes. This was similar to the command and 
planning hybrid, although with a noticeably stronger element of 
incrementalism. In these cases, the command parameters (as 
in the above processes) were taken as the framework for 
rational planning and incrementalism, sometimes in the form 
of special project teams, used to manage cases of localised 
turbulence (e.g. changes in the competitive environment). As 
before, political and cultural strands of incrementalism were 
clearly visible and more prevalent than deliberate 
incrementalism. 
Of the eighteen cases examined, fourteen fitted into one of the three 
types of hybrid marketing strategy making processes described 
above. Each of those fourteen had a distinct, characteristic process 
and was not identical to any other case. However, the similarities 
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 between them were sufficient to group them broadly as above, and as 
described in the summary of results  (page 104). Table 11
The remaining four cases were all capable of description by the 
model, but were sufficiently unique to warrant a specific description. 
• Case B was in a transition phase, attempting to create a more 
planning oriented process from a formerly command and 
incremental process. Its current process was best described as 
planning plus incrementalism. However, as will be discussed 
later, the planning component of the process was not yet 
embedded and was still hindered by cultural habits associated 
with command. 
• Case O was an unusually pure form of command, with virtually 
no rational planning (other than tight budgeting processes) and 
some incrementalism (that was itself hindered by a command 
culture). This company was partly owned by venture capitalists 
and the external control pressures were high and facilitated by 
a strong leader. 
• Case K showed noticeable differences between the espoused 
process (planning and incrementalism) and that suggested by 
actual behaviour (command and incrementalism). There was 
evidence of politicisation and strong command processes, but 
little sign of rational planning. The best interpretation of this 
case was that it was a command and incrementalism process 
which was trying to “fake” planning because it perceived that to 
be a more desirable status. 
• Case P is qualified by being only one respondent, with all the 
limitations on data reliability that implies. However, it also 
contains interesting contrasts between the espoused process 
(planning and incrementalism) and that suggested by actual 
behaviour (strongly command). There was evidence of a 
strongly harmonised formal process but this appeared to be a 
very centrally driven procedure. The best interpretation of this 
case was of a command process attempting to use planning as 
a means of centralising control. 
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 All of the respondents in the study recognised the sub-processes 
suggested by the McDonald model, and the interviews suggested that 
it was a useful tool for facilitating discussion on the topic. From the 
findings of this part of the work, two salient points emerge that will 
be discussed later. Firstly, an uneven distribution of process was 
visible, with command processes being prevalent. This may be an 
artefact of the capital intensive, research driven and regulated nature 
of the industry used for this research, in which much of the strategy 
is, of necessity, prescribed by centralised product development 
choices. Secondly, a suggestion of process evolution emerges as 
organisations shift from command and incremental hybrids to 
processes containing a more even distribution of all three sub-
processes. 
5.2.3 Market Conditions of Complexity and Turbulence  
This work sought to understand the difference in market conditions 
between different cases. The questioning structure was designed to 
uncover salient market conditions by open probes and then to focus 
on those two dimensions (complexity and turbulence) suggested by 
the literature. Despite this approach, no salient market feature other 
than complexity or turbulence emerged from the questioning. 
Both complexity and turbulence were taken to be multifactorial, and 
respondents were probed in terms of the customer environment, 
channels to market, competitors and macroenvironmental factors 
such as political, economic, social and technological trends. From 
this questioning emerged clear differences between cases at the level 
of individual factors (e.g. customer complexity, or technological 
turbulence). However, when consolidated, there was an uneven 
distribution of market conditions. Overall, the majority of the cases 
were in stable environments and high levels of market turbulence 
were rare. Conversely, the level of complexity of the market 
conditions was more evenly spread, with both complex and simple 
markets present. This overall distribution is not, on reflection, 
unexpected. The nature of the industry studied (regulated and for the 
most part mature) would imply stability, whilst the spread of case 
types might be expected to provide a variety of levels of market 
complexity. Hence the sample provided sufficient examples of 
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 differing market conditions to aid generalisation, although a bias 
towards stable markets was found. 
The differing conditions found are summarised below and in more 
case-specific detail in Section 5.4 (page 103). 
Market Complexity 
The most important difference in market complexity between cases 
was that of the customer environment. These were found to vary in 
terms of market breadth, decision making complexity and 
geographical spread. In terms of market breadth, cases ranged from 
very tightly defined “niches within niches” to broad markets 
containing multiple therapeutic areas, each of which contained sub-
sectors. The nature of the decision making process ranged from the 
individual clinician to a complex, formalised, multilevel decision 
making unit. Finally, the customer environment varied in level of 
geographical spread, from single country to global presence. This 
range of customer complexity was the most salient of all the 
variations in market conditions encountered in the study. 
After customer environment, channel to market was the next most 
significant variance in market complexity between cases. The 
majority of cases dealt directly with clinicians and a relatively minor 
role was attributed to distributors or other channels. However, in 
some cases distributor channels were significant and in rare cases 
multiple levels of distribution were involved. 
The third, and least significant, variance in market complexity 
between cases lay in the competitive environment. For the most part, 
the markets were well established and consolidation had reduced the 
competitive environment to a small number of major, established 
competitors. In a small number of cases, the competitive environment 
was a little more complex with multiple rivals falling into two or three 
broad types. However, complexity of the competitive environment was 
not a major differentiator between cases. 
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 Market Turbulence 
Overall, the level of turbulence in the markets examined by this study 
was noticeably lower than the level of complexity. As mentioned 
previously, respondents frequently pointed to the regulatory 
environment and product complexity as the reasons for this relative 
stability. However, variance in market turbulence between cases was 
noted and two main sources of turbulence (the customer and the 
technological environments) were commonly cited. 
Changes in the customer environment were the most frequently 
mentioned sources of turbulence. Most common among these were 
administrative changes to customer buying processes associated with 
reforms of health service providers. Consolidation and 
professionalisation of purchasing was also relevant in this context. 
The second customer environment factor mentioned was that 
associated with market development, either geographical or product 
sector related, leading to changes in the market addressed by the 
strategy making process. 
Technical changes were the second most commonly raised sources of 
market turbulence. These included direct changes, such as product 
development within the sector, or more fundamental market changes 
associated with two major technological developments in the 
industry, namely information technology and genomics. 
It was notable, however, that some cases reported no significant 
turbulence and others turbulence only in one aspect of the market. 
Hence for most cases, the market was relatively stable. Only in a 
minority of cases was there turbulence in several aspects of the 
market at once and hence an overall turbulent environment. 
The distribution of cases across levels of market complexity and 
turbulence is illustrated in Figure 4 (page 90). Note that this chart 
merely attempts to position each case relative to the others. The 
method and the data are inappropriate to suggest any absolute 
measure and this must not be inferred. 
Hence this part of the research reveals a distribution of cases across 
market conditions and adds depth to the literature-derived 
constructs of market complexity and market turbulence. 
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 Figure 4: Distribution of Cases in Terms of Relative Market Complexity and Market Turbulence 
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 5.2.4 Macrocongruence 
This work sought to identify and understand macrocongruence and 
macroincongruence, i.e. the manner and degree to which the hybrid 
marketing strategy making process succeeded or failed in managing 
market conditions effectively. The interviews probed first for any type 
of macrocongruence (or macroincongruence) between the market and 
the strategy process and then, with more directed probing, for 
examples of macrocongruence with respect specifically to market 
complexity or market turbulence. Hence both the degree of 
macrocongruence and its nature were explored. 
Analysis of the interviews indicated clear differences between cases in 
terms of the macrocongruence. Further, the findings illustrate the 
nature of macrocongruence beyond the theoretically based concept 
described in Burrell and Morgan’s work. The common themes which 
emerged are shown in  (page 92). The relative degree of 
macrocongruence, along with the relative degree of microcongruence, 
is shown in Figure 5 (page 98). 
Table 9
These results indicate that congruence between the hybrid marketing 
strategy making process and the market environment was exhibited 
by a number of artefacts of the process. 
The manner and degree to which the process managed market 
complexity was demonstrated by clarification and understanding of 
different parts of the market environment. Prominent amongst these 
were the understanding of major macro-environmental factors, such 
as the advent of genomics or the convergence of technologies. Cases 
with congruent processes were notable in their recognition of such 
factors. Also important was the way in which congruent strategy 
processes appeared to clarify customer and competitive environments 
and to co-ordinate responses. Cases with congruent processes were 
more likely to report “organised” and “structured” views of the 
market. Macroincongruent cases more frequently reported either a 
confusing, fragmented picture or a very simple, homogeneous picture 
of the market. Also frequently reported was the manner in which 
macroincongruent processes were prone to subjective and uneven  
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 Table 9: Examples of Macrocongruence and Macroincongruence 
 Complexity  Turbulence 
Macro- 
congruence 
Effective communication of macroenvironmental factors and 
their implications (e.g. regulatory or demographic changes). 
Effective understanding of market segmentation complexity 
(especially regarding intangible motivators). 
Clear understanding of the attractiveness of alternative 
segments beyond segment size. 
Clarification and “stratification” of competitive threats. 
Coherence between local and international objectives. 
Coherence across geographical strategies.  
Effective screening of new product opportunities 
at an international level. 
Rapid transfer of effective responses to market 
turbulence across geographical boundaries. 
Early identification of the combined implications 
of macroenvironmental changes such as 
technology and globalisation. 
Forewarning of competitive threats arsing in other 
markets. 
Efficient knowledge transfer within market by the 
use of ad hoc teams 
Macro- 
incongruence 
Failure to give due weight to local market factors when 
consolidating plans. 
Undue weight given to personal opinions of key individuals, 
especially when data is not available. 
Irrational screening of market data when it is consolidated 
across markets. 
Failure to evaluate properly some intangible data (e.g. 
relationship strength) and undue emphasis given to “hard” 
data. 
Failure to understand significant differences between 
market sectors.  
Reduction in speed of innovation created by 
centralised or bureaucratic processes. 
Failure of fixed planning schedules to allow for 
shortening life cycles or unplanned contingencies. 
Weakness in learning from previous turbulence, 
especially when staff turnover or merger/ 
acquisition occurs. 
Failure to understand temporary market 
anomalies.  
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 assessment of market situations. This was demonstrated in the 
management of market complexity during the consolidation of plans 
from product and national to business and international. Cases 
which reported process incongruence with the market complexity 
cited undue political influence, combined with inconsistent 
“screening” or selection of data. This was especially true when 
quantitative data was in short supply and the market complexity was 
the result of an intangible factor, for instance relationship strength. 
The manner and degree to which the process managed market 
turbulence was demonstrated by both faster responsiveness to 
change and more rapid communication between organisational sub-
units, such as geographical subsidiaries. This was commonly seen as 
rapid assimilation and communication of important implications of 
market turbulence, such as changes in the technical or regulatory 
environment. The visible artefacts of this were transfer of knowledge 
from leading markets to following markets. Examples of this were 
cited for competitive launches, changes in customer behaviour and 
the convergence of technologies. A commonly cited example of 
macrocongruence was of command and incremental processes 
driving product strategy based on the experience of the lead market 
(usually the US). By contrast, cases which exhibited 
macroincongruence in relation to market turbulence demonstrated 
examples of their process reducing responsiveness and internal 
communication. Most frequently, this was cited as strongly 
bureaucratic processes reducing freedom to re-allocate resources in 
the face of changed market conditions. This was most notable when 
those changes occurred at “inconvenient” times in relation to a 
planning or budgeting cycle. When, as in many of the cases, staff 
turnover or merger/acquisition activity had recently taken place, 
responsiveness to change was further hindered because the learning 
from previous turbulence had been lost. 
Hence this part of the research showed differences between cases in 
terms of the degree to which their hybrid marketing strategy making 
process managed market complexity and turbulence. Further, these 
findings add depth to the nature of macrocongruence beyond its 
literature-derived definition. 
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 Table 10: Examples of Supportive and Hindering Cultural Artefacts 
Process 
component 
Supportive cultural artefacts Hindering cultural artefacts  
Command Clear demarcation between the roles of central and local 
resource allocation. 
Autonomy of SBUs within an agreed strategic framework. 
Multiple, rather than annual, linkages between central and 
local processes. 
Small, ideologically coherent Top Management Teams. 
Highly quantitative Management information systems. 
Stable Top Management Teams and enculturation of 
newcomers. 
Close monitoring of performance indicators by functional 
“Barons”. 
Leadership of globally homogeneous market by most advanced 
market. 
Product led cultures and technically complex products. 
Leadership autocracy and Venture Capitalist pressure. 
Rigorous and short term financial measurement.  
Strong financial drivers combined with 
autocratic style reducing mutual trust. 
Turnover or ideologically fragmented Top 
Management Team leading to confused or 
contradictory messages. 
Meddling of senior management in relatively 
small scale but politically high-profile decisions. 
Locally strong culture at variance with command 
culture leading to local resistance. 
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 Process 
component 
Supportive cultural artefacts Hindering cultural artefacts  
Planning Prevalence of formal planning knowledge and skills. 
Top Management Team endorsement of rational 
approaches. 
Rapid increases in business complexity (e.g. via 
acquisition) allowing a basis for challenging former non-
planning processes. 
Acceptance of the need for market research and 
allocation of appropriate resources. 
Market, rather than product, oriented IT systems. 
Dedication of resource to extensive internal 
communication processes. 
Appointment of new, external, managers with planning 
orientation. 
Allocation of time and resources to planning skills 
training or consultancy. 
Process driven approach within a command framework. 
Cross functional working between departmental silos.  
Belief in primacy of product or technical 
knowledge or skills. 
Belief in primacy of hard data over soft, 
intangible, data. 
Resistance to use of formal information and 
control systems. 
Reluctance to speak out openly, often a 
cultural “lag” effect from former command 
processes. 
De facto isolation of planners, either self 
imposed or imposed by other functions. 
Adherence to rigid planning processes. 
Weak habits of communication across 
functions. 
Fear of data costs, often a cultural lag of 
command cultures.  
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 Process 
component 
Supportive cultural artefacts Hindering cultural artefacts  
Increment-
alism 
HR policies designed to provide staff with skills greatly 
superior to nominal role. 
Symbolism and example to reduce blame culture. 
Demarcation of large and small decisions between 
management levels. 
HR policies designed to reduce turnover. 
Actively managed cultures, by identification and 
communication of core beliefs. 
Reduction in level of quantification required for 
decisions, allowance for decision makers’ “instinct”. 
Habits of small, incremental, proposition changes rather 
than discontinuous proposition changes. 
Development of clusters of expertise within functions. 
Habits of measurement and feedback on incremental 
changes.  
Bureaucracy of decision approval. 
Flat structures, requiring multiple peer 
approval rather than approval by a limited 
number of superiors. 
Technical complexity of R&D projects, 
increasing lead times and costs. 
Interference by senior management with 
relatively low level changes to resource 
allocation. 
Belief in primacy of hard data, increasing the 
barriers to change. 
Requirements to justify financially 
incremental change to a detailed level. 
Close management control (e.g. low budget 
approval limits on managers). 
Weak communication processes across 
functions.  
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 5.2.5 Microcongruence 
This work sought to identify and understand microcongruence and 
microincongruence, i.e. the manner and degree to which the hybrid 
marketing strategy making process was supported or hindered by the 
organisational culture. The interviews probed first for any type of 
microcongruence (or microincongruence) between the organisational 
culture and the strategy process and then, with more directed 
probing, for examples of microcongruence with respect specifically to 
rational planning, visionary command and incremental processes. 
Hence both the degree of microcongruence and its nature were 
explored. 
Analysis of the interviews indicated clear differences between cases in 
terms of microcongruence. Further, the findings illustrate the nature 
of microcongruence beyond the theoretically based concept described 
in Burrell and Morgan’s work. The common themes which emerged 
are shown in  (page 94). The relative degree of 
microcongruence, along with the relative degree of macrocongruence, 
is shown in Figure 5 (page 98)  
Table 10
The findings indicated a wide variety of ways in which organisational 
culture supported or hindered hybrid strategy making processes. 
These cultural artefacts were not always discrete and defined and, to 
an extent, they overlapped. However, it was possible to discern a set 
of organisational artefacts that supported or hindered each 
component of the hybrid marketing strategy making process. 
Rational processes were supported by three sets of cultural artefacts 
that have been commented upon by earlier researchers: top 
management support, knowledge and skills of planning techniques 
and appropriate information systems. In addition, this work 
suggested that a deliberate attempt to communicate market-oriented 
values within the company was also necessary. These cultural 
conditions had most often been met by a set of deliberate actions to 
attempt cultural change, such as recruitment of new senior 
executives from already planning-oriented firms, the recruitment and 
training of marketing-trained managers and the use of extensive  
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 Figure 5: Distribution of Cases in Terms of Macrocongruence and Microcongruence 
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 internal communications programmes to embed market-oriented 
assumptions. Conversely, rational processes were hindered by the 
lack of the preconditions mentioned above. Notable artefacts 
mentioned as hindering planning included autocratic objective 
setting, senior management meddling in low level projects and 
cultural resistance to speaking out. Often, it was mentioned that 
formal planning was hindered by the obedient but restrained habits 
of communication that were previously associated with command 
processes. Another aspect of this was the limitation on cross-
functional working (a planning-supportive element of some cultures) 
created by a rigid management by objectives process. Finally, 
budgetary control habits that did not allow for “unjustifiable” 
resources such as market research were seen to hinder planning 
processes. 
Visionary command processes were supported by cultures that clearly 
demarcated resource allocation responsibilities between senior and 
middle executives. Notable amongst these cultures were habits of 
“acceptance” of strategic frameworks from above and the 
corresponding willingness of senior executives to allow freedom of 
action within that framework. Visionary command processes were 
also supported by compact, tightly knit management teams sharing 
similar views. Such teams often used detailed financial measurement 
systems to enable control. Conversely, visionary command processes 
were hindered by either staff turnover or disagreement within a top 
management team, which led to confusion over objectives and 
strategy. Similarly, lack of clear demarcation between roles (of senior 
executives and their subordinates) was seen to lead to lack of mutual 
trust and reluctance to execute strategies. 
Incremental processes were supported by cultures that clearly 
identified the scope of incremental resource allocation and enabled 
incremental decisions. Foremost amongst these were human 
resource and management practices that allowed incrementalism. 
Examples of these included apparent “overskilling” in key roles, such 
that some individuals were recruited and trained “above” their 
nominal role in order to enable incremental development of the 
strategy at ground level. Where strategy development was necessarily 
carried out at a higher level, systems to measure and evaluate the 
results of incremental changes had been put in place. Another 
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 notable, yet intangible, action to enable incrementalism was the use 
of symbolism and example by senior managers to reduce “blame” 
cultures, seen to limit incrementalism by middle and junior 
managers. Finally, the reduction of the burden of proof in justifying 
incremental actions was also notable. This ran parallel to a cultural 
belief in managers’ instinct as a guide to decision making. 
Conversely, incrementalism was seen to be hindered by lack of skills, 
fear of blame and high justification barriers. This latter factor 
included both formal barriers (e.g. strict pay-back time requirements) 
and less tangible barriers, such as bureaucratic systems which were 
expensive in terms of management time. 
Hence this part of the research showed differences between cases in 
terms of the degree to which their hybrid marketing strategy making 
was supported or hindered by the organisational culture. Further, 
these findings add depth to the nature of microcongruence, beyond 
its literature-derived definition, by elucidating those parts of the 
culture which hinder or support different process components. 
5.3 The Relationships Between the Variables 
Section 5.2 presented the findings for each of the variables under 
discussion for each case: strategy quality, market complexity, market 
turbulence, macrocongruence and microcongruence. In all cases, 
variance was seen between the cases, but no attempt to associate or 
correlate those variables has yet been made. 
This section presents the findings of this work in terms of the 
interrelationship between those variables. These relationships are the 
basis of the model proposed in Section 3.2 (page 46) and the 
propositions cited in Section 3.3 (page 51). The implications of these 
relationship findings for the model and propositions are discussed in 
Section 6 (page 202). 
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 5.3.1 The Relationship Between Strategy Quality, 
Macrocongruence and Microcongruence 
This section considers the relationship between strategy quality and 
the degree to which the hybrid marketing strategy making process is 
congruent with its organisational and market environments. In doing 
so, it brings together the findings reported in Sections 5.2.2, 5.2.3 
and 5.2.4 (beginning page 84). 
The findings are visualised in Figure 6 (page 102) Strategy Quality in 
Relation to Macrocongruence and Microcongruence. This 
demonstrates that strategy quality is unevenly distributed across the 
range of macrocongruence and microcongruence and suggests an 
association between them. 
All of the cases which met closely the conditions of a strong strategy 
also exhibited high levels of macrocongruence and microcongruence. 
The exception to this was Case G, which scored only moderately 
highly in terms of strategy quality. However, this case contained only 
one respondent and its validity was therefore questionable. 
The cases which did not meet the conditions of a strong strategy 
exhibited lower levels of microcongruence or both microcongruence 
and macrocongruence. 
Only one case did not fit this pattern. Case N exhibited moderate 
levels of macrocongruence, microcongruence and strategy quality. 
Hence this part of the research indicates a demonstrable association 
between macrocongruence, microcongruence and strategy quality. 
This association suggests support for the Burrell and Morgan 
congruency hypotheses, as will be discussed in Section 6 (page 202). 
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 Figure 6: Strategy Quality in Relation to Macrocongruence and Microcongruence 
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5.4 A Summary of the Results for Each Case 
This section summarises the findings for each case in order to allow 
cross-comparison between cases. 
An explanation of the column headings is as follows: 
Case 
All cases have been identified only by a letter for reasons of 
confidentiality. An outline description is given in Section 5.5 
(page 122). 
Implications for the congruency hypotheses 
This column indicates whether the case provides support or 
otherwise for the Burrell and Morgan congruency hypotheses. That 
is, if strong strategy is associated with a hybrid marketing strategy 
making process that is both macrocongruent and microcongruent. 
Strategy quality 
This column indicates the strength of the marketing strategy in terms 
of whether or not it exhibited the properties of a strong marketing 
strategy. 
Strategy process 
This column indicates the nature of the hybrid marketing strategy 
making process in terms of the three components suggested by 
McDonald’s model. 
Market conditions 
This column indicates the nature of the market conditions in which 
the case operated, in terms of market complexity and market 
turbulence. 
Macrocongruence 
This column indicates the level of macrocongruence observed 
between the hybrid marketing strategy making process and the 
market conditions. 
Microcongruence 
This column indicates the microcongruence observed between the 
hybrid marketing strategy making process and the organisational 
culture. 
Supporting or hindering cultural artefacts 
This column indicates the nature of any observed cultural artefacts 
that were seen to support or hinder the hybrid marketing strategy 
making process. 
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 Table 11: A Summary of the Results for Each Case 
Case Implications 
for congruency 
hypotheses 
Strategy 
quality 
Strategy 
process 
Market 
conditions 
Micro-
congruence 
Macro-
congruence 
Supporting and 
hindering cultural 
artefacts 
A Supports  Strong 
Motivator 
targeting within 
a defined 
market 
Complex, 
tailored 
augmented 
product 
Command plus 
incrementalism 
Stable and 
simple 
Yes 
Slight signs of 
financial control 
strain due to 
preparations for 
IPO 
Yes 
Slight signs of 
strain due to 
international 
complexity 
Planning hindered by 
product-led culture and 
accompanying 
technical skill sets 
Incrementalism 
supported by HR 
policies and blame 
reduction symbolism 
Command supported 
by role demarcation 
and acceptance, 
hindered slightly by 
IPO driven demands 
reducing trust 
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 Case Implications 
for congruency 
hypotheses 
Strategy 
quality 
Strategy 
process 
Market 
conditions 
Micro-
congruence 
Macro-
congruence 
Supporting and 
hindering cultural 
artefacts 
B Supports Weak 
Proposition 
tailoring to a 
very limited 
degree 
Failure to 
segment, 
despite 
deliberate effort
Planning and 
some 
incrementalism 
(change from 
formerly strongly 
command)  
Complexity 
arising from 
both breadth 
of market and 
international 
variation 
Moderate 
turbulence, 
arising mostly 
from changes 
in customer 
processes 
No 
Remnants of 
command 
culture hinder 
feedback and 
MIS system 
usage 
No 
Signs of both 
complexity and 
turbulence 
incongruence 
Planning enabled by 
formal qualifications, 
resource allocation to 
research, top-level 
commitment and IT 
systems 
Planning hindered by 
primacy of hard data 
assumptions, lack of 
system use and lack of 
feedbacks, due to 
cultural lag from 
command culture 
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 Case Implications 
for congruency 
hypotheses 
Strategy 
quality 
Strategy 
process 
Market 
conditions 
Micro-
congruence 
Macro-
congruence 
Supporting and 
hindering cultural 
artefacts 
C Supports Very weak 
No indication of 
segmentation 
Little targeting 
Strongly 
command, with 
some 
incrementalism 
Complexity 
arising from 
spread of 
businesses 
Stability due 
to mature 
markets 
Yes 
Very strong 
shared 
assumptions 
within small top 
management 
team 
No 
Failure to grasp 
complexity of 
variances 
between sectors 
and segmentation 
within sectors 
Command process 
supported by small 
management team 
with similar 
backgrounds and 
historical habit of 
command acceptance 
Incrementalism limited 
to small decisions 
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 Case Implications 
for congruency 
hypotheses 
Strategy 
quality 
Strategy 
process 
Market 
conditions 
Micro-
congruence 
Macro-
congruence 
Supporting and 
hindering cultural 
artefacts 
D Supports Strong 
Motivator 
targeting within 
a defined 
market 
Complex, 
tailored 
augmented 
product 
Command plus 
incrementalism  
Stable and 
simple  
Yes 
Role 
demarcation, 
autonomy and 
acceptance of 
central 
command 
Yes 
Slight signs of 
international 
complexity strain 
Command supported 
by role demarcation 
and acceptance 
Incrementalism 
supported by low staff 
turnover and actively 
managed culture 
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 Case Implications 
for congruency 
hypotheses 
Strategy 
quality 
Strategy 
process 
Market 
conditions 
Micro-
congruence 
Macro-
congruence 
Supporting and 
hindering cultural 
artefacts 
E Supports  Strong  
Good 
understanding 
of segments 
Good 
proposition 
tailoring  
Relatively even 
hybrid of all three 
processes 
Complexity 
arising from 
multiple 
sectors and 
international 
variations 
Moderate 
turbulence 
arising from 
changes in 
customer 
processes 
Yes 
Very deliberate 
cultural change 
and internal 
communication 
process led by 
changes in 
senior 
management 
Yes 
Sampling at HQ 
level may hide 
some international 
complexity 
incongruence 
Planning supported by 
senior appointments 
from outside industry, 
formal training and 
extensive internal 
communication 
processes 
Incrementalism 
supported by culture of 
encouraging 
suggestions, reduction 
in “quantifying” 
justification of smaller 
decisions 
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 Case Implications 
for congruency 
hypotheses 
Strategy 
quality 
Strategy 
process 
Market 
conditions 
Micro-
congruence 
Macro-
congruence 
Supporting and 
hindering cultural 
artefacts 
F  Supports Weak 
No indication of 
real 
segmentation 
or targeting 
except at sales 
team level 
Command plus 
incrementalism 
Complexity 
arising from 
multiple 
sectors 
Moderate 
turbulence 
arising from 
changes in 
customer 
processes 
No 
Command type 
culture 
hindering 
incrementalism 
No 
failing to grasp 
market complexity 
Command supported 
by acceptance and 
quantitative 
management 
information systems 
Incrementalism 
hindered by reluctance 
to act independently 
(remnants of command 
culture)  
Recent attempts to 
introduce more 
planning not yet visible 
Interesting example of 
cultural lag between 
leaders and sub-
ordinates, with 
subordinates retaining 
command mentality 
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 Case Implications 
for congruency 
hypotheses 
Strategy 
quality 
Strategy 
process 
Market 
conditions 
Micro-
congruence 
Macro-
congruence 
Supporting and 
hindering cultural 
artefacts 
G Partially 
supports  
Moderately 
strong  
Targeting weak 
Proposition and 
SWOT 
alignment 
moderate 
Command and 
planning 
Intended 
incrementalism 
neutralised by 
culture 
Market 
complexity 
arising from 
multiple 
sectors 
Stable with 
recent local 
turbulence 
from changes 
in customer 
processes 
Yes 
Limits on micro-
congruence to 
incrementalism 
Yes 
Limits on 
managing 
turbulence due to 
hindered 
incrementalism 
Planning supported by 
clear processes and 
command framework 
Command supported 
by frequent 
interconnects between 
local and higher 
processes, plus 
acceptance 
Incrementalism 
hindered by size, 
bureaucracy and flat 
structures 
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 Case Implications 
for congruency 
hypotheses 
Strategy 
quality 
Strategy 
process 
Market 
conditions 
Micro-
congruence 
Macro-
congruence 
Supporting and 
hindering cultural 
artefacts 
H Supports Strong 
Product 
defined target 
but 
homogeneous 
niche 
Proposition 
leverages 
competencies 
well 
Strongly 
command plus 
incrementalism 
by governing 
cabal 
Simple and 
stable – 
international 
complexity a 
recent 
addition 
Yes 
Strongly 
microcongruent 
inherited from 
family founder 
Evidence of 
recent transition 
in culture 
Yes 
Only within home 
market; evidence 
of international 
problems 
Command supported 
by history and stable 
staff, strong cohesion 
and enculturation in 
management team  
Incrementalism 
enabled by closely 
related product 
development and high 
levels of focussed 
expertise 
Rationalism hindered 
by embedded fears of 
costs such as research 
Indications that 
command is vulnerable 
to turnover of key staff  
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 Case Implications 
for congruency 
hypotheses 
Strategy 
quality 
Strategy 
process 
Market 
conditions 
Micro-
congruence 
Macro-
congruence 
Supporting and 
hindering cultural 
artefacts 
I Supports Strong  
Well defined 
targets in a 
tight niche 
Complex 
augmented 
proposition 
Mostly planning, 
within a 
command 
framework, 
some 
promotional 
incrementalism 
Internationally 
complex and 
stable 
Anticipated 
discontinuous 
change not 
yet realised 
Yes 
Planning 
oriented central 
cabal with 
strong leader 
Yes 
Seems to cope 
well with 
complexity 
Unrealised fear of 
discontinuous IT 
change 
Planning supported by 
committed leadership, 
formal training and 
belief in tools 
Command supported 
by role demarcation 
and autonomy 
Incrementalism 
hindered by R&D 
complexity, supported 
by measurement and 
feedback 
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 Case Implications 
for congruency 
hypotheses 
Strategy 
quality 
Strategy 
process 
Market 
conditions 
Micro-
congruence 
Macro-
congruence 
Supporting and 
hindering cultural 
artefacts 
J Supports Strong  
Exceptional 
use of 
segmentation 
Good use of 
proposition 
tailoring 
Strongly 
planning within a 
command 
framework, plus 
topical 
incrementalism 
to manage 
localised 
turbulence 
Market 
complexity 
from multiple 
sectors 
Mostly stable 
with localised 
turbulence 
from changes 
in customer 
processes 
Yes 
Planning well 
established and 
acceptance of 
command from 
international 
headquarters 
Yes 
Copes well with 
market complexity 
and manages 
local turbulence 
with formalised 
incrementalism 
Planning supported by 
formal processes, 
designed by consultant 
Cross functionalism, 
driven by needs of 
larger company 
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 Case Implications 
for congruency 
hypotheses 
Strategy 
quality 
Strategy 
process 
Market 
conditions 
Micro-
congruence 
Macro-
congruence 
Supporting and 
hindering cultural 
artefacts 
K Supports Weak 
No indication of 
segmentation 
or proposition 
targeting 
Espoused 
planning, but 
apparently 
strongly 
command via 
“planning” 
processes and 
political 
incrementalism 
International 
complexity 
and stability  
No 
Command 
process 
isolated from 
implementers 
No 
Fails to cope with 
complexity of 
segmentation and 
international 
variance 
Command supported 
via tight financial 
controls and close 
monitoring by “Barons” 
Planning disabled by 
planners’ isolationism 
and rigid 
communication 
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 Case Implications 
for congruency 
hypotheses 
Strategy 
quality 
Strategy 
process 
Market 
conditions 
Micro-
congruence 
Macro-
congruence 
Supporting and 
hindering cultural 
artefacts 
L Supports Strong 
Motivator sub-
segmentation 
in a tight niche 
Tailored 
proposition 
including 
strategic 
partnering 
Strongly 
command plus 
local 
incrementalism 
for the 
augmented 
proposition 
Simple and 
turbulent – 
relatively 
young in PLC 
Yes 
Clear 
acceptance and 
demarcation 
Yes 
Helped by US 
leadership of 
global market 
Command enabled by 
acceptance of US 
leadership for core 
technology, global 
market homogeneity 
and demarcation of 
augmented proposition 
building 
Incrementalism 
supported by HR 
recruitment and 
retention policies 
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 Case Implications 
for congruency 
hypotheses 
Strategy 
quality 
Strategy 
process 
Market 
conditions 
Micro-
congruence 
Macro-
congruence 
Supporting and 
hindering cultural 
artefacts 
M Supports Weak 
No indication of 
segmentation 
or proposition 
tailoring except 
marginally at 
sales level 
Command plus 
some limited 
local 
incrementalism 
Very recent 
attempts to 
introduce 
planning 
Moderate 
market 
complexity 
Stable with 
small 
amounts of 
local 
turbulence 
from changes 
in customer 
processes.  
Yes 
Clear command 
culture 
Some small 
indications of 
that limiting 
incrementalism 
No 
Clear indications 
of failure to grasp 
segmentation and 
international 
complexity 
Command process 
supported by product 
led culture and 
accompanying skills 
Incrementalism partly 
disabled by lack of 
demarcation 
Recent attempts at 
planning, hindered by 
cultural lack of 
communication 
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 Case Implications 
for congruency 
hypotheses 
Strategy 
quality 
Strategy 
process 
Market 
conditions 
Micro-
congruence 
Macro-
congruence 
Supporting and 
hindering cultural 
artefacts 
N Partially 
supports 
Moderately 
weak  
No real 
segmentation 
Good tailoring 
of propositions 
Command and 
local 
incrementalism 
with some limited 
indications of 
planning at sales 
level only 
Market 
complexity 
moderated by 
divisional-
isation 
Moderate 
turbulence in 
customer 
processes 
Moderate 
Indications of 
some micro-
incongruence in 
all three 
directions 
Moderate 
Indications of 
command failing 
to cope with 
international 
complexity and 
incrementalism 
failing to cope 
with discontinuous 
changes 
Command supported 
by US market 
leadership and extant 
management 
information system 
Incrementalism 
hindered by data 
primacy assumptions 
Planning hindered by 
product led culture 
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 Case Implications 
for congruency 
hypotheses 
Strategy 
quality 
Strategy 
process 
Market 
conditions 
Micro-
congruence 
Macro-
congruence 
Supporting and 
hindering cultural 
artefacts 
O Supports Very weak 
No indication of 
segmentation 
or targeting 
Strongly 
command with 
some limited 
incrementalism 
Market 
complexity 
arising from 
multiple 
channels and 
segments 
Stability 
arising from 
mature 
segments 
Yes 
Strongly 
command with 
autocrat and 
Venture 
Capitalist 
pressure 
No 
Failure to cope 
with market 
complexity 
Command supported 
by autocrat and 
external VC pressure, 
strong financial control 
Incrementalism 
hindered by tight 
control and financial 
primacy 
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 Case Implications 
for congruency 
hypotheses 
Strategy 
quality 
Strategy 
process 
Market 
conditions 
Micro-
congruence 
Macro-
congruence 
Supporting and 
hindering cultural 
artefacts 
P Supports Weak  
No indication of 
segmentation 
or proposition 
tailoring 
Espoused 
mixture, but 
appears very 
command with 
planning as a 
command tool 
Market 
complexity 
arising from 
multiple 
sectors 
Stable apart 
from some 
customer 
process 
changes 
Yes 
Strong 
centralised 
command 
culture 
No 
Failure to cope 
with market 
complexity 
Command supported 
by formal, international 
processes 
Planning formalisation 
appears to support 
command rather than 
rationality 
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 Case Implications 
for congruency 
hypotheses 
Strategy 
quality 
Strategy 
process 
Market 
conditions 
Micro-
congruence 
Macro-
congruence 
Supporting and 
hindering cultural 
artefacts 
Q Supports Strong  
Unusual 
segmentation 
and proposition 
Intelligent 
SWOT 
alignment 
Even mixture of 
all three 
processes 
Recently 
developed from 
command plus 
incrementalism 
Complex 
Moderate 
turbulence 
Complexity 
recently and 
rapidly 
developed by 
acquisition 
Turbulence 
arising from 
customer 
process 
changes 
Yes 
Interesting 
mirroring of 
cultural change 
with process 
change 
Yes 
Turbulence 
congruence 
always been 
good, complexity 
congruence now 
improved by new 
process 
Command supported 
by acquisition, product 
process and 
demarcation 
Planning supported by 
senior champions, 
formal skills and 
explicit internal 
communication 
Incrementalism 
restricted to 
augmented proposition 
and supported by HR 
policies 
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 Case Implications 
for congruency 
hypotheses 
Strategy 
quality 
Strategy 
process 
Market 
conditions 
Micro-
congruence 
Macro-
congruence 
Supporting and 
hindering cultural 
artefacts 
R Supports Weak 
No indication of 
segmentation, 
proposition 
tailoring, 
SWOT 
alignment or 
uniqueness 
Strongly 
command for 
core product and 
incremental for 
service element 
Simplicity 
created by 
divisional-
isation 
Stable but 
with some 
customer 
process 
changes 
No 
Both processes 
hindered by 
heterogeneous 
culture 
No 
Command failing 
to cope with 
international 
complexity and 
incrementalism 
failing to keep 
pace with 
customer 
changes 
Command hindered by 
lack of demarcation 
and local resistance 
Incrementalism 
hindered by weak 
communication and 
bureaucracy 
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 5.5 Outlines of Each Case 
This section provides an overview of the transcript analysis in each 
case in greater detail than that given in Section 5.4 (page 103). To 
allow better cross-comparison, the same structure is given for each 
case, as follows: 
• Case description  
A description of the size and standing of the firm, the 
organisational unit considered and the product and 
geographical scope of the business. 
• Market situation 
A description of market complexity and market turbulence 
conditions. 
• Strategy process 
A description of the process used in terms of rational planning, 
incremental or visionary command processes. 
• Macrocongruence 
A description of the degree to which the strategy process 
accommodated market complexity and market turbulence. 
• Microcongruence 
A description of the degree to which the strategy process was 
supported by the organisational culture. 
• Strategy quality 
A description of the extent to which the strategy had the 
properties of a strong strategy. 
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 5.5.1 Case A 
Case A was an example of a strong strategy associated with high 
levels of both macrocongruence and microcongruence. The case was 
the UK sales and marketing subsidiary of a large multinational firm 
from the In-Vitro Diagnostics (IVD) sector. As such, the SBU had a 
narrow focus both geographically and in product range. Its customer 
base was small and very tightly defined. Within this sector, this 
company held a very strong, market leading, position.  
The market in which Case A operated was relatively simple and 
stable: 
Complexity 
Despite the technical complexity of its proposition (which included 
instrumentation, reagents and support), simplicity was implied by 
the tightly defined nature of its market. This SBU dealt only with the 
UK, and the product range was limited to multiple variations based 
around a very specific technology. One customer (the National Health 
Service) accounted for almost the entire turnover and that customer 
had only about 400 decision-making units for this market. To a 
significant degree, the motivational drivers of these units was 
“homogenised” by their NHS membership, although some 
segmentation existed. Case A dealt directly with its customers, so no 
channel complexity was involved. There were a very small number of 
significant competitors. What complexity existed in this case arose 
from the very complex technical nature of the proposition and the 
often convoluted nature of the bureaucratic decision making process 
of the customer. 
Stability 
The stability of this market arose from both its relative maturity, in 
terms of product form life cycle, the extended development time for 
new products and the highly regulated nature of the market. As a 
result, this case had experienced relatively little challenge in terms of 
market turbulence. Market changes had arisen from major reforms to 
the regulatory environment and from National Health Service 
reforms, leading to customer consolidation. However, neither change 
was sudden or unpredictable. It is worth noting that this case 
anticipated major technologically driven change in the future, 
although this was not exhibited in the current market. 
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 The hybrid marketing strategy making process in use was clearly 
command and incrementalism, with a very minor strand of rational 
planning process. The core of the product strategy (which necessarily 
defines the target customers at market level) was determined by 
global headquarters via direction of the research and development 
process. Deliberate processes existed to gather the views of 
subsidiary SBUs, but this central part of the process remained 
heavily command. Wrapped around this globally-derived command 
process was a locally-derived incremental process. This part of the 
process partly determined the emphasis of resource allocation across 
the centrally-commanded product range. More importantly, however, 
the local process determined the emphasis between target segments 
and the design of the augmented product, especially the service and 
support components. In a maturing market, this augmented 
component appeared to have as much or greater importance than the 
core products of instruments and reagents. Very little in the way of 
formal rational planning was seen beyond the basics of budgeting. 
Interestingly, attempts had been made at this, and a significant 
knowledge of formal techniques existed within the middle 
management layer. It would appear that rational planning had been 
implicitly rejected by the organisation. The other notable factor in 
this respect was the high degree of openness and agreement by the 
respondents about the features of the case, suggesting a high degree 
of validity of the findings. 
The central command plus local incrementalism process was highly 
macrocongruent to the market. In particular, such a process seemed 
to fit well with the highly regulated nature of the market and was 
effective at anticipating and communicating the important 
implications of regulatory changes. Further, the command process 
was mostly effective at consolidating international product 
requirements and directing research and development accordingly. 
Some mis-match between central product strategy and local demand 
was noted, but only marginally. The local incremental component of 
the hybrid marketing strategy making process was effective at 
creating and delivering the augmented service and support 
proposition. As noted later, this depended crucially on certain 
aspects of the organisational culture. 
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 This case exhibited a high degree of microcongruence between the 
hybrid marketing strategy making process and the organisational 
culture. 
The command process was facilitated by two notable cultural 
artefacts: 
• Acceptance of central command with relatively little 
questioning.  
Although channels existed and were used to provide local 
feedback, respondents showed a high degree of acceptance of 
the need for central command. They justified this in terms of 
the complexity of the product (and hence its research-intensive 
nature) and the core similarity of the major international 
markets. 
• Demarcation of responsibility.  
Accompanying the acceptance of command was the 
understanding of demarcation. Respondents spoke of being 
allowed “to get on with it” and of significant degrees of freedom 
within the centrally derived strategy framework. Whilst there 
were processes for testing local plans by headquarters, this was 
in the context of trusting the detail to local managers. 
Notably, some weakness in this central-local trust was noted as a 
recent result of discontinuous changes in the demands placed upon 
the subsidiary due to (confidential) internal changes. 
The incremental process was supported by two notable cultural 
artefacts: 
• Human resource policies of recruitment, retention and training 
which led to an especially well technically qualified sales and 
marketing team. As a result, understanding of detailed 
customer needs and ability to design and deliver the 
augmented proposition was strong. Staff turnover was low and 
mentions of mutual respect were high. 
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 • The culture had a deliberate approach to reducing fear of 
blame to encourage expression and experimentation. Symbols 
were used to parody blame cultures and reduce internal 
criticism. 
The rational planning process was hindered by culture. The culture 
valued technical knowledge above commercial qualifications and 
previous attempts at planning had been unsupported by the culture. 
Significantly, formal knowledge of planning existed only at middle 
levels of management and was not recognised as sufficiently valuable 
at senior or headquarters level. 
The marketing strategy resulting from the above had the properties of 
a strong strategy. Even within the tight product sector definition, 
respondents spoke of differentiating target customers based on 
motivational drivers of personal ego and technical prowess. 
Deliberate strategies to manage non-targets effectively were 
described. The differentiation of value propositions was described, 
although this was within the constraints of the core product strategy. 
The use of service, support and collaborative development to 
assemble propositions for target customers was described. This 
combination of targeting and positioning was shown to leverage 
organisational strengths of human resource skills and reputation. 
Conversely, the strategy was a defence against “commoditisation” 
threats associated with the maturing market. Finally, the strategy 
was identified as different in both targeting and propositions from the 
competitors. 
In conclusion, Case A was an example of a strong strategy arising 
from a hybrid marketing strategy making process that was both 
macrocongruent and microcongruent. The stable and simple market 
conditions may have been partly responsible for this. However, the 
case offered insights into effective marketing strategy making: 
The way in which simple, stable markets appear to be well managed 
by command and incremental processes. 
The combination of cultural artefacts (HR policies, blame reduction, 
command acceptance and demarcation) that is supportive of 
command and incremental processes. 
The case left unanswered how the strategy making process might 
adapt to increased market turbulence arising from imminent 
technological change or complexity, if the company attempted to 
move out of its current niche. 
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 5.5.2 Case B 
Case B was an example of a weak strategy associated with low levels 
of both macrocongruence and microcongruence. This case was the 
global headquarters of a large multinational firm from the medical 
devices sector, specialising in relatively complex single use devices. 
The case had a broad focus both geographically and in product range 
(although this latter aspect was narrowing rapidly). This SBU was 
part of a conglomerate with interests in other medical sectors but 
also non-medical industry sectors. Its customer base was large and 
moderately varied. Within this sector, this company held a very 
strong, but not dominant, position. 
The market in which Case B operated was relatively complex and 
moderately turbulent: 
Complexity 
The complexity of this case arose from its international scope and 
relatively broad product offering, the nature of which meant that 
several customer groups were involved. Further, the nature of the 
product implied a moderate degree of proposition complexity in terms 
of clinical evidence and application setting. Despite the similarity of 
core customer needs across national markets, the difference in 
standards of healthcare, clinical procedures and reimbursement/ 
payment systems implied a complex market. Multiple distribution 
channels and a variety of competitor types added to the market 
complexity to be addressed. 
Stability 
The moderate turbulence of the market was due principally to health 
care reforms around the world and subsequent changes in customer 
procurement processes. Technological change was a secondary 
contributor to market turbulence. However, both customer and 
technological change was incremental and continuous and hence 
predictable. The regulatory environment and the product 
development process both contributed to market stability, although 
these were noticeably less restrictive than in some of the other 
sectors considered, due to the lack of “active” components. Finally, 
the market appeared to be entering its mature phase, which further 
implied stability. 
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 The hybrid marketing strategy making process in use was planning 
and incrementalism, having recently undergone deliberate change 
from what appeared to have been a command and incremental 
process. External consultants had facilitated the development of 
these planning processes. A formal rational process was in place and 
planning tools and techniques were used and were integrated into the 
product development process. The incremental process operated 
alongside this process and was especially dominant in the local 
tailoring of the centrally derived strategic marketing plan. Both 
political and cultural aspects of incrementalism were clearly visible. 
Command processes were little in evidence, other than the clearly set 
financial performance targets cascaded down from the group 
headquarters. Noteworthy in this case was the apparent pride in the 
“new” planning process and the evident support for it, tangible and 
intangible, amongst the management team. 
This planning plus incrementalism hybrid marketing strategy making 
process was observed to have low levels of macrocongruence with the 
market environment. Most notable of the macroincongruence factors 
observed were: 
• Segmentation failure 
There was a self-confessed failure to address segmentation 
adequately. Product categories and geographical ways of 
structuring the market dominated and the respondents 
expressed frustration at their inability to “extract a 
segmentation pattern from the sales data”. 
• Geographical variation 
Secondary examples of macroincongruence were seen as 
difficulties in reconciling the needs of different geographical 
markets. Related to this, macroincongruence with market 
turbulence was also noted, albeit in a limited fashion, arising 
from changes in the various national healthcare systems. 
This case also exhibited a low degree of microcongruence between the 
hybrid marketing strategy making process and the organisational 
culture. This lack of microcongruence was the combined effect of 
recently introduced and long-standing, cultural artefacts. 
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 • Recently developed explicit cultural artefacts 
There were explicit cultural artefacts supporting the rational 
planning process, such as top management commitment, newly 
instituted management information systems, and well-qualified 
(in terms of formal training) managers. All of these were 
relatively new. 
• Long standing implicit cultural artefacts 
There were clear signs of the more implicit and long-
established cultural artefacts that hindered the rational 
planning process. These appeared to be vestiges of a former 
command-oriented culture. The two notable examples of this 
both concerned the use of data: 
• Hard data was held to be of primary importance and valued 
very highly. This cultural assumption led to the relegation of 
less tangible data (such as customer attitudes). As a result, the 
planning process was constrained within the limits of available 
(purely quantitative) market research data. 
• The gathering of data by customer contact staff was important 
and had been facilitated by a new information technology 
system. However, this system was hindered by cultural habits 
of withholding data and concentrating on tasks with tangible 
short term outcomes. Hence, sales teams did not “feed” the new 
system with data. 
Other, less prominent, cultural hindrances of planning were noted, 
such as the primacy of technical product knowledge, but these first 
two factors were most noticeable. Less evidence was visible of 
microcongruence between the organisational culture and incremental 
processes. This may have been a sampling effect, as all three 
respondents were in the headquarters function. Hence, the case 
provides an interesting example of microincongruence. It is notable 
that no deliberate attempt had been made to modify the culture, 
despite the obvious investment in structures and systems. 
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The marketing strategy resulting from the above had the properties of 
a weak strategy. As already mentioned, the most obvious example of 
this was failure to segment effectively beyond product categories. 
Consequently, proposition tailoring was limited to that carried out at 
 sales level or in targeting some promotional activity. The organisation 
had a weak grasp of its distinctive competencies and relative 
weaknesses. Other than a general “premium” positioning, SWOT 
alignment was weak. Finally, there was no noticeable difference in 
either targeting or proposition design, from the major competitors. 
In conclusion, Case B was an example of a weak strategy arising from 
a hybrid marketing strategy making process that was neither 
macrocongruent nor microcongruent. The complex and moderately 
turbulent market conditions were not well managed by the planning 
and incremental process. This is especially interesting since the 
process had been deliberately changed. The findings are consistent 
with the planning component of the hybrid marketing strategy 
making process being disabled by the organisational culture more 
consistent with the former command-oriented process. It may be 
possible therefore to infer from Case B an example of cultural lag, in 
which a deliberate change of hybrid marketing strategy making 
process is not accompanied by a corresponding change in 
organisational culture. Hence, an attempt to achieve 
macrocongruence has resulted in loss of microcongruence. The 
resulting actual process (disabled planning plus incrementalism) is 
also macroincongruent, even if the intended process (planning and 
incrementalism) may not have been. 
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 5.5.3 Case C 
Case C was an example of a weak strategy associated with low levels 
of macrocongruence but high levels of microcongruence. The case 
was the headquarters of a medium sized, UK based, international 
firm in the medical disposables sector. In addition to its medical 
products, the same business unit dealt with branded and own label 
consumer products. As such, the business had a broad focus 
geographically, in channel type and in product type. Overall, Case C 
was a minor player with a weak market position. 
The market in which Case C operated was very complex but notably 
stable: 
Complexity 
Despite the relative technical simplicity of its products when 
compared to many of the other cases, Case C faced a complex 
market. This complexity arose from the broad spread of product 
sectors and channels in which it operated. The company operated in 
medical and consumer markets, with both own label and branded 
products. Its route to market was both direct and via multi-tier 
channels. As a consequence of this breadth, it faced a large number 
of different competitors and significant indirect competitive pressure 
from buyer power. Within many of its sectors, the complexity was 
compounded by market fragmentation and a variety of customer 
decision making processes from the clinically-specified to the pan-
European tender.    
Stability 
Despite facing a lesser burden of regulation and having shorter 
product development times, this market was relatively stable. This 
arose from the maturity of the market and the consequent stability of 
technologies, competitors and the macroenvironment. Such 
turbulence as did exist arose from changes in the customer arena. 
The market was influenced by health service reforms and 
consolidation in the retail sector. 
The hybrid marketing strategy making process in use was strongly 
command with a secondary element of incrementalism. The bulk of 
strategy formation occurred within a small and tightly knit group of 
senior managers who exhibited cohesion and agreement and a 
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 similar industry background. Product strategy was the core of the 
proposition and this implied much of the targeting. There was a 
limited amount of augmented proposition, much of which was also 
decided by the centre. To the degree that incrementalism was 
observed, it was of the political and cultural form, rather than 
controlled experimentation. No significant rational planning process 
was observed, beyond the normal budgeting, and no use was made of 
formal tools and techniques. 
This strongly command process with some incrementalism 
demonstrated low levels of macrocongruence to the market 
conditions. As might be expected in a stable market, the lack of 
macrocongruence was mostly associated with the market complexity. 
Respondents characterised the market as relatively simple, despite 
the wide variance in sectors, channels, product types and competitive 
forces. Consequently, proposition development was essentially 
“me-too” despite the failure of this approach to address 
macroenvironmental trends towards commoditisation. 
This case exhibited a high degree of microcongruence between the 
hybrid marketing strategy making process and the organisational 
culture. 
The command process was facilitated by two notable cultural 
artefacts: 
• A tightly knit and long established management team.  
The respondents shared an industry background and 
demonstrated a strong cohesion regarding their perception of 
the market and the necessary critical success factors. Their 
answers suggested that they had formed a strong culture, 
including a consensus about core assumptions. 
• Strongly traditional organisational habits.  
Case C had its origins as a family-run business and retained 
many observable vestiges of that culture, such as informal HR 
policies and tight financial controls. On questioning, 
respondents pointed to the conservative nature and acceptance 
of command as elements of the culture. 
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 Notably, some hindrance of the limited incremental process was noted 
as a result of the relatively autocratic style and, particularly, the tight 
financial controls. 
Since no significant rational planning took place, beyond routine 
budgeting, no interaction between this and the organisational culture 
was observed. However, evidence of knowledge of rational planning 
techniques and formal qualifications was found, suggesting that 
these were present but not valued by the company. 
The marketing strategy resulting from the above had the properties of 
a weak strategy. The target market definition was a combination of 
product and channel, with no suggestion of homogeneity. The 
proposition tailoring was very limited, being restricted to minor 
modifications of the core product and pricing to affect tender results. 
The organisation had little grasp of its relative strengths and 
weaknesses and consequently little visible SWOT alignment. Most 
notable in connection with this was the largely undifferentiated, cost 
based nature of the proposition. Given that the organisation did not 
benefit from economies of scale, the commoditising nature of the 
market and the threats from both direct competitors and buyers, this 
represented a notably weak strategy. Finally, no strategy uniqueness 
could be seen in either the nature of the targets nor the value 
proposition. 
In conclusion, Case C was an example of a weak strategy arising from 
a hybrid marketing strategy making process that was not 
macrocongruent but which was microcongruent. In this case, the 
process seemed to arise directly from the culture and to reflect it 
strongly. However, it did not fit well with the complexity of the 
markets with which it was faced. Hence, the case offered an 
interesting insight into marketing strategy making. It would suggest 
that microcongruence alone does not imply an effective hybrid 
marketing strategy making process if that process is not 
macrocongruent to the market conditions. 
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 5.5.4 Case D 
Case D was an example of a strong strategy associated with high 
levels of both macrocongruence and microcongruence. The case was 
the UK sales and marketing subsidiary of a medium sized 
multinational pharmaceutical company. Unusually, this company 
was primarily focussed on one therapeutic sector, although it had 
minor interests in some others. As such, the SBU had a narrow focus 
both geographically and in product range. Its customer base was 
small and very tightly defined. Within this sector, this company held 
a very strong, market leading, position. 
The market in which Case D operated was relatively simple and 
stable: 
Complexity 
This case dealt only with the UK and almost entirely in one, tightly 
defined, therapeutic area. As a result, the range of competitors was 
also very narrow. The product range was, in practice, very narrow 
and the company dealt through one simple channel to market. The 
decision making unit was primarily based upon General Practitioners 
(local community based physicians) although hospital based 
specialists (consultants) were also important. Almost all of these 
decisions took place within the relatively homogeneous structure of 
the National Health Service. What complexity did exist in this market 
arose from variations in motivations between the General 
Practitioners and the augmented support propositions aimed at 
them. 
Stability 
The stability of this market arose from its relative maturity, in terms 
of product form life cycle, the extended development time for new 
products and the highly regulated nature of the market. In addition, 
the comparatively niche nature of the therapeutic area  had led to 
relatively little change in market conditions (e.g. few new entrants). 
Hence, this case had experienced relatively little challenge in terms of 
market turbulence. Market changes had arisen from major reforms to 
the regulatory environment and from National Health Service 
reforms, leading to customer consolidation. However, neither change 
was sudden or unpredictable. 
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 The hybrid marketing strategy making process in use was clearly 
command and incrementalism, with almost no indication of rational 
planning processes. The core of the product strategy (which 
necessarily defines the target customers at market level) was 
determined by global headquarters via direction of the research and 
development process. Deliberate processes existed to gather the views 
of subsidiary SBUs and to co-ordinate central and local plans. 
However, the core of the strategy was decided at the central 
headquarters. Supplementing centrally-derived command process 
was a locally-derived incremental process. The main contribution of 
the local process determined emphasis between different customers 
and the design of the augmented product, especially the support 
components. In this market, the support components (especially 
relationship activity and continuing medical education) appeared to 
have equal or greater importance than the core product, the 
therapeutic agent. Very little in the way of formal rational planning 
was seen beyond the basics of budgeting. 
This hybrid process of central command plus local incrementalism 
process was highly macrocongruent to the market. The command 
process allowed rapid transfer of ideas across borders in a market 
that was relatively homogeneous internationally, and coordination of 
national market strategies in a sector where parallel importing was a 
threat. Further, the command process allowed some performance 
benchmarking between countries. Finally, although the tight 
therapeutic area focus obviated the need for internationally 
consolidated portfolio management, it did allow consolidation of 
demands on central support resources, such as the development of 
clinical trials data. The incremental component of the hybrid 
marketing strategy making process addressed those needs of the 
market that were country-specific. Incrementalism had enabled the 
evolution of a motivator-based segmentation within the therapy-area 
defined niche and understanding of the complex opinion-leader/ 
prescriber decision making process. 
Some macroincongruence was noted, particularly regarding the 
centralised (and European-biased) process having struggled to grasp 
the implications of the UK’s relatively unusual healthcare system, 
which differs in some important respects from most European 
systems. No noticeable lack of macrocongruence was noted with 
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 market turbulence. This was unsurprising given the stable nature of 
the market. Notably, most examples of lack of macrocongruence 
referred to new initiatives or product launches, during the initial 
phase when, as it were, the incremental process had not yet 
“knocked the edges off” the core strategy. 
This case exhibited a high degree of microcongruence between the 
hybrid marketing strategy making process and the organisational 
culture. 
The command process was facilitated by two notable cultural 
artefacts: 
• Acceptance of central command 
Although channels existed and were used to provide local 
feedback, Case D exhibited a large degree of habitual 
acceptance of a core product strategy from central 
headquarters. This was explained in terms of difficulty and 
timescale of product development and its cost relative to any 
single market opportunity. Further, similarity of core needs 
between markets was cited as justification for a core strategy. 
• Demarcation of responsibility 
Complementing the acceptance of command was the 
understanding of demarcation between central and local roles. 
Respondents spoke of tactical independence and of significant 
degrees of freedom around the core product strategy. The 
processes for the “testing” of local plans by headquarters were 
largely financial and involved a notable lack of “meddling” by 
headquarters in the design of the augmented proposition. 
The incremental process was supported by two notable cultural 
artefacts: 
• Human resource policies of recruitment, retention and training 
which led to an especially stable sales team. Such a stable 
team was seen as an important factor in maintaining customer 
relationships and an image of therapy area expertise. 
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 • A deliberately managed culture of proactivity. In addition to the 
above mentioned HR policies, the respondents cited a 
deliberately managed culture which valued personal initiative 
and responsibility. 
Microcongruence with rational planning processes was not observed. 
On probing, it was perceived as inappropriate to a market that was so 
constrained by technical and regulatory factors and of little benefit in 
such a niche market. These beliefs in themselves suggest, of course, 
a set of cultural beliefs that might hinder rational planning 
processes. 
The marketing strategy resulting from the above had the properties of 
a strong strategy. Even within the tight product sector definition, 
respondents spoke of differentiating target customers based on 
personal motivators and aspirations. The differentiation of value 
propositions was described, built around the core product strategy. 
The use of education, relationships and personal expertise to build 
augmented propositions was described. This combination of targeting 
and positioning was shown to leverage organisational strengths of 
human resource skills and reputation. In addition, this strategy was 
seen as a defence against the threat of less specialised but larger new 
entrants. Finally, the strategy was identified as different in 
proposition from the competitors, although the targeting was different 
only in emphasis, not in absolute terms. 
In conclusion, Case D was an example of a strong strategy arising 
from a hybrid marketing strategy making process that was both 
macrocongruent and microcongruent. As with other cases, the stable 
and simple market conditions may have been partly responsible for 
this. However, the case offered two insights into effective marketing 
strategy making: 
• The way in which simple, stable markets appear to be well 
managed by command and incremental processes. 
• The combination of cultural artefacts (HR policies, deliberately 
managed proactive cultures, command acceptance and role 
demarcation) that is supportive of command and incremental 
processes. 
The case left unanswered how the strategy making process might 
adapt to increased complexity, if the company attempted to move out 
of its current niche. 
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 5.5.5 Case E 
Case E was an example of a strong strategy associated with high 
levels of both macrocongruence and microcongruence. The case was 
the global headquarters of a very large multinational pharmaceutical 
firm. The business had a wide therapeutic area spread and a global 
geographic interest. Its customer base was wide and varied. This 
company was in the first rank of its industry. 
The market in which Case E operated was relatively complex with 
moderate market turbulence: 
Complexity 
The complexity of the market conditions facing Case E arose from its 
global interests, broad product portfolio and increasingly 
non-product value proposition. The global interests of this case 
meant that the hybrid marketing strategy making process was 
responsible for many different geographical markets with varying 
healthcare market structures. For instance, the important differences 
between developed and developing markets and across the three 
largest pharmaceutical markets (the US, Japan and EU) were cited, 
including regulatory, reimbursement and advertising restrictions. The 
broad product portfolio included several therapeutic areas and 
covered acute and chronic conditions in both primary and secondary 
care. Further, the increasing importance of health economics needs 
arising from healthcare reforms was cited as an example of 
proposition complexity beyond the traditional product-based 
approach. This implied a much more complex decision making 
process than the traditional prescriber-only model. There was some 
complexity arising from a mixture of direct and indirect channels to 
market. The competitive aspect of the market was relatively 
straightforward, with a small number of similar global competitors 
and a tier of local generic manufacturers. 
Stability 
This market had some aspects of stability arising from its relative 
maturity, in terms of product form life cycle, the extended 
development time for new products and the highly regulated nature 
of the market. However, other signs of turbulence were exhibited in 
the changes in the customer processes of the various markets in 
which it operated. For instance, the US market was experiencing 
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 turbulence as a result of rapid expansion of DTC (direct to consumer) 
marketing and changes to government funded payment systems. In 
addition, the structure of buying processes in many European 
markets was also cited as an example of turbulence. Furthermore, 
the changes associated with patent expiry (and subsequent generic 
competition) were notable in some therapeutic areas. 
The hybrid marketing strategy making process in use was an 
unusual mixture of all three processes: visionary command, rational 
planning and incrementalism. The core of the product strategy (which 
necessarily defines the target customers at market level) was 
determined via the organisation’s research and development process. 
The very long timescale of this and the associated regulatory approval 
process was a fundamental factor upon which much of the strategy 
was dependent. Deliberate incremental processes existed to gather 
the views of subsidiary SBUs and to test strategies in limited 
geographical areas. Further, evidence of political incrementalism was 
exhibited by the “weighting” of opinions based on role-power. 
However, the most notable feature of the hybrid marketing strategy 
making process was a formal rational planning process that had been 
adopted throughout the organisation and was cited by the 
respondents at every opportunity. This process had been developed 
with some external consultancy. Frequent mention was made of 
various tools and techniques above and beyond what might be 
expected of traditional budgeting processes. The headquarters’ formal 
process was connected to local planning processes in order to achieve 
coherence and consistency. 
This three component mixed process was highly macrocongruent to 
the market. Evidence of accommodation to market complexity with 
respect to different national healthcare systems was seen, as was 
understanding of the more complex health-economic buying 
processes arising from healthcare reforms. Macrocongruence to 
market turbulence was cited as better prediction of market changes 
and their implications. Further, the co-ordinated nature of the 
process fitted well with the highly regulated nature of the market and 
was effective at anticipating and communicating the important 
implications of regulatory changes and global trading legislation. The 
command process was mostly effective at consolidating international 
product requirements and directing research and development 
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 accordingly. Interestingly, this involved not just the assessment of 
traditional data such as demographics and disease patterns, but also 
the assessment of less tangible motivator data. Some mismatch 
between central product strategy and local demands was noted, but 
only marginally. 
This case exhibited a high degree of microcongruence between the 
hybrid marketing strategy making process and the organisational 
culture. 
The rational planning process was facilitated by two notable cultural 
artefacts: 
• Culture management 
A deliberate and very high profile attempt to change the 
organisational culture in favour of planning. This involved an 
obvious (and notably well resourced) internal communications 
programme, sponsored and driven by the head of marketing, 
who himself sat on the main board. 
• Key people with marketing orientation 
A number of new key appointments had been made in an 
attempt to implant a marketing oriented culture. This had been 
initiated by the CEO (himself from a non-pharmaceutical 
marketing background) and included the numerous senior 
sales and marketing executives. 
The incremental process was supported by two notable cultural 
artefacts: 
• Culture management 
Interviewees reported deliberate attempts to reduce the fear of 
expression that was associated with a previous command 
culture. In its place, both formal and informal mechanisms had 
been put in place to encourage exchange of ideas and 
constructive challenge. 
• Modification of decision justification 
It was reported that the formal decision approval processes had 
been modified. This involved two aspects: some reduction in 
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 financial justification and a corresponding increase in the 
quality of non-financial data needed to support propositions. 
Little evidence was seen in Case E of support or hindrance of the 
command process. It was clear that the command process consisted 
of two components: financial targets and product pipeline. The 
culture seemed to accept both of these as givens and, within this 
framework, considerable freedom was exhibited. Thus, although the 
evidence was slight, this case exhibited some of the acceptance, 
demarcation and autonomy traits suggested by other cultures with 
microcongruent command processes. 
The marketing strategy resulting from the above balanced hybrid 
marketing strategy making process had the properties of a strong 
strategy. It was notable that target definition was in terms of 
customer motivations and psychological drivers, suggesting high 
degrees of homogeneity. The value proposition development was 
based upon augmented packages driven by health economic 
arguments and allocation of resource in a portfolio approach (both 
within and between therapy areas) was cited. The strategy was 
intended to leverage particular management competencies and non-
product related strengths in evidence-based medicine, whilst 
compensating for dual threats of larger premium competitors and low 
cost generic followers. Finally, the strategy was claimed to target 
differently from the major competitors (this seemed plausible) and to 
be significantly but not totally different in terms of proposition. 
In conclusion, Case E was an example of a strong strategy arising 
from a hybrid marketing strategy making process that was both 
macrocongruent and microcongruent. Given the complex and 
moderately turbulent market conditions, this case therefore offered 
important insights into effective marketing strategy making: 
• The way in which complexity and turbulence, appear to be well 
managed by a three component mixture of hybrid marketing 
strategy making process. 
• The way in which the organisational culture may be managed, 
by key appointments and internal communication, to support 
the new process. 
This case left unanswered how the strategy making process might be 
fully translated into local subsidiaries, although the extent of cultural 
management effort used suggests ideas in this direction. 
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 5.5.6 Case F 
Case F was based on four respondents. 
Case F was an example of weak strategy associated with low levels of 
both macrocongruence and microcongruence. Case F was the UK 
sales and marketing subsidiary of a very large multinational 
pharmaceutical firm. The business had a wide therapeutic area 
spread, but a purely UK geographic interest. Its customer base was 
wide and varied. This company was in the first rank of its industry. 
The market in which Case F operated was relatively complex with 
some market turbulence: 
Complexity 
The complexity of the market conditions facing Case F arose from its 
broad product portfolio, increasingly complex customer decision 
making processes and increasingly non-product value proposition. 
The broad product portfolio included several therapeutic areas and 
covered acute and chronic conditions in both primary and secondary 
care. The reforms within the UK National Health Service, partly in an 
attempt to reduce spending on pharmaceuticals, had also led to a 
more complex customer decision making process. The increasing 
importance of health economics needs arising from healthcare 
reforms was cited as an example of proposition complexity beyond 
the traditional product-based approach. This implied a much more 
complex decision making process than the traditional prescriber-only 
model. There was some complexity arising from a mixture of indirect 
channels to market. The competitive aspect of the market was 
relatively straightforward, with a small number of similar competitors 
and a tier of generic manufacturers. 
Stability 
This market had some aspects of stability arising from its relative 
maturity, in terms of product form life cycle, the extended 
development time for new products and the highly regulated nature 
of the market. There were some moderated signs of market 
turbulence arising from changes in the customer buying processes 
and the use of information technology, for instance, GP (local 
community based physicians) use of computer aided prescribing 
tools. 
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 The hybrid marketing strategy making process in use was a 
combination of command and incrementalism, although some 
attempts had recently been made to introduce some element of 
formal rational planning process. The core of the product strategy 
was determined centrally via the research and development process. 
This occurred in a UK based group, but the structure of the 
organisation was such that the UK subsidiary was on the same 
footing as other national subsidiaries. The very long timescale of 
research and development programmes and the associated regulatory 
approval process were fundamental factors upon which much of the 
strategy was dependent. This global command process therefore 
presented the subsidiary with a product portfolio, much of the 
augmented product (in the form of clinical evidence) and financial 
targets. Further evidence of an external command process was 
exhibited by legally binding pricing constraints applied by the UK 
government. The incremental process was then added to this core 
strategy and was responsible for allocation of sales and marketing 
resources. This involved political and cultural processes with little 
evidence seen of deliberate experimentation. Planning was little 
observed, beyond routine budgeting. Some evidence of planning 
failures were cited, as discussed later. 
This mixture of command and incremental processes did not 
demonstrate macrocongruence with the market conditions. Examples 
were given of inability to manage some aspects of market complexity 
such as market segmentation and decision making process 
complexity. For instance, the impact of consolidation of secondary 
care purchasing was indicated to be poorly understood. Fewer 
indications were seen of lack of macrocongruence with market 
turbulence, but this case exhibited less ability to predict the 
implications of market changes than some of the comparable cases. 
Finally, the command process did not seem to be effective, as it was 
in some other cases, at communicating knowledge and successful 
models across national boundaries. 
This case also exhibited a low degree of microcongruence between the 
hybrid marketing strategy making process and the organisational 
culture. 
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 The visionary command process was facilitated by two notable 
cultural artefacts: 
• Command acceptance 
The acceptance of the product pipeline and (with political 
negotiation) financial targets was, as with some other cases, a 
notable aspect of microcongruence between the command 
process and the organisational culture. 
• Well developed management information systems 
Case F appeared to have an especially well developed set of IT 
systems and processes for justifying and monitoring allocation 
of financial resources. This was cited as enabling the command 
component of the hybrid marketing strategy making process. 
The incremental process was hindered by two notable cultural 
artefacts: 
• Reluctance to act independently 
Examples of failure to act independently, or to move beyond 
conventional thinking, were cited as barriers to 
incrementalism. 
• Primacy of data 
Dependence on validated quantitative data was, to a lesser 
extent, cited as a culture hindrance to incrementalism, 
implying that lack of supporting data prevented action. 
Little evidence was seen in Case F of support or hindrance of the 
planning process. Some indication of earlier, failed attempts at 
planning were suggested but their details were not uncovered well. 
The most interesting aspect of this case was the evidence of cultural 
lag between the senior managers and the middle managers. 
Examples were cited of middle managers failing to engage in either 
planning or incrementalism and showing a habit of awaiting 
command instructions. This suggested that a command culture 
remained in this layer of management, despite attempts to change 
that by the senior management team. 
The marketing strategy resulting from this command and 
incrementalism hybrid marketing strategy making process had the 
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 properties of a weak strategy. Target definition was in terms of 
product categories with no indication of needs based segmentation. 
The value proposition development was augmented with components 
such as CME (continuing medical education) but was not 
significantly differentiated between customers. There was some 
indication of differential resource allocation at sales level, based on 
opportunity size. Understanding (and therefore alignment) of relative 
strengths and weaknesses was weak. Finally, the strategy was not 
significantly different from those of the major competitors in terms of 
either targeting or the nature of the proposition. 
In conclusion, Case F was an example of a weak strategy arising from 
a hybrid marketing strategy making process that was neither 
macrocongruent nor microcongruent. Given the complex and slightly 
turbulent market conditions, this therefore offered important insights 
into effective marketing strategy making: 
• The way in which a complex market is not well managed by a 
process with a large command element. 
• The way in which an organisational culture that is supportive 
of command processes may hinder incremental or planning 
processes. 
This case left unanswered what hybrid marketing strategy making 
process might be macrocongruent to complex market conditions or 
how such a process might interact with a command culture. Taken in 
the context of other cases, however, this case may suggest possible 
answers for both situations. 
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 5.5.7 Case G 
Case G was based on only one respondent. 
Case G was an example of a moderately strong strategy associated 
with moderately high levels of macrocongruence and 
microcongruence. Case G was the UK sales and marketing subsidiary 
of a very large multinational pharmaceutical firm. The business had a 
wide therapeutic area spread but a purely UK geographic interest. Its 
customer base was wide and varied. This company was in the first 
rank of its industry. 
The market in which Case G operated was relatively complex with 
some market turbulence: 
Complexity 
The complexity of the market conditions facing Case G arose from its 
broad product portfolio, increasingly complex customer decision 
making processes and increasingly non-product value proposition. 
The broad product portfolio included several therapeutic areas and 
covered acute and chronic conditions in both primary and secondary 
care. The increasing importance of health economics needs arising 
from healthcare reforms was cited as an example of proposition 
complexity beyond the traditional product-based approach. This 
implied a much more complex customer decision making process 
than the traditional prescriber-only model, involving more complex 
interaction of different stakeholders. There was some complexity 
arising from a mixture of indirect channels to market. The 
competitive aspect of the market was relatively straightforward, with 
a small number of similar competitors and a tier of generic 
manufacturers. 
Stability 
This market had many aspects of stability arising from the extended 
development time for new products, the highly regulated nature of 
the market and the culture of its single main customer, the UK 
National Health Service. There were some moderated signs of market 
turbulence arising from changes in customer buying processes, 
namely the advent of bodies to control drug usage (such as NICE, the 
National Institute of Clinical Excellence) and the use of information 
technology by patients, prescribers and distribution channels. 
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 The hybrid marketing strategy making process in use was a 
combination of planning and command. Some limited evidence of 
attempts at incrementalism was cited but these, as discussed later, 
were nullified by the organisational culture. 
The core of the product strategy was determined centrally via the 
research and development process. This occurred in a UK based 
group but the structure of the organisation was such that the UK 
subsidiary was on the same footing as other national subsidiaries. 
The very long timescale of research and development programmes 
and the associated regulatory approval process was a fundamental 
factor, around which much of the strategy was dependent. This 
global command process, therefore, presented the subsidiary with a 
product portfolio, much of the augmented product (in the form of 
clinical evidence) and financial targets. Further evidence of an 
external command process was exhibited by legally binding pricing 
constraints applied by the UK government. A formalised rational 
planning process was then added to this core strategy and was 
responsible for allocation of sales and marketing resources. Most 
notably, there was evidence of significant coordination between the 
centralised process and the local rational planning process, as 
discussed later. There was little evidence of incrementalism exhibited, 
either deliberately or otherwise. 
This mixture of command and planning processes demonstrated 
significant but not complete macrocongruence with market 
conditions. The process accommodated well the complexities of the 
product portfolio and, to a large degree, the recently developed 
complexities of the decision making process and the augmented, 
health economics based value propositions. More limited was the 
degree to which turbulence was accommodated. Examples of market 
turbulence, such as changes in market structures and competitor 
tactics, were not rapidly or well managed by the hybrid marketing 
strategy making process. This was cited as being due to the inability 
of the process to make incremental changes. 
This case also exhibited some, but not complete, microcongruence 
between the hybrid marketing strategy making process and the 
organisational culture. 
 
The Effectiveness of Marketing Strategy Making Processes in Medical Markets 
 (2003)  Page 147 
 The visionary command process was facilitated by two notable 
cultural artefacts: 
• Command acceptance 
The acceptance of the product pipeline and (with political 
negotiation) financial targets was, as with some other cases, a 
notable aspect of microcongruence between the command 
process and the organisational culture. 
• Process interconnects 
Case G cited clear, frequent interconnects between the local 
and central strategy making processes as important to effective 
marketing strategy making. This was contrasted with previous 
practice of only annual interconnects. Further, the quality of 
the interconnects (i.e. communicated market data and 
intangible opinions rather than just hard financial data) was 
suggested as an important factor in making the overall process 
work. 
The incremental process was hindered by two notable cultural 
artefacts: 
• Bureaucratic processes 
As with other cases, decision approval processes that were 
heavily formalised and time-demanding were cited as intangible 
barriers to the effectiveness of incremental processes. 
• Flat structures 
Interestingly, flat structures were cited as a hindrance to 
incrementalism and speed of reaction. Although designed to 
improve top-down coordination, they were claimed to reduce 
flexibility when cross-function responses were needed. The 
mechanism that was perceived to cause this hindrance was the 
need to gain approval from a large number of near-peers, as 
compared with a need for the approval of one or two superiors 
in a hierarchy structure. 
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 The rational planning process was hindered by two notable cultural 
artefacts: 
• Extensive management information systems 
The case exhibited extensive management information systems, 
integrating internal and external data. An usually large amount 
of resource was dedicated to business information gathering 
and analysis to support the rational planning process. 
• Strong process demarcation 
Case G was noteworthy to the extent that its processes were 
clearly demarcated and interconnected. A planning calendar 
was the basis for a set of interconnected planning processes 
that went far beyond merely connecting sales and marketing 
plans to financial budgets and targets. 
The marketing strategy resulting from this command and 
incrementalism hybrid marketing strategy making process was 
moderately strong. Target definition was in terms of product 
categories, with little indication of needs based segmentation; 
however, some evidence of this existed at sales level and may have 
been outside the knowledge of the respondent. The value proposition 
development was augmented with components such as CME 
(continuing medical education) and other support elements and was 
significantly differentiated between customers, but at a sales level. 
There was further indication of differential resource allocation at 
sales level, based on opportunity size. Understanding and alignment 
of relative strengths and weaknesses was moderately strong, with the 
organisation attempting to leverage its size and concomitant support 
capabilities. Finally, the strategy was not significantly different from 
those of the major competitors in terms of targeting, but had some 
degree of differentiation in its proposition. 
In conclusion, Case G was an example of a moderately strong 
strategy arising from a hybrid marketing strategy making process 
that was macrocongruent and microcongruent to a limited degree. 
Given the complex and slightly turbulent market conditions, this 
therefore offered important insights into effective marketing strategy 
making: 
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 • The way in which a complex market is well managed by a 
process with a large planning element. 
• The way in which an organisational culture may support 
rational planning processes with artefacts such as clear 
processes, interconnects and management information 
resources. 
• The way in which organisational culture may hinder 
incrementalism with artefacts such as flat structures and 
bureaucratic systems. 
The case contrasted with Case F, with which it shared important  
similarities and contrasts.  
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 5.5.8 Case H 
Case H was an example of a strong strategy associated with high 
levels of both macrocongruence and microcongruence. Case H was 
the UK headquarters of a small medical equipment company, part of 
a large medical devices group which was itself part of a conglomerate. 
This company had a very tightly focussed product area, and operated 
mostly in a single niche within that area. As such, the business had a 
very narrow focus. Whilst it operated internationally via distributors, 
this was a very small part of its business. Similarly, although it had a 
product range, all products within that range were closely based 
around one core technology. Within its area of interest, this company 
held a very strong, market leading position. 
The market in which Case H operated was relatively simple and 
stable: 
Complexity 
This case dealt largely within the UK and almost entirely in one 
tightly defined product area. As a result, the breadth of competitors 
was also very narrow. In practice, the product range was also very 
narrow and the company dealt directly with the market rather than 
through channels. Some complexity arose from the decision making 
unit consisting of users, specifiers and purchasers, with almost all of 
these decisions taking place within the relatively homogeneous 
structure of the UK National Health Service. The very tight, albeit 
product defined, nature of the market, implied little segmentation 
within the niche. It was notable that the company’s recent attempts 
to internationalise were introducing significant complexity into its 
situation, as discussed later. 
Stability 
The stability of this market arose from both its relative maturity, in 
terms of product form life cycle, and the relatively niche nature of the 
sector, which had led to comparatively little change in market 
conditions (e.g. few new entrants). Hence, this case experienced 
relatively little challenge in terms of market turbulence. Such change 
as had occurred in the market had been of the nature of gradual 
change to underlying technologies. 
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 The hybrid marketing strategy making process was strongly 
command with some incrementalism and almost no indication of a 
rational planning process. The core of the strategy was dictated by a 
pair of senior managers who worked closely together. Interestingly, 
the company had a strong history of command and the leading pair 
had inherited this role from the founder of the company, now retired. 
No significant command came from the group headquarters, other 
than financial objectives. In addition to the core command process, 
some evidence of incrementalism was visible. This was principally in 
the form of, firstly, incremental product changes driven by research 
and development and, secondly, political and cultural 
incrementalism, arising from negotiation within what appeared to be 
a fairly highly politicized setting. Almost no indication of rational 
planning was noted, even though the formal qualifications and skills 
were available. 
This hybrid of visionary command plus limited incrementalism 
process was highly macrocongruent to the home (UK) market, 
although noticeably less so for the international arena. In the home 
market, the command process coped well with the limited complexity 
and turbulence and was noted to be effective at understanding the 
needs of the market. Furthermore, it transmitted those needs well 
within the organisation and supported effective strategy 
implementation. For such a small company, it was significant that 
the command process maintained the focus that seemed key to its 
success. The degree of incrementalism was effective in keeping pace 
with the limited turbulence of the market and also with some of the 
complexity associated with entering less developed overseas markets, 
which involved only the production of line extensions. 
Some lack of macrocongruence was noted in the development of more 
developed markets such as the US. In such cases, the greater 
complexity associated with channels, buying processes and market 
segmentation were not well understood by the command process. 
This case exhibited a high degree of microcongruence between the 
hybrid marketing strategy making process and the organisational 
culture. 
 
The Effectiveness of Marketing Strategy Making Processes in Medical Markets 
 (2003)  Page 152 
 The command process was facilitated by two notable cultural 
artefacts: 
• Strength of the managing team cohesion 
This case was remarkable in the cohesion and consensus 
between the managing pair and, less obviously, their peers. 
This seemed to be an artefact of long service and enculturation. 
Both managers were developed under the reign of the founder. 
• Acceptance culture by the whole organisation 
Case H continued to demonstrate the strong, patriarchal and 
accepting conservative culture which respondents associated 
with the founder. Numerous examples were cited in which this 
facilitated the command and incremental hybrid marketing 
strategy making process and, to a lesser extent, hindered 
attempts at rational planning. Prime among these examples 
was the belief in tacit knowledge and the resistance to objective 
data. 
Note however, that the command process had been temporarily 
weakened in the past by key staff turnover and this was seen as a 
threat to management team cohesion. 
The incremental process was supported by two notable cultural 
artefacts: 
• Technical values 
The organisation was notable for the value placed upon 
technical expertise within its niche. This enabled incremental 
change by an “overskilling” effect also seen in other cases. 
• Narrow focus 
The remarkably narrow focus of the organisation, to the extent 
that it had eschewed even closely related product development, 
was seen to enable the incremental process by creating a very 
strong internal base of market knowledge, along with artefacts 
such as shared jargon, that was noticeably stronger than in 
more diversified organisations. 
As mentioned, the degree of rational planning was so small as to hide 
any microcongruence between it and the organisational culture. 
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 The marketing strategy resulting from the above process had the 
properties of a strong strategy. The target market appeared to be 
homogeneous, although with tiered levels of needs reflecting some 
kind of contextual segmentation. Accordingly, the differentiation of 
tiered value propositions was described, built around the core 
product strategy. The use of service, support and personal expertise 
to build augmented propositions was described. This combination of 
targeting and positioning was shown to leverage the organisational 
strengths of human resource skills and reputation. In addition, this 
strategy was seen as a defence against the threat of less specialised 
but cheaper new entrants. Finally, the strategy was identified as 
different from the competitors in its proposition, although the 
targeting was different only in focus, not in absolute terms. 
In conclusion, Case H was an example of a strong strategy, arising 
from a strongly command process that was both macrocongruent and 
microcongruent. As with other cases, the stable and simple market 
conditions may have been partly responsible for this. However, the 
case offered insights into effective marketing strategy making: 
• The way in which simple, stable markets appear to be well 
managed by strongly command processes with limited 
incrementalism. 
• The combination of cultural artefacts (coherent teams, strong, 
focussed cultures) that is supportive of command and 
incremental processes. 
The case left unanswered how the strategy making process might 
adapt to increased complexity, as indicated by attempts to 
internationalise. 
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 5.5.9 Case I 
Case I was an example of a strong strategy associated with high 
levels of macrocongruence and microcongruence. The case  was the 
UK headquarters of a medium sized medical equipment company, 
part of a large medical devices group which was itself part of a 
conglomerate. This company was tightly focussed within a product 
sector, although this case was responsible for the business in that 
sector across many geographical markets. Within its area of interest, 
this company held a strong position against a number of larger 
competitors. 
The market in which Case I operated was relatively complex and 
stable: 
Complexity 
The complexity of this case arose mostly from its geographical 
spread, but also from other parts of the market situation. This case 
dealt with a large number of geographical markets, with varying 
needs and different healthcare systems. There was a moderate 
number of competitors, varying across the product range. The 
product range, although quite narrow, met a number of different 
usage contexts. Distribution channels varied from direct to via 
channels in different markets. Some complexity arose from the 
decision making unit consisting of users, specifiers and purchasers. 
The value proposition contained a complex mixture of capital goods, 
consumables, support and service. 
Stability 
The stability of this market arose from the long product development 
times, and the associated capital investment, which both deterred 
entrants and reduced the frequency of new product introduction. In 
addition, the pharmaceutical-related approval procedures associated 
with this equipment further dampened market turbulence. Hence, 
this case experienced relatively little challenge in terms of market 
turbulence. Such change as had occurred in the market had been of 
the nature of gradual change to underlying technologies, together 
with some customer changes associated with clinical practice or 
healthcare system reforms. 
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 The hybrid marketing strategy making process was strongly rational 
planning with some incrementalism and little indication of a 
visionary command process. Case I appeared to make significant use 
of rational planning tools and techniques and these were mentioned 
often in the interviews. This rational planning process was largely 
responsible for development of the core propositions, their augmented 
service and support components, and the targeting of resources. The 
respondents at first cited no incremental activity, pointing to the 
restrictions created by product development. However, on probing, 
incremental activity (including deliberate experimentation) was cited 
in the allocation of promotional resources. Further, some evidence of 
political and cultural incrementalism was noted. The command part 
of the process was very limited. The broad sphere of market activity 
was defined by the headquarters of the medical division of the 
conglomerate. This was done to ensure no conflict with other 
companies within the group. Further, the divisional headquarters set 
financial targets. Within this framework however, Case I was granted 
a high degree of autonomy. 
This process of rational planning plus limited incrementalism was 
highly macrocongruent to the market situation faced by Case I. The 
rational planning process coped well with the complexity of the 
market, for instance in prioritising market opportunities across the 
global market and differentiating the competitive threats from large 
generalist and smaller specialist rivals. The rational planning process 
faced little challenge from market turbulence and, unsurprisingly, 
little sign of macroincongruence with market turbulence was seen. It 
was notable that the respondents identified possible future 
shortcomings of the planning process in terms of its inability to 
understand likely discontinuous change; however, no evidence of this 
was cited. The incremental part of the process was used to assess the 
impact of small changes in promotional resource where other 
techniques, such as modelling, were inappropriate due to lack of 
data. Hence deliberate testing of promotional campaigns was carried 
out. 
This case also exhibited a high degree of microcongruence between 
the hybrid marketing strategy making process and the organisational 
culture. 
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 The rational planning process was supported by: 
• Senior management commitment 
The planning process was clearly sponsored by the leadership 
of the organisation. This was evidenced by commitment to 
formal processes and allocation of resources to acquiring 
market research data. 
• The value attributed to planning knowledge 
Case I was one of the few cases in which knowledge of formal 
planning techniques was both extant and valued. Recruitment 
and training policies had encouraged this and the language of 
the organisation reflected it also. 
The incremental process was supported by the cultural belief in 
measurement, and hence the willingness to defer action until testing 
was carried out. Note, however, that incrementalism in terms of the 
core product was seen to be limited by cultural artefacts of complex 
product development programmes with long lead times. 
The visionary command process, in as much as it contributed in this 
case, was supported by a combination of clear role demarcation and 
autonomy within the strategic framework. 
The marketing strategy resulting from the above process had the 
properties of a strong strategy. The product-defined target markets 
were, by their nature, quite homogeneous and there was evidence of 
motivator-based segmentation in addition to that. In each of the two 
product areas, there was only one type of value proposition, but this 
reflected the premium segment targeted. The use of service, support 
and personal expertise to build augmented propositions was 
described. This combination of targeting and positioning was shown 
to leverage organisational strengths in product development but also 
in support and service. The positioning adopted was clearly aligned to 
minimise the threats arising from the two different types of 
competitors. Finally, the strategy was identified as different in both 
targeting and proposition from the competitors, although this was 
limited within the confines of a tightly defined market. 
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 In conclusion, Case I was an example of a strong strategy arising 
from a strongly rational planning process that was both 
macrocongruent and microcongruent. Whilst the market conditions 
offered little challenge in terms of turbulence, the hybrid marketing 
strategy making process coped well with a high degree of market 
complexity. The case therefore offered insights into effective 
marketing strategy making: 
• The way in which complex, stable markets appear to be well 
managed by strongly rational planning processes with limited 
incrementalism. 
• The combination of cultural artefacts (top management 
sponsorship, valued technique knowledge, belief in 
measurement) that is supportive of rational planning and 
incremental processes. 
The case left unanswered how the strategy making process might 
adapt to increased, discontinuous turbulence, as anticipated by the 
respondents. 
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 5.5.10 Case J 
Case J was based on only two respondents. 
Case J was an example of a strong strategy associated with high 
levels of macrocongruence and microcongruence. The case was the 
UK sales and marketing subsidiary of a very large multinational 
pharmaceutical firm. The business had a moderately wide 
therapeutic area spread, but a purely UK geographic interest. Its 
customer base was broad and varied. This company was in the first 
rank of its industry. 
The market in which Case J operated was relatively complex with 
some market turbulence: 
Complexity 
The complexity of the market conditions facing Case J arose from its 
product portfolio, increasingly complex customer decision making 
processes and increasingly non-product value proposition. The 
product portfolio included several therapeutic areas and covered 
acute and chronic conditions in secondary care. The increasing 
importance of health economics needs arising from healthcare 
reforms was cited as an example of proposition complexity beyond 
the traditional product-based approach. This implied a much more 
complex decision making process than the traditional prescriber-only 
model, involving more complex interaction of different clinical and 
non-clinical audiences. Channels to market were relatively simple. 
The competitive aspect of the market was slightly complex, with 
different competitors in different therapeutic areas. 
Stability 
This market had many aspects of stability arising from the extended 
development time for new products, the highly regulated nature of 
the market and the culture of its single main customer, the UK 
National Health Service. There were some moderated signs of market 
turbulence arising from changes in the customer buying processes, 
the advent of bodies to control drug usage (such as NICE, the 
National Institute of Clinical Excellence) and the development of new 
approaches to product assessment, such as evidence based medicine. 
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 The hybrid marketing strategy making process in use was primarily 
rational planning within a command framework, supplemented by 
topical incrementalism in some circumstances. 
The core of the product strategy was determined centrally via the 
research and development process. This occurred at a global level 
and although processes existed for subsidiaries to contribute to the 
decision, these fundamental decisions were taken at the US 
headquarters. Not only did the US base of the company influence 
strategy, but so did the relative dominance of the US market, in 
terms of its size and growth. This global command process therefore 
presented the subsidiary with a product portfolio, much of the 
augmented product (in the form of clinical evidence for efficacy 
claims) and financial targets. Further evidence of an external 
command process was exhibited by legally binding pricing 
constraints applied by the UK government. A formalised rational 
planning process was then added to this core strategy and was 
responsible for the allocation of sales and marketing resources. Case 
J exhibited one of the most clear examples of a rational process seen 
in this work and respondents pointed out that external consultant 
help had been used to create their process. Significantly, this formal 
process was also used to optimise coherence between central and 
subsidiary processes. Apart from a “base” level of political 
incrementalism seen at a tactical level, there was no significant 
evidence of incrementalism playing a constant role in the hybrid 
marketing strategy making process. However, it was notable that this 
company made frequent use of ad hoc teams to address localised 
areas of market turbulence, such as competitor activity or customer 
re-structuring. Hence Case J was an example of a predominantly 
planning process, albeit within a command framework and 
supplemented by controlled and localised incrementalism. 
This mixture of processes demonstrated strong macrocongruence to 
the relatively complex market, with some market turbulence, faced by 
the company. The process accommodated well the complexities of the 
product portfolio and, to a large degree, the recently developed 
complexities of the decision making process and the augmented, 
health economics based value propositions. Especially interesting 
was the manner in which the planning process accommodated the 
complex segmentation amongst clinicians that was partly the result 
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 of transition between individual and group decision making units. 
Moreover, the planning process identified areas of turbulence and 
then “delegated” responsibility for those to temporary, ad hoc, cross 
functional teams. Examples of this were to address competitor 
activity or changes in customer buying processes. The command 
framework allowed transfer of ideas across national markets, 
something that was significant in the relatively globalised therapeutic 
areas in which the company was operating. 
This case also showed strong microcongruence between the hybrid 
marketing strategy making process and the organisational culture. 
The visionary command process was facilitated by two notable 
cultural artefacts: 
• Command acceptance 
The acceptance of the product pipeline and (with political 
negotiation) financial targets was, as with some other cases, a 
notable aspect of microcongruence between the command 
process and the organisational culture. 
• Role demarcation and local autonomy 
Case J demonstrated clear separation between the resource 
allocation responsibilities of the visionary command process 
(located centrally) and the rational planning process (located in 
the subsidiary). This demarcation, and the accompanying 
autonomy within the roles, was cited as important. 
The incremental process was supported by two notable cultural 
artefacts: 
• Ad hoc teams 
More than other cases, Case J supported incremental 
processes by the deliberate and organised use of ad hoc teams 
to address specific areas of turbulence, but notably as a 
complement to the command framework and the rational 
planning process. 
• Managerial experience 
Interestingly, there was some indication of how human 
resource policies were seen to support incrementalism. The 
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 sample did not allow confirmation, but it appeared that 
maturity and experience were more highly valued in Case J 
than in some comparable cases. 
The rational planning process was supported by two notable cultural 
artefacts: 
• The use of external consultants 
Case J had employed external consultants to help develop its 
rational planning process. This was cited as important to the 
creation of a process that addressed the circumstances of the 
company. However, it was clear that the external development 
had been supported by internal training processes. 
• Top management sponsorship 
It was notable that the rational planning process was motivated 
and supported by senior management, both within the case 
and by the US headquarters. Significant financial and other 
resources had been allocated to planning and it was valued in 
reward and recognition systems. 
The marketing strategy resulting from the above blend of processes 
exhibited the properties of a strong strategy. Target definition was 
especially strong. Within the traditional therapy area and job-title 
definition of customers, a sophisticated motivational segmentation 
process was demonstrated, leading to distinct and homogeneous 
target definition. The value propositions were developed to reflect 
those motivations and, in addition to the core product, components 
such as CME (continuing medical education) and other support 
elements were significantly differentiated between customers, within 
the constraints of the UK National Health Service. Understanding and 
alignment of relative strengths and weaknesses was strong, with the 
organisation attempting to leverage its therapy area expertise and 
concomitant support capabilities, but also its management skills. 
Hence, the strategy was significantly different from those of its major 
competitors, especially in terms of targeting but also, to some degree, 
in the differentiation of its proposition. 
In conclusion, Case J was an example of a strong strategy arising 
from a hybrid marketing strategy making process that was both 
macrocongruent and microcongruent. Given the complex and slightly 
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 turbulent market conditions, this therefore offered important insights 
into effective marketing strategy making: 
• The way in which a complex market is well managed by a 
process with a large planning element. 
• The way in which an organisational culture may support 
rational planning processes with artefacts such as top 
management sponsorship and the use of external consultants. 
• The way in which organisational culture may support 
incrementalism with artefacts such as ad hoc teams and by 
valuing managerial experience. 
The case provided an interesting comparison to Cases G, J and P, 
with which it shared important similarities and differences. 
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 5.5.11 Case K 
Case K was an example of weak strategy associated with low levels of 
both macrocongruence and microcongruence. The case was an 
international SBU of a UK based manufacturer of medical devices. 
The business therefore had a narrow product interest but a very wide 
geographic interest. Its customer base included a number of clinical 
roles and other members of a complex DMU. This company was in 
the first rank of its industry. 
The market in which Case K operated was relatively complex with 
little market turbulence: 
Complexity 
The complexity of the market conditions facing Case K arose not from 
its relatively narrow product portfolio but mostly from its 
international interests. The therapy area in which it worked varied in 
clinical approach between national markets. In addition, 
progressively more complex customer decision making processes and 
an increasingly non-product value proposition added to the 
complexity. The product covered mostly secondary care, in domestic 
and institutional settings, for a chronic rather than acute condition. 
The increasing importance of overall patient management was cited 
as an example of proposition complexity beyond the traditional 
product-based approach. This implied a much more complex decision 
making process than the traditional user-only model, involving more 
complex interaction of different clinical and non-clinical audiences. 
Channels to market were relatively complex, varying from country to 
country. The competitive aspect of the market was slightly complex, 
with different competitors in each of the therapeutic areas and more 
than one product form in competition. 
Stability 
This market had many aspects of stability arising from the relatively 
niche area of the treatment and the nature of its core technology. 
Although there was some technological turbulence, this was relatively 
minor. In addition, the secondary care, chronic, nature of the market 
implied a high level of stability. There were some signs of turbulence 
associated with healthcare reforms, but these were gradual and 
predictable. 
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 The hybrid marketing strategy making process in use was primarily 
command with political incrementalism. It was notable that the 
respondents initially espoused planning, but probing revealed this to 
be in fact a heavily command oriented process. 
The core of the strategy was determined centrally by a group of senior 
managers. This command process determined the product strategy, 
pricing frameworks, the clinical support (which dictated positioning) 
and set financial targets. This core strategy was then moderated by 
political incrementalism, i.e. negotiation between senior managers at 
international and national level. In addition, the parameters of the 
core strategy were set by a central strategy group which co-ordinated 
SBU strategies and allocated research, development and regulatory/ 
clinical resources. Very little evidence was seen of rational planning 
processes. These were espoused, but no significant evidence for them 
emerged even after close probing. Instead, “planning” was apparently 
used as a euphemism for control mechanisms, especially budgeting. 
This strongly command and political incrementalism process 
exhibited many signs of poor macrocongruence and 
microcongruence. Macrocongruence to market complexity was 
evidenced in poor explication of market differences across the 
international scope of the SBU. In addition, the respondents showed 
little sign of being able to differentiate the nature of the competitive 
threats arising from the different product forms in the market. The 
process did not demonstrate understanding of the change from 
product-based propositions to condition management, despite the 
importance of this cited by the respondents. Nor, despite probing, 
was there significant comprehension of the effects of demographic 
and political changes, both important to this market. The relative 
lack of macroincongruence to market turbulence was commensurate 
with the stable nature of the market. However, it was noted that the 
rather rigid “planning” (i.e. budgetary) calendars hindered response 
to local turbulence arising from competitor activity. 
This case also demonstrated poor microcongruence between the 
hybrid marketing strategy making process and the organisational 
culture. 
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 The incremental process was hindered by two notable cultural 
artefacts: 
• Lack of communication 
In contrast with some other cases, Case K demonstrated a lack 
of communication between the central body, which produced 
the command component of the strategy and the subsidiary 
responsible for implementation of the strategy. This was 
evidenced in both the mode of communication (mostly top 
down) and its content (financials and product features, with 
little concerning market or customer factors). 
• Lack of role demarcation or local autonomy 
Case K demonstrated much less demarcation in the resources 
allocated by the central and local functions. Compared with 
other cases, the level of decisions made in the centre appeared 
to be much lower (i.e. more tactical) and the framework within 
which the incremental process could operate was considerably 
less clear in Case K. 
The visionary command process was supported by two notable 
cultural artefacts: 
• Strong “Barons”  
It was notable that the political influence wielded by certain 
key managers (at international and local level) was critical in 
the visionary part of the process. 
• Financial control systems 
Case K exhibited financial and other control mechanisms 
aligned to its product, rather than market, structures and this 
was cited as an important part of the mechanism by which the 
command process was implemented. 
The rational planning process was hindered by the low valuation of 
planning tools. Case K was interesting in that although the strategy 
making team included staff who were qualified and knowledgeable of 
planning techniques, the culture did not appear to value these skills 
highly. It appeared that greater value was placed on a combination of 
product knowledge and political abilities. 
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 The marketing strategy resulting from the above blend of processes 
exhibited the properties of a weak strategy. Target definition was 
purely a combination of national and product categories, with no sign 
of homogeneous target definition. The value proposition was mostly 
fixed, with only a small degree of tactical tailoring carried out at sales 
team level. Similarly, such differential allocation of resources as 
occurred was a tactical manoeuvre carried out at a very low level. The 
case demonstrated poor understanding of relative strengths and 
weaknesses. Hence, alignment to market opportunities and threats 
was not discernible. Finally, there was no significant differentiation 
between Case K and its competitors in the nature of its targeting or 
the value proposition. 
In conclusion, Case K was an example of a weak strategy arising from 
a hybrid marketing strategy making process that was neither 
macrocongruent nor microcongruent. Given the complex and stable 
market conditions, this therefore offered important insights into 
effective marketing strategy making: 
• The way in which a complex market is not well managed by a 
process with a strong command element. 
• The way in which an organisational culture may support 
command processes but, perhaps, at the cost of rational 
planning and incremental processes. The role of “Barons” and 
control systems seems prominent in this. 
The case provided an interesting comparison to Case L, with which it 
shared important similarities and contrasts. 
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 5.5.12 Case L 
Case L was an example of strong strategy associated with high levels 
of both macrocongruence and microcongruence. The case was the UK 
SBU of a US based manufacturer of medical devices and equipment. 
The business therefore had a narrow product interest and a narrow 
UK geographic interest. Its customer base was tightly defined to a 
small number (300-400) of similar decision making units, almost all 
within the UK National Health Service, and in the acute sector. This 
company was the market leader of its sector, and was part of one of 
the world’s top medical companies. 
The market in which Case L operated was comparatively simple but 
exhibited relatively high market turbulence: 
Complexity 
The lack of complexity of the market conditions facing Case L was 
particularly interesting, in that it was artificially created. Case L was 
part of a very large medical devices group, which operated in many 
diverse market sectors. Unusually, however, the parent company had 
chosen to structure itself as a large number of self-contained 
business units that were largely autonomous from the other SBUs. 
Hence Case L was, like the other SBUs in the group, very tightly 
focussed upon one well defined market sector. This contrasted 
significantly with its competitors and other cases in this study. As a 
result, the customer, competitor and channel factors for Case L all 
suggested a simple market. Some complexity was suggested in the 
nature of the value proposition and the decision making process, but 
this was limited by the fact that almost all of the decision making 
units were within a single, specified part of the acute sector. 
Stability 
This case was prominent as the most turbulent of the cases 
examined in this work. The product sector in which it operated was 
in a growth phase of its product form life cycle, demonstrating 
notable degrees of turbulence in product form, clinical practice and 
purchasing behaviour. Competitive turbulence was declining, due to 
industry consolidation, but the sector remained turbulent. This was 
evidenced, for instance, by the development of new clinical 
applications for the product category. Notably, although product 
development times were significant, both they and the regulatory 
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 burden were somewhat less of a moderator of market turbulence 
than in many of the other cases. 
The hybrid marketing strategy making process in use was primarily 
command with local incrementalism. The core of the strategy was 
determined centrally via the product development programme based 
in the US. It was cited that this was partly because of the structure of 
the division, but also because the US was the lead market in this 
globalised sector. This command process determined the product 
strategy, the clinical support (which dictated positioning) and set 
financial targets. This core strategy was then developed by local 
incrementalism that was responsible for the augmented proposition, 
as well as pricing and allocation of local sales and marketing 
resources. There was no evidence of a formal rational planning 
process at this level, other than routine budgeting processes. The 
respondents did not espouse significant use of tools and techniques. 
This strongly command and local incrementalism process exhibited 
many signs of strong macrocongruence and microcongruence. 
Macrocongruence to market complexity was not evidenced in relation 
to the relatively simple conditions regarding the core product. The 
direct channels and simple competitive picture was well managed by 
the command process, particularly as this did not vary greatly across 
national markets. More significant was the allocation of resource to 
the augmented product in the face of significant market complexity 
with respect to customer needs and buying processes. Not only were 
these important, but they differed between national markets. The 
augmented product included not only service and support, but 
frequently extensive non-core elements such as financial and logistics 
management. This part of the market conditions was handled well by 
local incrementalism within the strategic framework created by the 
command-created product strategy. In addition to this 
macrocongruence to local market conditions, the command process 
was cited to work well in communicating the implications of 
macroenvironmental changes, such as technology, demographics or 
changes in clinical practice. 
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 This case also demonstrated strong microcongruence between the 
hybrid marketing strategy making process and the organisational 
culture. 
The incremental process was supported by two notable cultural 
artefacts: 
• Strongly held cultural assumptions 
This case demonstrated a particularly strong set of cultural 
assumptions that were commonly held amongst the 
respondents. These arose from a combination of the core 
assumptions of the larger organisation and the additional 
assumptions of the SBU. In particular, these assumptions 
concerned the primacy of clinical care and the role of financial 
objectives to support that. 
• Human resource policies 
As in other cases, the incremental process appeared to depend 
critically on human resource policies. Unusually for the 
industry, recruitment valued commercial skills over clinical or 
product skills; training and retention activity reinforced this. 
The incremental creation of the augmented proposition was 
dependent on the same “overskilling” human resource policy 
seen, for instance, in Case A. 
The visionary command process was supported by two notable 
cultural artefacts: 
• International leadership 
The visionary command process was facilitated by the global 
leadership of the US headquarters. Whilst this was a result of 
the external factor of US market primacy in this sector, it was 
also a cultural assumption that was important to making the 
incremental process work. 
• Role demarcation and autonomy 
Once again, Case L demonstrated the paired cultural artefacts 
of clear demarcation between centre and subsidiary, combined 
with a high degree of local autonomy within this strategic 
framework. These were seen as important in supporting the 
visionary command process. 
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 The rational planning process was not significantly present in this 
case and hence microcongruence to it was not noted. 
The marketing strategy resulting from the above blend of processes 
exhibited the properties of a strong strategy. In addition to tight 
product market scope, market segmentation based upon attitudes 
and motivation was clearly observed. This segmentation drove 
allocation of promotional, sales, service and support resource. Value 
propositions were clearly tailored around this segmentation by the 
creation of individualised propositions using heavily augmented 
products which included management support. To do this, strategic 
alliances with third parties were created and managed. The case 
demonstrated clear understanding of relative strengths and 
weaknesses and alignment to market opportunities and threats 
reflected that. Finally, there was significant differentiation between 
Case L and its competitors in the nature of its targeting and the value 
proposition, albeit within the confines of a tightly defined market. 
In conclusion, Case L was an example of a strong strategy arising 
from a hybrid marketing strategy making process that was both 
macrocongruent and microcongruent. Given the simple and 
turbulent market conditions, this therefore offered important insights 
into effective marketing strategy making: 
• The way in which a complex market is effectively simplified by 
divisionalisation. 
• The way in which a strongly command process manages a 
simple global market. 
• The way in which local incrementalism handles localised and 
limited customer complexity. 
• The way in which an organisational culture supports command 
and incremental processes by strong shared assumptions, and 
human resource policies. 
The case provided an interesting comparison to Case K, with which it 
shared important similarities and contrasts. 
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 5.5.13 Case M 
Case M was an example of a weak strategy associated with low levels 
of macrocongruence but high levels of microcongruence. The case 
was the UK SBU of a multinational pharmaceutical company. The 
SBU had a moderate range of products and a narrow, purely UK, 
geographical focus. Its customer base was moderately diverse in both 
primary and secondary sectors. This company, although of significant 
size was in the second tier of global pharmaceutical companies. 
The market in which Case M operated was moderately complex with 
relatively stable market conditions:  
Complexity 
The moderate complexity of the market conditions facing Case M 
arose from the product range and customer groupings it served. Its 
primary interest lay in managing a chronic condition and its 
proposition was commensurately complex, including devices and 
pharmaceuticals. Its customers were primarily in the secondary care 
area but the decision making unit was a complex mix of primary and 
secondary care customers, both clinicians and others. The large 
numbers of patients involved implied a fragmented market, whilst the 
secondary care bias emphasised the importance of distribution 
channels such as pharmacies. However, this case did not have a 
large number of widely different therapy areas, nor did it operate 
outside the UK. Hence it faced moderate market complexity. 
Stability 
This case contained many of the stabilising factors mentioned in 
other cases. Foremost amongst those was the lengthy product 
development and regulatory approval process that limited product 
introductions. Further, the comparatively niche nature of this market 
limited new entrants and no significant technological turbulence was 
reported. In addition, much of the market dynamics in the most 
important, chronic therapy area were driven by demographics with 
concomitant slow change. Some aspects of market turbulence were 
noted, driven by a degree of competitor activity and by changes in 
customer structures resulting from healthcare system reforms. Hence 
the case exhibited only a slight degree of turbulence. 
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 The hybrid marketing strategy making process in use was primarily 
command with local incrementalism, although with very recent 
attempts to introduce rational planning. However, these latter 
attempts were so recent as to be mostly irrelevant to the current 
process or its outcomes. The core of the strategy was determined 
centrally via the product development programme based in the 
European headquarters. This visionary command process determined 
the product strategy, the clinical support (which dictated positioning) 
and set financial targets. It also heavily influenced some of the 
promotional strategy by its use of opinion leaders. This core strategy 
was then developed by local incrementalism that was responsible for 
allocation of local sales and marketing resources. Pricing was agreed 
by a political incremental process, although within tight 
governmental controls. Distribution or channel strategy was, to a 
large extent, dictated by product strategy. With the exception of 
espoused recent changes, there was no evidence of formal rational 
planning process at this level, other than routine budgeting 
processes. The respondents did espouse some use of tools and 
techniques but this was very recent and had not yet fed through to 
resource allocation decisions. In any case, this latter rational process 
was restricted to the UK subsidiary. 
This visionary command and local incrementalism process exhibited 
strong microcongruence but a notable lack of macrocongruence. 
Lack of macrocongruence was evidenced in relation to the moderate 
complexity of the market conditions. Respondents reported a lack of 
understanding of some of the complexity of customer structure, 
channel management and different types of competitive threats. 
Furthermore, there were indications that the variations between 
different national markets were not well addressed by the command 
element of the process. Respondents cited this lack of understanding 
as justification for recent attempts at rational planning. Some slight 
indications were also given that the process had not yet understood 
recent localised turbulence in customer structures and buying 
processes. 
This case demonstrated strong microcongruence between the hybrid 
marketing strategy making process and the organisational culture. 
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 The incremental process was hindered by lack of clear role 
demarcation between central and local processes. This was especially 
cited as regards promotional positioning. 
The visionary command process was supported by the product based 
structure and valuation of product, rather than customer knowledge. 
The rational planning process was not significantly present in this 
case but initial hindrance to it was reported in the form of 
communication and market data barriers. 
The marketing strategy resulting from the above blend of processes 
exhibited the properties of a weak strategy. Beyond basic product 
category definition, there was no evidence of targeting homogeneous 
groups or of needs based targeting. Consequently, value proposition 
tailoring and differential allocation of resources was seen only to a 
very limited degree at sales team level. Recognition and 
understanding of relative strengths and weaknesses was low and no 
noticeable alignment to market opportunities or threats was seen. 
Finally, neither the targeting nor the propositions were cited as 
significantly different from that of the major competitors. 
In conclusion, Case M was an example of a weak strategy arising 
from a hybrid marketing strategy making process that was 
microcongruent but not macrocongruent. Given the moderately 
complex and slightly turbulent market conditions, this therefore 
offered important insights into effective marketing strategy making: 
• The way in which a moderately complex market is not managed 
effectively by a visionary command process when the 
accompanying incremental process is hindered by the 
organisational culture. 
• The way in which a strongly command process is supported by 
a product-oriented set of values. 
The case provided an interesting comparison to Cases F, G and J, 
with which it shared important similarities and differences. 
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 5.5.14 Case N 
Case N was an example of a moderately weak marketing strategy 
associated with moderate levels of both macrocongruence and 
microcongruence. The case was the UK SBU of a US based 
manufacturer of medical devices and pharmaceuticals. The case had 
a UK only geographical focus but had a broad product range built 
around two closely related therapy areas. It was concerned with the 
management of a single tightly defined therapy area, covering a 
mixture of primary and secondary care. The case was the market 
leader in its sector and was part of a divisionalised multinational that 
was one of the largest medical companies in the world. 
The market in which Case N operated was both moderately complex 
and moderately turbulent: 
Complexity 
The moderate complexity facing Case N arose from the clinical 
process for managing this therapy area. As a result, the proposition 
included a complex mixture of devices and pharmaceuticals. In 
addition, the long-term nature of the condition required a complex 
augmented proposition to allow patient management. Further 
complexity was added by a variety of competitors and a mixture of 
delivery channels. Conversely, Case N covered only two closely 
related sectors and only in the UK. Overall, this represented an 
example of moderate market complexity. 
Stability 
This case contained many of the stabilising factors mentioned in 
other cases. This included a lengthy product development and 
regulatory approval process that limited product introductions, 
although this was slightly less constraining than in some purely 
pharmaceutical markets. Further, the relatively mature nature of this 
market discouraged new entrants and the market dynamics in this 
therapy area were largely driven by demographics with concomitant 
predictable change. However, some changes in underlying 
technologies, or convergence of technologies, was reported. In 
addition, significant changes in the manner in which healthcare 
providers chose to manage provision of this service to patients was 
noted. Hence Case N provided an example of moderate market 
turbulence. 
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 The hybrid marketing strategy making process in use was primarily 
command with local incrementalism. Initial claims of rational 
planning were, upon investigation, merely budgeting and simple 
prioritisation at sales team level. The core of the strategy was 
determined centrally via the product development programme based 
in the US and, to a lesser extent, by European divisional 
headquarters. This command process determined the product 
strategy (which largely defined target markets) and set financial 
targets. This core strategy was then developed by local 
incrementalism that was responsible for the augmented proposition, 
as well as pricing and allocation of local sales and marketing 
resources. There was little evidence of formal rational planning 
process at this level, other than routine budgeting processes and 
sales team prioritisation. The respondents did not espouse significant 
use of tools and techniques. 
This strongly command and local incrementalism process exhibited 
signs of moderate macrocongruence and microcongruence. 
Macrocongruence was indicated in relation to market turbulence. The 
command and incremental processes were cited as being able to cope 
well with continuous market change. However it was also cited that 
the process seemed to lag behind any discontinuous change, and 
that aspects of market complexity, especially with regards to 
customer needs, were not always well managed by the command 
process. To the limited extent that rational planning existed, it was 
noted as failing to respond to market turbulence. Hence this case 
represented a mid-way point in terms of macrocongruence, with some 
indications of the hybrid marketing strategy making process being 
both congruent and incongruent to the market conditions. 
This case also demonstrated moderate microcongruence between the 
hybrid marketing strategy making process and the organisational 
culture. 
The incremental process was supported by strong internal 
relationships, which were also cited as ameliorating any examples in 
which the command process and the incremental process conflicted. 
However, incrementalism was also hindered by beliefs in the primacy 
of hard data, which acted as a barrier to incrementalism when only 
intangible data was available or relevant. 
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 The visionary command process was supported by acceptance of the 
US market leadership and further facilitated by an extensive 
management information system. However, the command process 
was sometimes hindered by the matrix structure of the organisation. 
The rational planning process, insofar as it existed in this case, was 
hindered by cultural values relating to product expertise and 
consequent lack of value given to planning techniques and tools. 
The marketing strategy resulting from the above blend of processes 
exhibited both strong and weak properties. Target market definition 
was mostly product oriented, with only weak signs of sub-targeting 
within that. Value proposition tailoring and differential resource 
allocation was more noticeable, albeit mostly at a sales level rather 
than higher up the value chain. Some understanding of relative 
strengths and weaknesses was shown and there was a degree of 
alignment as emphasis was placed on customers who valued the 
organisation’s strengths in service and support. However, the 
targeting and proposition of this case were not markedly different 
from that of the competition. 
In conclusion, Case N was an example of a moderately weak strategy 
arising from a hybrid marketing strategy making process that was 
both moderately macrocongruent and moderately microcongruent. 
Since the case was also mid-range in terms of both complexity and 
turbulence, it represented a mid-point in each of the key variables. 
As such, it suggested the following important insights into effective 
marketing strategy making: 
• The way in which a very complex market is partly simplified by 
divisionalisation. 
• The way in which moderate degrees of macrocongruence and 
microcongruence are associated with moderate strength of 
marketing strategy. 
The case provided an interesting comparison to Case M, with which it 
shared important similarities and differences. 
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 5.5.15 Case O 
Case O was an example of a weak marketing strategy associated with 
low levels of macrocongruence, but high levels of microcongruence. 
The case was the UK headquarters of a small UK based manufacturer 
of medical equipment. The case had a UK only geographical focus but 
had a very broad product range. It covered a mixture of usage 
contexts and was concerned with the management of a wide 
spectrum of patient needs via a mixture of channels. The case was a 
small company in its sector and was part owned by venture 
capitalists. 
The market in which Case O operated was both relatively complex 
and relatively stable: 
Complexity 
The relative complexity facing Case O arose not from its products, 
which were reasonably simple, but from its complex proposition and 
market. The proposition included a complex specification, design and 
installation service in addition to the core products. The market was 
fragmented according to patient context and served by a number of 
different channels. As a result, the market scenario contained 
multiple competitors and customer types. The market was heavily 
influenced by government funding, channelled through a variety of 
bodies. There were a number of different decision making processes 
and complex decision making units. Hence Case O faced 
comparatively complex market conditions. 
Stability 
Unlike many of the cases in this study, the market turbulence facing 
Case O was not moderated by long product development and 
approval processes. In this case, neither factor applied particularly. 
However, the market was mature and of a relatively tight, niche 
nature. This had the effect of reducing product development and 
competitive activity. Further, the market was technologically 
relatively simple and showed no significant technological turbulence. 
Much of the market dynamics arose from basic demographic drivers 
and, as such, were relatively stable. Such turbulence as existed 
derived from changes in local government and other funding 
arrangements which implied turbulence at a detailed level, but 
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 overall stability. Hence Case O provided an example of relatively low 
market turbulence. 
The hybrid marketing strategy making process in use was strongly 
command with a small amount of local incrementalism. Respondents 
stated that no rational planning process was in place beyond 
extensive financial control systems. In fact, Case O was perhaps the 
strongest, most purely visionary command processes seen in any of 
the eighteen cases. The core of the strategy was determined centrally 
via a dominant leader, with some input from a small management 
team. This part of the process determined the core product range and 
the service and support elements that made up the most 
differentiating components of the proposition. Further, this command 
process was also responsible for many of the smaller scale resource 
allocation decisions concerning sales and marketing programmes and 
service and support activity. In addition, there was an element of 
external command dictated by external venture capitalists who held 
some of the organisation’s shares. Some limited political and cultural 
incrementalism was noted, which moderated some of the command 
process. However, this was limited to small changes to the core 
strategy. 
This strongly command process with limited incrementalism 
exhibited weak macrocongruence but strong microcongruence. 
Lack of macrocongruence was indicated in relation to market 
complexity. The strongly command process showed weak ability to 
understand the complexity of an unusually fragmented and 
complicated market which, despite its maturity and small size, 
contained many different channels and regional variations. In 
addition, the command process showed little ability to rationalise the 
competitive environment or to anticipate the implications of the 
important macroenvironmental forces acting on the market. Case O 
was unusually simplistic in its characterisation of its market. The 
stability of the market meant that lack of macrocongruence, with 
respect to turbulence, was not observed. 
This case also demonstrated strong microcongruence between the 
hybrid marketing strategy making process and the organisational 
culture. 
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 The visionary command process was supported by a somewhat 
autocratic culture with a high degree of decision making 
centralisation. This was further facilitated by detailed financial 
control measures. In addition, the cultural influence of external 
venture capitalists also supported the command process. The fairly 
flat structure associated with a small company also seemed to be 
important in supporting a visionary command process. 
The incremental process, to the extent that it existed in this case, was 
hindered by cultural artefacts of tight financial control systems, low 
levels of management autonomy and the primacy of short term 
financial objectives. 
No rational planning existed with which the organisational culture 
could be macrocongruent or otherwise. 
The marketing strategy resulting from the above strongly command 
process exhibited the properties of a weak strategy. Target market 
definition was either channel or product oriented, with no signs of 
sub-targeting to more homogeneous segments. Value proposition 
tailoring occurred to a small degree, at sales level, but there was no 
indication of differential resource allocation among targets. No 
significant understanding of relative strengths and weaknesses was 
shown; consequently, there was no noticeable deliberate alignment to 
market opportunities or threats. Finally, neither targeting nor value 
proposition showed any degree of uniqueness from the major 
competitors. 
In conclusion, Case O was an example of a weak strategy arising 
from a hybrid marketing strategy making process that was not 
macrocongruent but which was microcongruent. Since market 
conditions for this case were both stable and complex, it suggested 
the following important insights into effective marketing strategy 
making: 
• The way in which a very complex market is not understood by 
a strongly command process. 
• The way in which a visionary command process is supported 
by an autocratic culture with strong financial controls and 
external pressure. 
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 • The way in which incrementalism is hindered by low levels of 
management autonomy. 
The case provided an interesting comparison to Cases C, I, K and P, 
with which it shared important similarities and differences. 
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 5.5.16 Case P 
Case P was based on one respondent only. 
Case P was an example of a weak marketing strategy associated with 
low levels of macrocongruence, but high levels of microcongruence. 
The case was the UK sales and marketing subsidiary of a very large 
multinational pharmaceutical firm. The business had a wide 
therapeutic area spread but a purely UK geographic interest. Its 
customer base was wide and varied. This company was in the first 
rank of its industry. 
The market in which Case P operated was relatively complex but 
relatively stable: 
Complexity 
The complexity of the market conditions facing Case P arose from its 
broad product portfolio, increasingly complex customer decision 
making processes and increasingly non-product value proposition. 
The broad product portfolio included several therapeutic areas and 
covered acute and chronic conditions in both primary and secondary 
care. The reforms within the UK National Health Service, partly in an 
attempt to reduce spending on pharmaceuticals, had also led to a 
more complex customer decision making process. The increasing 
importance of health economics needs arising from healthcare 
reforms was cited as an example of proposition complexity beyond 
the traditional product-based approach. This implied a much more 
complex decision making process than the traditional prescriber-only 
model. There was some complexity arising from a mixture of indirect 
channels to market. The competitive aspect of the market was 
relatively straightforward, with a small number of similar competitors 
and a tier of generic manufacturers. 
Stability 
This market had many aspects of stability arising from its relative 
maturity, in terms of product form life cycle, the extended 
development time for new products and the highly regulated nature 
of the market. There were no significant signs of market turbulence 
reported by the single respondent. 
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 The hybrid marketing strategy making process in use was espoused 
to be a strongly planning process with significant strands of visionary 
command and incrementalism. However, the responses given by the 
single respondent suggested a much less evenly balanced process, 
closer to a strongly command process in which the rational planning 
techniques were used as a mechanism to enable command. The 
hybrid marketing strategy making process was based upon a formal 
process developed by external consultants for the headquarters of the 
company and was used almost throughout the entire international 
organisation. This process was responsible for developing, 
communicating and implementing core product strategy and was also 
the mechanism by which the non-core parts of the proposition were 
justified by the subsidiary. This process was formal and quantified, 
but showed relatively little actual use of planning tools and 
techniques. It was heavily financially oriented, together with other 
control mechanisms such as calendars of promotional activity. There 
were minor indications that the hybrid marketing strategy making 
process also contained a small element of political and cultural 
incrementalism. Hence, the process could best be described as 
strongly command, but using a financial planning model as an 
implementation mechanism. 
This strongly command process exhibited microcongruence to the 
organisational culture but not macrocongruence to the market 
conditions. 
Lack of macrocongruence with market conditions was exhibited with 
respect to market complexity, rather than market turbulence in this 
relatively complex but stable market. In particular, macrocongruence 
was exhibited as a mis-match between the centrally created 
proposition and the detailed needs of subsidiary markets. Examples 
of this were cited in which UK market structures in the primary care 
area were not well addressed by propositions designed to meet the 
needs of their US based equivalents. 
This case exhibited a high degree of microcongruence between the 
hybrid marketing strategy making process and the organisational 
culture. 
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 The visionary command process was facilitated by two notable 
cultural artefacts: 
• Explicit processes 
This case exhibited an especially well defined and widely used 
formal process. It was defined for use across the company and 
its use was reinforced by the planning cycle calendar. 
• Strongly held cultural assumptions 
Case P was notable for the strength of the espoused cultural 
assumptions regarding the value of formality and discipline 
elements of a hybrid marketing strategy making process. If the 
single respondent were taken as representative, this would 
seem to indicate that a strong culture supports the visionary 
command process. 
Neither microcongruence nor microincongruence to incrementalism or 
rational planning were observed in this case. 
The marketing strategy resulting from the above strongly command 
hybrid marketing strategy making process had the properties of a 
weak strategy. Target definition was made in terms of product 
categories, with no indication of needs based segmentation. The value 
proposition development was augmented with components such as 
CME (continuing medical education) but was not significantly 
differentiated between customers. There was some indication of 
differential resource allocation at sales level, based on opportunity 
size. Understanding (and therefore alignment) of relative strengths 
and weaknesses was weak. Finally, the strategy was not significantly 
different from those of major competitors in terms either of targeting 
or the nature of the proposition. 
In conclusion, Case P was an example of a weak strategy arising from 
a hybrid marketing strategy making process that was not 
macrocongruent but which was microcongruent. Given the complex 
and stable market conditions, this case offered important insights 
into effective marketing strategy making: 
• The way in which a complex market is not well managed by a 
process with a large command element. 
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 • The way in which an organisational culture that is supportive 
of command processes may hinder incremental or planning 
processes. 
This case left unanswered what hybrid marketing strategy making 
process might be macrocongruent to a complex market or how such a 
process might interact with a command culture. Taken in the context 
of other cases, however, this case may suggest possible answers for 
both situations. 
The case offered interesting comparisons to Cases F, G and J with 
which it shared some similarities and differences. 
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 5.5.17 Case Q 
Case Q was an example of a strong marketing strategy associated 
with high levels of both macrocongruence and microcongruence. The 
case was the UK subsidiary of a medium sized multinational 
pharmaceutical firm. The business had a wide therapeutic area 
spread but only a UK geographic interest. Its customer base was wide 
and varied, in both primary and secondary care and across a number 
of functional roles. This company was in the second tier rank of its 
industry. Importantly, both the company and the subsidiary had 
grown exceptionally quickly in recent years due to acquisition. 
The market in which Case Q operated was relatively complex with 
moderate market turbulence: 
Complexity 
The complexity of the market conditions facing Case Q arose from its 
broad product portfolio and increasingly non-product value 
proposition. This was the result of a very rapid period of recent 
acquisition which not only increased the company turnover, but also 
significantly increased the complexity of the market situation facing 
the company in each geographical market. The broad product 
portfolio included several therapeutic areas and covered acute and 
chronic conditions in both primary and secondary care. Further, the 
increasing importance of health economics needs arising from 
healthcare reforms was cited as an example of proposition complexity 
beyond the traditional product-based approach. This implied a much 
more complex decision making process than the traditional 
prescriber-only model. This non-product proposition was, as 
discussed later, central to the organisation’s strategy. There was 
some complexity arising from channels to market. The competitive 
aspect of the market also implied some complexity with a number of 
different competitors in each of the therapeutic areas. 
Stability 
This market had some aspects of stability arising from its relative 
maturity, in terms of product form life cycles, the extended 
development time for new products and the highly regulated nature 
of the market. Although the organisational complexity had increased 
discontinuously in the past few years, these industry factors meant 
that the market overall was relatively stable. Some signs of 
turbulence were exhibited in the changes in the customer processes 
and structures as a result of UK National Health Service reforms. 
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 Further, the changes associated with patent expiry of competitors’ 
products were notable in some therapeutic areas. 
The hybrid marketing strategy making process in use was an 
unusually even mixture of all three processes: visionary command, 
rational planning and incrementalism. Notably, respondents stated 
that this was a change in recent years from a former strongly 
command process with some incrementalism. 
The core of the product strategy (which necessarily defines the target 
customers at market level) was determined via the research and 
development process or the acquisition process. This product pipeline 
issue was a fundamental factor around which much of the strategy 
was dependent. Incremental processes were not significantly involved 
in the development of this core strategy and instead were restricted to 
the development of the augmented proposition, which was especially 
important in this case. Furthermore, some political incrementalism 
was evidenced in headquarters/subsidiary negotiation. The most 
notable feature of the hybrid marketing strategy making process was 
a formal rational planning process that had been recently adopted 
throughout the organisation and was cited extensively by the 
respondents. This process had been developed quite deliberately by 
the organisation to meet the challenges of the newly-complex market 
conditions that arose as a result of the company’s acquisition 
programme. Hence the organisation would appear to have gone from 
a simple market situation to a more complex one. In response, it had 
moved its hybrid marketing strategy making process from command 
plus incrementalism to a more even mixture of the three. Frequent 
mention was made of various tools and techniques above and beyond 
what might be expected of traditional budgeting processes. This 
process was an organisation-wide practice rather than just a 
headquarters or subsidiary activity. 
This three component mixed process was macrocongruent to the 
market. Evidence was cited of effectively managing the portfolio by 
assessing relative attractiveness and strength and of understanding 
the different sorts of competitive threats. The most significant 
evidence of macrocongruence to market complexity was that exhibited 
in relation to assessing the implications of macro-environmental 
political and economic trends. The hybrid marketing strategy making 
process was also reasonably congruent to the moderate market 
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 turbulence faced by the case. Some indications of difficulty in 
assimilating the new portfolio with sufficient speed was suggested; 
however, the case overall exhibited macrocongruence with the market 
conditions. 
This case exhibited microcongruence between the hybrid marketing 
strategy making process and the organisational culture. 
The rational planning process was facilitated by two notable cultural 
artefacts: 
• Deliberate internal communications 
A deliberate extensive programme of internal communication 
supported the rational planning process. This was described as 
part of a conscious attempt to shift the culture from that 
associated with the smaller company (suggested as a visionary 
command supportive culture) to one more supportive of a 
rational planning process. 
• Senior management endorsement 
It was notable that the newly rational process was initiated, 
driven and monitored by a cohesive management team. This 
team used the rapid acquisition phase as justification for the 
development of the process. 
The incremental process was supported by two cultural artefacts 
• Role demarcation 
Case Q exhibited, as in other cases, clear demarcation between 
the command process (responsible for the core product 
strategy) and the incremental process (responsible for the 
development of the augmented part of the proposition). There 
was notably less “meddling” by the headquarters in the roles of 
the subsidiary. 
• Human resource policies 
As with other cases, incrementalism was supported by human 
resource policies that led to relatively stable and particularly 
well qualified and experienced staff. This was seen as critical 
to the success and incremental development of the augmented 
proposition. 
The visionary command process was supported by the role 
demarcation and autonomy within a strategy framework discussed in 
other cases. This cultural artefact was seen as extant, a remnant of 
the former small company culture. 
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 The marketing strategy resulting from the above balanced hybrid 
marketing strategy making process had the properties of a strong 
strategy. It was notable that target definition was in terms of a 
pan-therapy area segment based upon customer motivations. This 
appeared to be homogeneous and distinct. The value proposition 
development was based upon augmented packages based on health 
economic arguments and allocation of resource was clearly 
differentially targeted to the target segment and away from the more 
traditionally minded customers. The strategy was intended to 
leverage particular management competencies and non-product 
related strengths in evidence based medicine whilst compensating for 
dual threats of larger premium competitors and low cost generic 
followers. Finally, the strategy was evidenced to target differently 
from the major competitors and to be significantly different in terms 
of proposition. 
In conclusion, Case Q was an example of a strong strategy arising 
from a hybrid marketing strategy making process that was both 
macrocongruent and microcongruent. Given the complex and 
moderately turbulent market conditions, this therefore offered 
important insights into effective marketing strategy making: 
• The way in which complexity and turbulence appear to be well 
managed by a three component mixture of hybrid marketing 
strategy making process. 
• The way in which the organisational culture may be managed, 
by key appointments and internal communication, to support 
the new process. 
This case offered useful comparisons to Case B with which it shared 
similarities and differences. 
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 5.5.18 Case R 
Case R was an example of a weak marketing strategy associated with 
low levels of both macrocongruence and microcongruence. The case 
was the UK subsidiary of a European manufacturer of medical 
devices and pharmaceuticals. The case had a UK only geographical 
focus and had a narrow product range built around a single therapy 
area, mostly in primary care. The case was the market follower in its 
sector and was part of a multinational that was in the second tier of 
the industry. 
The market in which Case R operated was both relatively simple and stable:  
Complexity 
The relative simplicity facing Case R arose from its tight focus into a 
single therapy area. This implied a small number of well defined 
customers and a single significant competitor. Access to market was 
direct so there was no channel complexity. The complex nature of the 
value proposition (involving devices, pharmaceuticals and a complex 
service component) did imply some market complexity, but overall 
the market conditions were relatively simple. 
Stability 
This case contained many of the stabilising factors mentioned in 
other cases. This included a lengthy product development and 
regulatory approval process that limited product introductions, 
although this was slightly less constraining than in some purely 
pharmaceutical markets. Further, the relatively mature nature of this 
market limited new entrants, and much of the market dynamics in 
this therapy area were driven by demographics, with concomitant 
predictable change. Some changes in the provision of this service to 
patients in this therapy area were noted. Case R therefore provided 
an example of limited market turbulence. 
The hybrid marketing strategy making process in use was primarily 
command with local incrementalism. The core of the strategy was 
determined centrally via the product development programme based 
at headquarters. This command process determined the product 
strategy and set financial targets. Further, it also overlapped 
significantly into lower levels of subsidiary decisions by controlling 
the clinical support and promotional resources to some extent. 
 
The Effectiveness of Marketing Strategy Making Processes in Medical Markets 
 (2003)  Page 190 
 This core strategy was then developed by local incrementalism that 
was responsible for the augmented proposition, as well as pricing and 
allocation of local sales and marketing resources. There was no 
evidence of formal rational planning process other than routine 
budgeting processes and sales management. The respondents did not 
espouse use of tools and techniques. 
This command and local incrementalism process exhibited signs of 
low macrocongruence and low microcongruence. 
The hybrid marketing strategy making process exhibited low 
macrocongruence with market complexity. Respondents pointed to 
the failure of the command process to cope with important market 
factors that differed from other European markets. In addition, the 
process failed to achieve an effective understanding of the 
implications of changes in clinical practice driven by healthcare 
reforms. To a lesser degree, the process also demonstrated low 
macrocongruence with market turbulence. Respondents pointed to 
the failure of the central command process to maintain a formerly 
held technical superiority. 
The command process was hindered by lack of the role demarcation 
and autonomy within the framework, something seen as important in 
other cases. There were also indications of cultural heterogeneity due 
to a recent merger which had not resulted in a merging of the 
cultures. 
The incremental process was hindered by bureaucratic processes 
which were cited as slowing down and creating barriers to 
incremental steps. Similarly, poor internal communications and 
functional silos were cited as cultural artefacts that hindered 
incremental processes. 
Since no significant rational planning took place, no interaction 
between this and the organisational culture was observed. 
The strategy resulting from this process had the properties of a weak 
strategy. Target market definition was in terms of products and 
showed no sign of homogeneous segmentation. Although the value 
proposition was, to some extent, individually tailored at sales level, 
there was no indication of differential resource allocation between 
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 targets. Awareness of relative strengths and weakness was low and 
so, commensurately, was alignment to market opportunities and 
threats. Finally, the strategy did not differ significantly in either 
targeting or proposition from that of the competition. 
In conclusion, Case Q was an example of a weak strategy arising 
from a hybrid marketing strategy making process that was neither 
macrocongruent nor microcongruent. Since the case was an example 
of a weak strategy in a simple and stable market, it suggested an 
important insight into effective marketing strategy making:  
• That even in a relatively simple and stable market, 
microcongruence is necessary to create a strong strategy. 
The case provided an interesting comparison to Cases A, D and H, 
with which it shared important similarities and differences.  
5.6 The Content of the Emergent Structures  
The congruency hypotheses which form the theoretical basis for this 
work offer a useful foundation for explaining the effectiveness of 
marketing strategy making processes, but offer little help in 
elucidating the nature of the key variables (in this case, hybrid 
marketing strategy making process, macrocongruence, 
microcongruence and strategy properties). The literature base 
provides some indication of the dimensions and characteristics of 
each of these variables, sufficient to inform research design, but is 
general and often decontextualised. By that is meant that the 
literature implies the nature of each of the four variables, but only in 
a non-specific manner and not related to the details of the situational 
context in any way. The findings of this work add to the extant 
literature in that they suggest more detail concerning the nature of 
these variables and how they vary by case. The following sections 
discuss the nature of each of the variables and the extent to which 
the findings develop the knowledge derived from the current 
literature.  
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 5.6.1 The Nature of Hybrid Marketing Strategy Process 
Whilst the literature is replete with descriptions of specific modes of 
strategy making process (as in the ten modes described by Mintzberg 
et al (Mintzberg, Ahlstrand, & Lampel1998), and with attempted 
typologies of strategy making processes (see Table 3, Page 22), 
empirical description of individual marketing strategy making 
processes is much less developed. That which has been attempted is 
mostly linear, in that it characterises marketing strategy making 
along the single dimension of the degree of formality or rationality 
employed (as discussed in Sections 2.4 and 2.5.1).  
The findings of this work indicate hybrid marketing strategy making 
processes that do not fit perfectly into any simple typology but are 
more accurately characterised than simply by degree of formality. 
They indicate that the McDonald three-component model is a useful 
approach to characterising the nature of an organisation’s marketing 
strategy making process and that the results of such a 
characterisation indicate that hybrid marketing strategy making 
processes are a more realistic description of the extant management 
process than the linear characterisation of earlier work. In this 
respect, they support the quantitatively derived findings of Bailey et 
al (see  page 24) and confirm the need for multidimensional 
characterisation of process in the study of marketing strategy making 
process effectiveness.  
Table 2
As discussed above, a limited range of hybrid marketing strategy 
making processes was observed in this work. This may have been an 
artefact of the sampling employed and implies a limitation of the 
research and an opportunity for further work.  
The most commonly observed hybrid marketing strategy making 
process, a combination of central command and local or peripheral 
incrementalism, was characterised by clear demarcation between 
those strategy components determined by the central and local parts 
of the organisation. Typically, the core of the product offering was 
determined centrally and this implied the framework within which 
targeting took place. This was true in both effective and ineffective 
processes. Where the command plus incremental process was 
effective, this was exhibited in local ability to recognise and 
implement local market needs and adapt the core strategy 
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 accordingly.  Where the command plus incremental process was 
ineffective, this was exhibited as failure of the local process to adapt 
and develop the core strategy to local conditions. Where it was 
ineffective, the core strategy was either regarded locally as “fixed”, 
with adaptation forbidden or, more commonly, the local culture was 
unable (through lack of skills or other resources) to adapt the core 
strategy.  
Command and planning processes, the second most commonly 
observed hybrid marketing strategy making process, was 
characterised by similar central determination of the core strategy 
but local or peripheral determination of targeting and the augmented 
product. This was true in both effective and ineffective examples of 
the command and planning hybrid marketing strategy making 
process. Where the process was effective, the local organisation was 
both enabled to carry out planning and to adapt the core strategy. 
Where the command plus planning process was ineffective, this was 
exhibited as failure of the local process to adapt and develop the core 
strategy to local conditions. Where this happened, the planning 
component was seen to be locally disabled, most often by local 
cultural artefacts more reminiscent of a non-planning culture.  
The other hybrid marketing strategy making processes observed were 
not recorded with sufficient frequency to detect common patterns in 
the way the process worked. Those that were not either command 
and incrementalism or command and planning were often noticeably 
in a state of transition from one process type to another. Such 
transitions were often associated with one of three types of initiating 
stimuli: significant change in market conditions, change in senior 
management or organisational change such as a merger or 
acquisition.   
5.6.2 The Nature of Macrocongruence 
The hybrid marketing strategy making processes observed in this 
work were each seen to be congruent or otherwise with different 
aspects of the external market environment. In particular, the 
processes were seen to be more or less congruent with changes in 
market conditions or with the multiplicity of market entities such as 
customer segments, competitive forces or channels. Hence, this work 
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 supported the work of Frederickson, Mintzberg, Eisenhardt and 
others, discussed in Sections 2.5.2 and 2.5.3, and the consensus in 
this literature that market complexity and market turbulence are the 
two most significant external mediators of marketing strategy making 
process effectiveness.  
Market complexity was seen to be most congruent with processes in 
which rational planning was a significant component, whilst the 
reverse was true of heavily visionary and incremental processes. In 
particular, planning-biased approaches were seen to develop 
congruence with market complexity in two ways: market 
understanding and internal communication. Planning appeared to 
enable market understanding when either the external macro-
environment (social, legal, economic, political or technological factors) 
or the external microenvironment (competitors, channels and 
customers) were complex and contained multiple factors. The most 
visible example of this was the manner in which planning enabled 
understanding of market segmentation. Further, planning was seen 
to provide “process benefits” of superior internal communication of 
market complexity. Examples of this were communication of 
priorities (of both targets and competitors) and coordination of 
activity between business units and between hierarchical levels 
within the organisation. By contrast, visionary and incremental 
processes were seen to exhibit incongruence with market complexity. 
Examples of this fell into two broad categories. Firstly, the inability of 
visionary or incremental processes to accurately assess and prioritise 
multiple market factors. This was especially true when the factors, 
such as competitive intensity or attractiveness, were not easily 
quantified and compared. Secondly, visionary and incremental 
processes were observed to be vulnerable to organisational politics 
and pronounced subjectivity in the assessment of market complexity.  
Market turbulence, by contrast, was seen to be more effectively 
addressed by processes containing significant elements of visionary 
command processes. In particular, visionary processes were seen to 
be congruent to market turbulence in two ways. Firstly, in the 
recognition and assessment of major market changes, especially 
when they were of an international or pan-market sector significance. 
Visionary processes enabled the effective prioritisation of new 
products and of the regulatory or other strategic issues. Secondly, 
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 visionary command processes demonstrated effectiveness at 
communicating and implementing responses to strategic changes 
well. Evidence of this was seen in both communicating centrally 
derived strategic responses and in transferring locally derived 
strategic responses across national boundaries or product sectors.  
Notably, incrementalism was not seen as especially congruent to 
either market complexity or market turbulence. Instead, it appeared 
to be a necessary complement of both planning and visionary 
command processes. In this way, incrementalism was observed to 
add responsiveness to planning led processes and sensitivity to 
visionary command led processes.  
5.6.3 The Nature of Microcongruence 
The nature of microcongruence was demonstrated in the manner in 
which each of the three sub-processes of the various hybrid 
marketing strategy making processes was seen to be either hindered 
or helped by various cultural artefacts.  
Command processes were seen to be congruent to organisational 
cultures in two ways. Firstly, demarcation between and coordination 
across central and local processes. There was clear demarcation 
between the central command process and body and the local or 
peripheral process and body, be that planning or incrementally 
oriented. In such demarcated cultures, the local processes were 
relatively autonomous and were connected to the central process by 
multiple, frequent, connective processes. These included formal, 
quantitative communication processes but also more qualitative 
processes based on cross-functional and pan-hierarchy teams. 
Secondly, command processes macrocongruence was seen to occur 
with stable and ideologically coherent command bodies. Such teams 
were often sustained by clear “enculturation” of new members. 
Conversely, visionary command processes were seen to be 
macroincongruent with “meddling” cultures in which demarcation 
between central and local processes and bodies was not well defined, 
or where the command group culture was weak or inconsistent. 
Interestingly, previously functioning command processes were seen 
to become macroincongruent when external pressures acted upon 
their common assumptions. Examples of this were when 
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 management turnover occurred and when extraordinary business 
situations such as takeover threat or initial public offering 
transpired.  
Planning processes were seen to be congruent to organisational 
cultures in two ways. Firstly, extensive and well-established 
commitment to planning. This notably extended from senior 
management downwards and was reflected in organisational 
structures and processes to support planning. Frequently, some form 
of external pressure (performance shortfalls, increased competitive 
intensity) was cited as “enablers” of this supportive culture. Secondly, 
resource allocation concomitant to planning led approaches was 
observed. This extended to capital expenditure (for instance into 
management information systems) and human resource investment 
(for instance into skills training or specialist recruitment). 
Conversely, planning processes were seen to be macroincongruent 
with “product led” cultures in which the value of planning was not 
widely accepted. In addition to the lack of resource allocation that 
followed from these cultural assumptions, intangible barriers to 
planning were observed in the reluctance to share data and 
communicate openly. Interestingly, cultures that were extremely 
quantitative in their approach were also incongruent to planning led 
approaches. In these cases, the primacy of “hard” data led to rigid 
adherence to formal processes, to the exclusion of more qualitative 
considerations. Examples of this were the failure to segment 
effectively when only descriptor data was available, following the 
cultural devaluation of useful but qualitative motivator data.  
Incremental processes were seen to be congruent with organisational 
cultures in two ways. Firstly, incrementalism was allowed within the 
overall hybrid marketing strategy making process. This allowance 
took both formal and informal forms. Formally, demarcation of 
responsibilities between the centre and peripheral parts of the 
organisation allowed the incremental processes to occur. Informally, 
cultural traits such as blame reduction and encouraging 
experimentation were observed. Secondly, incrementalism was 
enabled within the permissive culture. The primary way in which this 
was achieved by the use of “over-skilled” people in roles that required 
incrementalism. This was complemented by policies to increase skills 
and reduce staff turnover. The secondary way in which 
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 incrementalism was enabled was the provision of management 
systems and resources with which to attempt and monitor 
implementation of incrementalism. Conversely, microincongruence 
with incrementalism was observed in bureaucratic cultures with 
quantified, rigid, control systems. Interestingly, flat structures, cited 
as an attempt to improve upon bureaucratic hierarchies, were also 
seen as incongruent with incrementalism. This reflected the difficulty 
of gaining buy-in and rapid decision-making across large flat 
organisational structures.  
5.6.4 The Nature of Marketing Strategy Quality 
The nature of the marketing strategies observed in this work were 
seen to vary across the four dimensions or properties investigated. In 
all four cases, clear differentiation was observed between the cases in 
terms of the degree to which they met the criteria for a strong 
strategy derived from the literature. However, none of the cases met 
all of the idealised criteria perfectly and the resultant 
characterisation of strong and weak marketing strategies provides 
useful insight into the nature of marketing strategy differentiation 
within the context of this market.  
Target market definition was a notable differentiation between the 
cases in this work, but was also significantly different from that 
idealised in the literature. Prescriptive texts suggest that effective 
target market definition consists of one or more segments that are 
both homogenous and distinct in terms of their motivations, buying 
behaviour and response to propositions. The literature also suggests 
that product or channel segmentation rarely meets these criteria. 
What emerges from this work, however, is that product or channel-
based segmentation is the norm in the industry sector studied. This 
seems to be associated with the technical product complexity and the 
difficulty of building necessary product expertise across a number of 
sectors. However, strong strategies were clearly differentiated from 
weak strategies in that they involved target market definition at a 
level beyond product or channel, whereas weak strategies went no 
further than product or channel target definition. Strong strategies 
were noted to apply a level of motivation-based target market 
definition within the initial level of segmentation. This segmentation 
was usually limited to one or two target segments within the product 
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 or channel category, such limitation seemingly associated with 
technical, legally or organisationally created inflexibility. Hence, the 
nature of marketing strategy quality is not quite as expected based 
upon the extant literature. Rather than motivator based segments, a 
combination of product or channel and motivator based segments is 
used to accommodate proposition complexity and organisational 
inflexibility.  
Proposition differentiation between segments is also a notable point 
of differentiation between the cases in this study. However, as with 
target market definition, the nature of proposition differentiation 
amongst the cases studied is not as idealised by the literature. The 
prescriptive texts suggest propositions that are individually tailored 
to the needs of true (i.e. homogeneous and distinct) segments, with 
variation across all parts of the proposition in according with 
variance between segment needs and motivations. This work suggests 
a lesser form of proposition differentiation. In all cases, the marketing 
strategies employed by the case studies involved a relatively fixed and 
non-variable core proposition. This was largely accounted for by the 
difficulty and cost of product adaptation (a consequence of product 
technical complexity and regulatory constraints). The fixed nature of 
the proposition was also influenced by legal constraints on pricing 
variation and by the often homogeneous nature of the customer base 
in terms of channel and communication needs. All of the strategies 
observed in this work therefore demonstrated a variance from the 
literature ideal by means of a fixed core product. However, stronger 
strategies were differentiated from weaker strategies to the extent to 
which the augmented, non-core product was differentiated between 
targets. Often, such differentiation involved both active tailoring to 
the needs of the target and passive defocusing on non-targets by 
virtue of building a proposition inappropriate to the non-target 
segment. Examples of this included the development of service, 
logistical, financial and educational product components.  Hence, the 
nature of proposition tailoring is not quite as expected based upon 
the extant literature. Rather than segment specific propositions, 
relatively fixed non-tailored core propositions are supplemented with 
tailored extended products in order to accommodate both internal 
organisational inflexibility, external constraints on tailoring and a 
degree of homogeneity within the product or channel defined sector. 
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 SWOT alignment provided a distinctive point of differentiation 
between the cases in this study. However, as with target market 
definition and proposition tailoring, the nature of SWOT alignment 
amongst the cases studied is not as idealised by the literature. The 
prescriptive texts suggest that marketing strategy (target market 
selection and proposition design) reflects the alignment of 
organisational strengths to market opportunities and organisational 
weaknesses to market threats.  This work suggests that a lesser form 
of SWOT alignment is prevalent amongst the cases observed in this 
study. All cases observed in this work demonstrated a “de facto” form 
of SWOT alignment. This arose from the enforced choice of targets 
and propositions dictated by the fundamental capabilities of the 
organisation. Examples of this were “premium customer” targeting 
enforced by high relative costs and some application-type targeting 
enforced by product portfolio. However, the weaker strategies were 
observed to limit their SWOT alignment to that imposed upon them 
by these de facto limitations. Stronger strategies went beyond this, 
developing both target and proposition to align with less tangible 
strengths and weaknesses. Examples of this included strengths in 
brand and skill levels and weaknesses in sales-force strength and 
clinical evidence. The characteristic difference in the SWOT alignment 
property of marketing strategy seemed to be associated with the 
degree to which the organisation had proved capable of recognising 
and understanding its own relative strengths and weaknesses. 
Hence, the nature of SWOT alignment is not quite as expected based 
upon the extant literature. Rather than deliberate choice of target 
and proposition to reflect SWOT alignment, much SWOT alignment 
was enforced and de facto. Strong strategies where then 
distinguished by the use of greater awareness of relative strengths 
and weaknesses to refine that de facto SWOT alignment.  
Strategy uniqueness provided a more subtle point of differentiation 
between the cases in this study. However, as with target market 
definition, proposition tailoring and SWOT alignment, the nature of 
strategy uniqueness amongst the cases studied is not as idealised by 
the literature. The prescriptive texts suggest that either target market 
selection or proposition design should be significantly different from 
the competitors in the market.  This work suggests that a lesser form 
of strategy uniqueness is prevalent amongst the cases observed in 
this study. All cases observed in this work demonstrated a superficial 
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 degree of strategy similarity with their competitors, both in target and 
proposition. This arose from the product or channel defined targeting 
and the fixed core proposition used by all cases, as discussed above. 
However, the weaker strategies were noted to go no further than this 
and therefore in no way differentiate their strategy from the 
competitors. By contrast, strong strategies were seen to develop 
target market definition and an augmented proposition beyond the 
basic level and thus differentiate both target and proposition from the 
competition. The characteristic difference in the strategy uniqueness 
property of marketing strategy seemed to be associated with the 
degree to which the organisation had proved capable of recognising 
and understanding market segmentation and proposition complexity.  
Hence, the nature of strategy uniqueness is not quite as expected 
based upon the extant literature. Rather than deliberate 
differentiation of target and proposition, much strategy uniqueness 
arises from the capability to go beyond product defined and core 
proposition strategy. It is therefore less a case of two or more 
competitors having deliberately different strategies, but more of one 
competitor differentiating its strategy beyond those of the other 
industry players by leveraging its understanding of the market and 
the proposition.  
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 6 Discussion of Results 
This section of the thesis draws meaning and implication from the 
results presented and described in Section 5. It is divided into five 
sections. 
1. Section 6.1 is concerned with testing the theoretical explanations 
of the effectiveness of marketing strategy making processes 
discussed in Section 3.3 (page 51). As will be seen, the findings of 
this work support the Burrell and Morgan hypotheses in this 
context. 
2. Section 6.2 is concerned with developing the congruency 
hypotheses beyond observations of association between 
phenomena and towards an understanding of the detailed 
mechanism of macrocongruence and microcongruence by which 
the properties of an organisation’s marketing strategy are 
influenced. This work makes some suggestions as to the nature of 
both forms of congruence. 
3. Section 6.3 examines the implications of these findings for 
practitioners. It advocates a contingency approach to the design of 
marketing strategy making processes and suggests a procedure by 
which external and internal contingencies might be accounted for. 
4. Section 6.4 examines the contribution to knowledge made by this 
work. It discusses the contribution made to theory, methodology 
and practice at the levels of replication, development or new 
contributions. This work contributes, to a greater or lesser degree, 
to all three areas. 
5. Section 6.5 gives a critique of this work and makes 
recommendations for future work. 
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 6.1 The Implications of the Results for the 
Propositions and the Combined Congruency 
Model 
This work attempts to explain the effectiveness of marketing strategy 
making processes. It is based on the congruency hypotheses of 
Burrell and Morgan, who propose that the effectiveness of a 
management process is related to the degree of congruence between 
that process and its internal (microcongruence) and external 
(macrocongruence) environments or contexts. This work has 
translated those concepts into the area of marketing strategy making, 
using concepts of strategy process, strategy content and internal and 
external environments drawn from the extant literature. 
As described in Section 3.3, the congruency hypotheses suggest that, 
if the congruency hypotheses are correct, the proposition P1 would be 
upheld: 
Proposition P1: 
The degree to which an organisation’s marketing strategy exhibits the 
properties associated with a strong strategy is proportional to the 
extent to which microcongruence (between strategy process and 
internal environment) and macrocongruence (between strategy 
process and market environment) are exhibited. 
As summarised in Figure 6 (page 102), these findings uphold 
proposition P1. All of the cases which exhibited the properties of a 
strong strategy also exhibited both macrocongruence and 
microcongruence. These were Cases A, D, E, H, I, J, L and Q. 
By contrast, those cases which exhibited the properties of a weak 
strategy also exhibited a lack of either macrocongruence or both 
microcongruence and macrocongruence. These were Cases C, M O 
and P (lacking macrocongruence) and B, F, K and R (lacking both). 
It is of interest that, whilst some cases which exhibited 
microcongruence lacked macrocongruence, the reverse was not 
found. In other words, no cases were found where the hybrid 
marketing strategy making process was congruent to the market 
without being congruent to the organisational culture. This might 
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 suggest that microcongruence is in some way an antecedent of 
macrocongruence. This study was not designed to examine this issue 
and the findings do no more than suggest an association between the 
two phenomena, but it remains an interesting point. 
Only two cases did not fully support proposition P1. Case G, which 
exhibited both microcongruence and macrocongruence, showed only 
a moderately strong strategy. No immediate explanation of this 
partial lack of support with the congruency is supported by the data. 
However, it must be borne in mind that Case G offered only a single 
respondent and cannot therefore be considered wholly reliable. Case 
N, offering three respondents, demonstrated mid-range values in 
each of the three variables (strategy quality, macrocongruence and 
microcongruence). Whilst this does not refute proposition P1, nor 
does it fully support it. 
The three other propositions offered in Section 3.3 are intended to 
falsify the congruency hypotheses and based upon other strands of 
the extant literature. 
Proposition P2:  
The degree to which an organisation’s marketing strategy exhibits the 
properties associated with a strong strategy is unrelated to the degree 
to which either microcongruence (between strategy process and 
internal environment) or macrocongruence (between strategy process 
and market environment) is exhibited. 
Proposition P2 is intended to represent the position of those, such as 
prescriptive planners, who hold that one single type of strategy 
making process produces the strongest strategy, irrespective of the 
internal or external context in which it operates. 
The findings of this work do not uphold this proposition. In addition 
to the strong correlation between strategy quality and combined 
congruency described above in support of P1, the lack of association 
between the type of hybrid marketing strategy making process and 
strategy quality refutes P2. Strong strategies were noted in cases with 
command and incremental processes (A and D), strongly command 
processes (H and L), planning and incrementalism processes (I and J) 
and three-way hybrid processes (E and Q). Weak strategies were 
noted in cases of command and incremental processes (F, M and R), 
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 strongly command processes (C, K, O, and P), and planning and 
incremental processes (B). Hence these findings do not support the 
universal use of any single hybrid marketing strategy making 
process, whatever its nature. Rather, these findings indicate that 
strategy quality is not simply a function of the hybrid marketing 
strategy making process but is indeed contingent upon the internal 
and external environments in which the process operates. Proposition 
P2 is not therefore upheld by these findings. 
Proposition P3: 
The degree to which an organisation’s marketing strategy exhibits the 
properties associated with a strong strategy is related to the degree to 
which microcongruence (between strategy process and internal 
environment) is exhibited but not to the degree to which 
macrocongruence (between strategy process and market 
environment) is exhibited. 
Proposition P3 is intended to represent the position of those who see 
organisational culture as the dominant, perhaps overriding, factor in 
determining the effectiveness of marketing strategy making 
processes. Such a position minimises the importance of the external, 
market environment. 
These findings do not uphold this proposition. Positive support for P3 
would be provided by cases that exhibited microcongruence without 
macrocongruence and had strong strategies. Four cases (C, M, O and 
P) exhibited microcongruence but did not exhibit macrocongruence. 
All of these cases had strategies which were weak. By contrast, those 
eight cases (A, D, E, H, I, J, L and Q) which exhibited 
microcongruence and also exhibited macrocongruence all had strong 
strategies. In addition to strong strategies in cases of 
microcongruence without macrocongruence, there is another set of 
possible conditions that might provide negative support for P3. This 
would be the existence of weak strategies in cases of 
macrocongruence without microcongruence. However, no cases of 
that type existed in the sample. Hence, proposition P3 is not upheld 
by these findings. 
It is interesting that the majority, twelve out of eighteen cases, 
exhibited microcongruence. This is partially supportive of those who 
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 see strategy process as largely an artefact of organisational culture. 
Such a culture-dominant view would hold that the organisational 
culture either leads to the strategy process or moulds it to fit with the 
culture. This would appear to be the situation in many of the cases 
(A, C, D, H, I, L, M and P). However, a minority of the cases exhibited 
evidence of having adapted the organisational culture to fit the 
strategy process (E, I, J and Q). A notable characteristic of all four of 
these examples of cultural adaptation is the deliberate and explicit 
manner in which it was achieved. The four cases exhibiting lack of 
microcongruence are also consistent with partial support for the 
culture-dominant view. Two of those cases (B and F) were attempting 
to use a hybrid marketing strategy making process that was different 
from that which had been historically prevalent in their organisation 
and had failed, as yet, to achieve the necessary adaptations to the 
organisational culture. The remaining two (K and R) both showed 
noticeable cultural heterogeneity or unevenness between 
headquarters and subsidiary cultures. Any process operating across 
an uneven culture might be expected, to some extent, to exhibit lack 
of microcongruence. Hence a consideration of the importance of 
microcongruence to strategy process would not support the view that 
fit between strategy process and culture is the dominant factor 
influencing the effectiveness of that process. However, it would 
support the view that culture is likely to drive or mould strategy 
process unless deliberate steps are taken towards adaptation of 
culture. 
Proposition P4: 
The degree to which an organisation’s marketing strategy exhibits the 
properties associated with a strong strategy is related to the degree to 
which macrocongruence (between strategy process and market 
environment) is exhibited, but not the degree to which 
microcongruence (between strategy process and internal 
environment) is exhibited. 
This fourth proposition P4, would be consistent with the views of 
those who see external market contingencies as the dominant, 
perhaps overriding, factor in determining the effectiveness of 
marketing strategy making processes. Such a position minimises the 
importance of the internal, organisational culture, environment. 
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 The findings neither uphold nor refute this proposition. Support or 
contradiction for proposition P4 would require the existence of cases 
which exhibited macrocongruence but not microcongruence. The 
existence of a strong strategy in such cases would provide support for 
P4. However, none of the eighteen cases demonstrated 
macrocongruence without microcongruence. Such lack of positive 
evidence, however, does not contradict P4. Negative evidence is 
provided by those four cases (B, F, K and R) which lacked 
macrocongruence and microcongruence and have weak strategies. 
However, this does not constitute support for P4. Hence, these 
findings, due to gaps in the sample, neither fully support nor entirely 
contradict this final proposition. 
Taken as a whole, a consideration of the four propositions provides 
qualified support for the congruency hypotheses. In the same way, 
they support the combined congruency model (see Figure 3, page 49) 
that is the graphical expression of the hypotheses. 
The findings are not entirely conclusive. It remains possible that only 
macrocongruence is significant in determining the effectiveness of 
hybrid marketing strategy making process. However, since the 
findings provided positive and negative examples not only of 
macrocongruence (see , page 92) but also of microcongruence 
(see , page 94), it seems most likely that mechanisms exist 
whereby both the external, market environment and the internal, 
cultural environment, moderate the effectiveness of hybrid marketing 
strategy making process. Hence, these findings support Burrell and 
Morgan’s congruency hypotheses in the context of marketing strategy 
making. The slight qualification of this support can be explored and 
better understood by a consideration of the mechanism of 
microcongruence and macrocongruence suggested by these findings. 
Those mechanisms are the subject of Section 6.2. 
Table 9
Table 10
6.2 An Examination of the Mechanism of 
Macrocongruence and Microcongruence  
The preceding examination of the findings supports the congruency 
hypotheses, the associated combined congruency model and offers an 
explanation of the effectiveness of marketing strategy making 
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 processes. It therefore answers the research question set out in 
Section 3.3 (page 51) 
However, it does little to explain the underlying mechanism of the 
model. Such an explanation is important both to substantiate the 
model and to inform changes in management practice. Sections 6.2.1 
and 6.2.2 therefore draw from the findings an explanation of the 
nature of macrocongruence and microcongruence and how they 
moderate hybrid marketing strategy making processes to influence 
the properties of a marketing strategy. 
6.2.1 The Underlying Mechanism of Macrocongruence 
The congruence between the hybrid marketing strategy making 
process and market conditions is, according to these findings, related 
to two dimensions of the market, complexity and turbulence. This is 
consistent with the work of Frederickson, Eisenhardt and Mintzberg 
amongst others, as discussed in Sections 2.5.2 and 2.5.3. In the 
cases observed in this work, market complexity arose principally from 
variation or heterogeneity within the market situation faced by the 
case. In the simplest cases, propositions, customers, channels, 
competitors and environmental factors showed little variation. In the 
more complex market situations, great variation was observed. 
Market turbulence arose principally from change in those market 
factors. In the most stable markets, little or slow change was 
observed, in the most turbulent, more extensive or faster change was 
noted. 
An understanding and explanation of the underlying mechanism of 
macrocongruence (and macroincongruence) effects is therefore best 
made in terms of the manner in which different hybrid marketing 
strategy making processes work under different conditions of 
complexity and turbulence. 
Complexity 
The findings of this work include the observation that the strategy 
process of most of the cases contains a very significant element of a 
visionary command process. The effectiveness of such processes, it 
was observed, varies according to the complexity of the market 
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 conditions. The command element of the hybrid marketing strategy 
making processes was seen to be more effective in simple markets 
than in complex ones. In simple markets, the command component 
was notably able to understand and draw out the implications of 
market conditions such as market segmentation, competitive activity 
or macroenvironmental factors. By contrast, more complex markets 
would seem to overload the capacity of a central command process to 
make sense of the market. Instead, the findings suggest that, in the 
face of complexity, command processes oversimplify markets and fail 
to draw out important implications of the variations between, for 
instance, customer groups or competitors. These findings suggest 
that visionary command processes have limited capacity to 
comprehend market complexity and that the result of overloading 
this capacity (as in the case of a complex market) is to create an 
oversimplification and consequently inadequate understanding of 
some or all of the market conditions.  
Examples of this were seen when international headquarters 
developed propositions that did not fit local market conditions (Case 
K for instance) or when multiple markets in a single country created 
too much complexity for a management team to grasp (Cases C and 
O). Also supporting this were cases in which the market was 
relatively simple, or homogeneous across countries. In these cases, 
the command process managed the limited complexity well (Cases H 
and L). More commonly, however, markets exhibited some elements 
of simplicity and some of complexity. In such cases, effective hybrid 
marketing strategy making processes combined command with either 
planning or incrementalism to cope with complexity. Typically, 
therefore, the command element managed effectively such important 
but internationally homogeneous factors as the core technology and 
the regulatory context, whilst the incremental component managed 
local market complexity in, for instance, market segmentation or 
channel management (see for instance Cases A and D). In such cases 
of command and incrementalism, clear demarcation between the two 
processes was a very important cultural artefact, as discussed later. 
This consideration of hybrid marketing strategy making processes 
with a strong element of visionary command clearly indicates that 
command processes struggle to cope with significant degrees of 
market complexity. Localised complexity in a market that is simple at 
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 a fundamental level can be managed by the addition of local 
incrementalism. However, incrementalism was observed to be very 
demanding of resources, both tangible (in terms of IT systems and 
data gathering costs such as market research) and intangible (such 
as management time and internal communication and internal 
transaction costs). Hence incrementalism was usually limited, either 
in a deliberate or de facto manner. No cases were observed of 
fundamentally complex markets in which incrementalism was the 
strongest element of the hybrid marketing strategy making process. 
Hence, although the possibility cannot be excluded that a strongly 
incremental process might be appropriate to a complex market, it 
seems unlikely that this would be the case. As discussed in the 
following paragraph, rational planning processes would seem to be 
the necessary response to market complexity. 
Consistent with the literature, relatively few cases exhibited a hybrid 
marketing strategy making process in which rational planning was a 
major component. However, those that did (B, E, G, I, J and Q) were 
all in complex markets and many explicitly cited planning as a 
necessary response to market complexity. In most of the cases where 
rational planning was important, macrocongruence with market 
complexity was strong. Understanding of market structures and 
other market conditions was notably superior to those cases in which 
market complexity was not addressed by rational planning (for 
instance, Cases C, F, K, M, O and P). The notable exception to this 
was Case B, which employed an impressive rational planning process 
in a complex market but with limited effect. This anomaly is 
attributable to lack of microcongruence. Case B is an example of the 
rational planning process being hindered by cultural artefacts (in this 
case, assumptions about the primacy of hard data, for example). 
Hence these findings support the idea that rational planning 
manages complexity better than visionary command processes, albeit 
with the caveat that microcongruence remains necessary. Further, 
the findings suggest that the mechanism by which rational planning 
accommodates market complexity lies in its ability to comprehend 
the market conditions and to provide a common language for 
communicating them. In addition, rational planning seems to be able 
to comprehend market complexity in a manner that is more 
economical of tangible and intangible resources than incrementalism.  
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 In summary then, these findings suggest an explanation of the 
underlying mechanism of macrocongruence as it relates to market 
complexity. The mechanism lies in the degree to which a process is 
capable of understanding the level of complexity and the concomitant 
level of market simplification. These findings suggest that visionary 
command processes have limited capacity to manage market 
complexity, and failure to do so is exhibited as an oversimplification 
of the market conditions. Unless other processes are involved, a weak 
strategy is created. By contrast, rational planning processes are 
better at understanding market complexity and at creating a model of 
the market that more closely matches reality. Further, planning 
provides a conduit to communicate market complexity efficiently. 
This market understanding is a necessary precursor to a strong 
strategy. Incremental processes would seem to have useful capacity 
to manage a degree of local complexity, but in doing so are profligate 
with resources, both tangible and intangible. As such, incremental 
processes are limited in their use by either explicit choice or de facto 
resource rationing. Used in conjunction with visionary command or 
planning, incremental processes enable better understanding of the 
market than an unalloyed process. However, the evidence suggests 
that incrementalism alone is not an efficient means of managing 
higher levels of market complexity. 
This consideration of the manner by which visionary command, 
rational planning and incrementalism function in low and high 
market complexity conditions therefore indicates an underlying 
mechanism of macrocongruence involving effectiveness and efficiency 
of comprehension. These emergent mechanisms are summarised in 
Table 12 (page 212).  
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 Table 12:  Mechanisms of Macrocongruence 
 Visionary command  Rational planning  Incrementalism 
Complexity  Mechanism: comprehension overload and over-
simplification 
Visionary command processes have limited 
ability to comprehend market complexity. In 
cases of low market complexity, this is 
sufficient. In cases of high market complexity, 
the visionary command process over simplifies 
the complexity of the market leading to a 
compromised understanding of the market 
conditions.  
Mechanism: analytical 
comprehension 
Rational planning processes have 
large capacity to comprehend 
market complexity. In cases of 
low market complexity, this is 
sufficient but not necessary. In 
cases of high market complexity, 
the rational planning process 
enables both comprehension and 
communication of market 
conditions.  
Mechanism: resource limited 
comprehension  
Incremental processes have some ability 
to comprehend market complexity but 
are resource intensive when doing so. In 
cases of low market complexity, this is 
sufficient. In cases of high market 
complexity, the incremental process is 
either profligate of resources or, more 
usually, insufficiently resourced leading 
to a compromised understanding of the 
market conditions. 
Turbulence  Mechanism: intuitive comprehension and 
communication 
Visionary command processes have a large 
capacity to identify,  prioritise  and 
communicate significant market changes. In 
cases of market stability, this is rarely needed. 
In cases of market turbulence, this capacity 
enables both comprehension and 
communication of changes in market 
conditions and of local responses to those 
changes. 
Mechanism: analysis paralysis 
Rational planning processes have 
limited capacity to react quickly 
to market turbulence. In cases of 
low market turbulence, this is 
sufficient. In cases of high 
market complexity, the rational 
planning process hinders timely 
reaction to changes in market 
conditions.  
Mechanism: bounded reactivity 
Incremental processes have some ability 
to react to market turbulence, but are 
resource intensive when doing so. In 
cases of low market turbulence, this is 
sufficient. In cases of high market 
turbulence, the incremental process is 
either profligate of resources or, more 
usually, insufficiently resourced leading 
to a compromised understanding of the 
market conditions.  
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Turbulence 
The cases represented in these findings presented a limited range of 
market turbulence. This arises from a number of factors shared by 
many of the cases: market maturity, long product development lead 
times, regulatory constraints and others. Hence the bias in the 
sample is partly an artefact of the industry selected for study. 
However, sufficient examples of macrocongruence or otherwise with 
market turbulence exist to draw some limited conclusions. 
Hybrid marketing strategy making processes in which visionary 
command processes are a major component appear capable of 
relatively rapid reallocation of resources and hence response to 
market turbulence. This is particularly noticeable when the visionary 
command process is close to the market turbulence, for instance 
when it is sited in the leading geographical market (as in Case L). The 
responsiveness of command processes to market turbulence is also 
better when the change is tangible, far reaching and relatively 
homogeneous across markets. Examples of this were seen in areas 
such as major technological shift, regulatory affairs or demographics 
(see Cases A, E, and O). As discussed with respect to complexity, 
visionary command processes are less effective at dealing with 
turbulence that is intangible and localised, such as changes in 
customer structures and the importance of relationships (see Cases 
K, P and R). In cases of localised turbulence, incremental processes 
seem to be used more often. These findings therefore suggest an 
underlying mechanism for macrocongruence as it relates to the fit 
between visionary command processes and market turbulence. They 
suggest that visionary command processes possess an intuitive (in 
the sense of non-systematised) ability to comprehend market changes 
and then action commensurate changes in resource allocation 
patterns. This ability is heightened when the visionary command 
body is close to the change and when the change is large. It is limited 
when the change is distant or small. In such cases, the most 
commonly observed phenomenon in this work was the alloying of 
visionary command processes with incremental processes.  
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 Hybrid marketing strategy making processes in which incremental 
processes are a major component appear capable of relatively rapid 
response to market turbulence when it is localised and requires 
relatively small scale reallocation of resources. Examples of this were 
seen in competitive response and local changes to customer 
behaviour, exhibited in most of the cases in this study. In one case, a 
more structured form of incrementalism was used to compensate for 
uncertainty concerning promotional effectiveness (see Case I). 
However, incrementalism is observed, as described above, to be 
inefficient in that it requires large amounts of resources in relation to 
the change it is attempting to address. In this work, therefore, 
incrementalism was cited as inadequate to manage large or 
discontinuous changes in the market environment. This was seen in 
instances of internationalisation (Cases H and Q) and major 
technological changes (Cases D and I). Incrementalism was also cited 
as failing where the market changes were unclear and open to 
interpretation. In such cases, political and cultural incrementalism 
led to very subjective rationalisation of the turbulence and 
subsequently to inferior strategies (see for instance Cases K and O). 
Although not fully substantiated from these findings, these 
limitations of incrementalism are consistent with the view that 
incrementalism is too “expensive” to address major changes in 
market conditions and is subsequently relegated to a supporting role 
in the hybrid marketing strategy making process. Hence, in the cases 
discussed above,  incrementalism can be seen as an adjunct to 
visionary command processes in the management of market 
turbulence. 
Hybrid marketing strategy making processes in which the rational 
planning process is a major component appear to differ from other 
processes in their capacity to manage turbulence. Some cases (see E, 
G, I and J) cited the capacity of rational planning processes to 
anticipate turbulence. On the other hand, many cases cited the 
relative inflexibility of rational processes and consequently poor 
ability to react to turbulence. Illustrations of this inflexibility included 
the effects of fixed planning calendars (and subsequent financial 
allocations) and the failure of formal processes to assimilate 
intangible information or learning experiences. By contrast, rational 
planning processes were observed to be macrocongruent to market 
situations in which turbulence was relatively low (see Cases I, G and 
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 J). In such cases, rational planning was seen not only to anticipate 
market turbulence, but also to predict its implications and translate 
them into changes in strategy. Moreover, rational planning appeared 
to be more effective in filtering signs of turbulence and differentiating 
between those with major and minor consequences. Hence rational 
planning was observed to be effective in cases of low market 
turbulence but less effective in cases where market turbulence was 
greater. These findings therefore suggest a mechanism for 
macrocongruence (in fact, macroincongruence) of rational planning to 
turbulent market conditions. The findings suggest that rational 
planning processes are slow, and that this slowness has its origins in 
the analysis, synthesis and communication processes that make up 
rational planning. Whilst adequate for stable markets, rational 
planning processes fail to keep up with rapid and major changes in 
market conditions. As with visionary command processes, 
incrementalism is used to augment rational planning and has the 
capacity to manage small scale changes in market conditions, but is 
too demanding of resources to be used extensively in turbulent 
markets. 
This consideration of the manner by which visionary command, 
rational planning and incrementalism function in low and high 
market turbulence conditions therefore indicates an underlying 
mechanism of macrocongruence involving effectiveness and efficiency 
of comprehension and reaction to market changes. These emergent 
mechanisms are summarised in  (page 212). Table 12
When taken as a snapshot of the cases studied, at a single point in 
time, these cases suggest a clear, albeit partial, mechanism for the 
congruency hypotheses. The explanation is partial at this stage in the 
discussion, as it relates only to the issue of macrocongruence and not 
microcongruence. This mechanism involves the capacity of hybrid 
marketing strategy making processes to cope well with market 
conditions. The first involves the capacity of the process to 
understand market complexity. Generally, strongly command 
processes fare less well in this respect than rational planning 
processes. This mechanism would appear to have its roots in 
cognitive limitations of the individuals or body in which the visionary 
command process is vested. Incremental processes offer some 
capability to cope with localised complexity, but this is expensive of 
 
The Effectiveness of Marketing Strategy Making Processes in Medical Markets 
 (2003)  Page 215 
 resources and therefore limited, either deliberately or otherwise. By 
contrast, rational planning processes have a notably larger capacity 
to comprehend market complexity. This mechanism would appear to 
have its roots in the use of tools and techniques to enable 
comprehension and in the inherently larger body involved in rational 
planning, compared with visionary command. Hybrid marketing 
strategy making process that are not macrocongruent to market 
complexity tend towards oversimplification of the market leading to 
weak market understanding and, hence, weak strategy. 
Macrocongruent processes enable a fuller understanding of market 
complexity and hence enable stronger strategies. 
Indications of strategic drift 
Although this study was not of a longitudinal design, detailed 
consideration of the findings indicates a longitudinal aspect to many 
of the cases. In many cases, respondents reported a significant long-
term change in the complexity of the market situation (see for 
example Cases B, C, E, G, J, O and Q). As mentioned earlier, some 
cases had proactively increased the rational planning component of 
their hybrid marketing strategy making process in response to this. 
However, some cases continued to use strongly command processes 
in the face of high levels of market complexity (see for instance Cases 
C, F, K and O). These cases usually demonstrated a significant lack 
of macrocongruence to market complexity. 
Although this study was not longitudinal, this interpretation of the 
findings does imply a time related phenomenon. The findings would 
seem to suggest that organisations develop a hybrid marketing 
strategy making process that is effective in a particular situation of 
market complexity. If this is not the case then they do not survive. 
Consequently, surviving (and therefore observable) organisations 
have a hybrid marketing strategy making process that is 
macrocongruent to the market situation in which the process 
developed. Frequently, this is a relatively simple market context and 
a hybrid marketing strategy making process that has a strong 
element of visionary command. Over time, the market conditions 
develop, frequently becoming either more complex or more turbulent; 
however, the hybrid marketing strategy making process is not always 
adapted to the new market conditions, leading to a lower level of 
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 macrocongruence and a weaker strategy. These findings would 
support this explanation of the development of low levels of 
macrocongruence, albeit with significant qualifications concerning 
the limitations of the methodology in this respect.  Hence this work 
suggests a mechanism for the development of macroincongruence 
over time.  This would seem to be complementary to the concept of 
strategic drift, in which organisational strategies drift over time from 
the appropriate to the inappropriate (Johnson & Scholes 2001). The 
gradual development of macroincongruence as market complexity 
and turbulence change is not mirrored by changes in the hybrid 
marketing strategy making process would suggest a possible 
mechanism for the origins of strategic drift.  As discussed in the 
following section, these mechanisms for the development of 
macroincongruence and the connection to strategic drift are further 
supported by a consideration of microcongruence. 
6.2.2 The Underlying Mechanism of Microcongruence 
The congruence between the hybrid marketing strategy making 
process and the organisational culture is, of course, extremely 
complex. In this work, it has been operationalised in terms of the 
manner in which the culture supports or hinders the three 
component processes of the hybrid marketing strategy making 
process. Hence, cultural artefacts were identified which supported 
and hindered all three component processes (see  page 94). 
Whilst recognising the limitations of this simplification, it provides a 
useful means to examine the underlying mechanism  of 
microcongruence between hybrid marketing strategy making process 
and organisational culture.  
Table 10
An explanation of the mechanism of microcongruence effects is 
therefore given below in terms of the manner in which different 
hybrid marketing strategy making processes are hindered or 
supported by artefacts of organisational culture. 
Visionary command processes  
Hybrid marketing strategy making processes in which visionary 
command processes were a major component were the most common 
in this sample. As such, it is significant that the findings indicated a 
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 number of cultural artefacts that appear necessary to support or 
hinder this component of the process. 
• Role demarcation, acceptance and autonomy 
In all cases of microcongruent command processes (see for 
example, Cases A, C, D and O) there was a common cultural 
artefact of role demarcation. In such cases, the command 
authority of the central body or leading cabal was accepted 
with relatively little dissent. Often, this was justified in terms of 
the capital intensive nature of the product and the relative 
homogeneity of the subsidiary markets in terms of core needs. 
Complementing this acceptance of command was the clear 
demarcation between central and local processes and a 
concomitantly high level of autonomy of local management over 
local issues. This combination of artefacts, which might 
usefully be called a subsidiarity culture, was a clear factor in 
the macrocongruence of visionary command processes. It 
resulted in effective management of large, tangible and global 
aspects of market conditions (by the command process) such 
as technological change, demographics and regulatory issues. 
At the same time, it resulted in effective management of 
smaller, less tangible, local issues (by local incrementalism or 
planning) such as competitive activity or customer behaviour. 
It also enabled rapid communication across geographical and 
functional boundaries, and hence reaction to market 
turbulence, by command processes. Where subsidiarity was 
not an element of the culture, it appeared that the component 
processes conflicted with each other leading to poorer 
management of the market conditions and weaker strategy (see 
for instance Cases K and R). 
• Cohesive management teams 
A characteristic of many cases in which visionary command 
processes were important was the cohesiveness of the top 
management team (see Cases C and H). This seemed to extend 
beyond simple agreement on strategic issues to a shared set of 
values and fundamental cultural beliefs about the best way to 
do business. Two cases provided an interesting counterpoint to 
the importance of management team cohesiveness. Case O 
substituted for this with a very strong leader, whilst Case F 
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 demonstrated an interesting gap between the values of the 
management team and their subordinates. Both these cases 
resulted in weak strategy. 
• Explicit and well supported management processes 
The third significant cultural artefact in the support or 
hindrance of visionary command processes was the existence of 
explicit and well supported management processes. Most 
strongly command processes exhibited this (see Cases A, C, H, 
L, M and O). Note that these management processes were not 
necessarily formal. However, they were always explicit (in terms 
of the power of the command process to make strategy) and 
well supported with detailed, often financially based, 
management information systems. Finally, some evidence 
emerged (Cases D, G, and J, for example) that a hybrid 
marketing strategy making process that combined visionary 
command processes with planning or incrementalism benefits 
from explicit and frequent interconnect between the different 
component processes. Where this did not occur (for instance, 
where connections were only annual and financial) conflict 
occurred between the component processes (see for instance 
Cases K and R). 
Rational planning processes 
Hybrid marketing strategy making processes in which rational 
planning processes were a major component were important in 
creating strong marking strategies in complex markets. As such, it is 
significant that the findings indicate a number of cultural artefacts 
that appear necessary to support or hinder this component of the 
process. 
• Top management team sponsorship 
In all cases of microcongruent planning processes (see, for 
example, Cases E, I, J and Q) there was a common cultural 
artefact of top management team sponsorship. In such cases, 
the value of rational planning was explicitly endorsed and in 
some cases (notably E) deliberately “sold” beyond the 
management team. In some cases, this active advocacy of 
rational planning by the top management team was aided by 
the importation of new, planning-oriented, managers. In 
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 others, it was supported by the use of consultants to design the 
process. Such support led to visible changes in artefacts such 
as human resource policies (e.g. the recruitment and retention 
of qualified marketers), and the provision of market research 
data. In contrast, organisations which lacked microcongruence 
to rational planning processes valued technical or product 
knowledge and placed notably low value on external data (for 
instance, Cases A, C, and O). It was also noticeable that those 
cases that had or were attempting rational planning, but which 
were struggling to make it work, cited lack of senior 
management endorsement (for instance Cases B and D). 
• Cross functional working 
A characteristic of many cases in which rational planning 
processes were dominant was the importance placed upon 
cross-functional working. In many cases, deliberate steps were 
taken to enable cross functional working (Cases E, G and Q, for 
instance) and this was often one of the cultural artefacts 
specifically endorsed by top management teams who were 
advocates of rational planning processes. By contrast, cultural 
resistance to pooling data was seen as a hindrance to rational 
planning (Cases B, M and R, for example). In such cases, both 
the lack of explicit communication processes and implicit, 
habitual, “silo” thinking were cited as barriers to planning. 
Moreover, in companies where cross-functional working was 
not an established or acquired habit, it appeared that rational 
planning processes were subverted away from cooperative 
exercises to become another means of control (Cases K and P). 
• Attitudes to non-traditional data 
The third significant cultural artefact in the support or 
hindrance of rational planning processes was the cultural belief 
placed in non-traditional types of data. Cases which exhibited 
microcongruence to rational planning processes (see Cases E, 
J, and Q) exhibited different attitudes towards some types of 
data than did cases which lacked microcongruence. In 
particular, companies with planning oriented processes placed 
high value on data which reflected customer attitudes and 
motivations. In most cases, this was a significant shift from 
dependence on traditional data concerning product usage. By 
 
The Effectiveness of Marketing Strategy Making Processes in Medical Markets 
 (2003)  Page 220 
 contrast, cases which exhibited lack of microcongruence to 
rational planning appeared wedded to the primacy of 
traditional data, as supplied by the dominant suppliers of 
market research data (Cases B, G, M, and P, for example). The 
result of this dissimilar attitude to data was a striking 
difference in the quality of the resultant strategy. Cases with 
positive attitudes to non-traditional data exhibited more 
homogeneous target markets and, consequently, strategies that 
were significantly different from those of the competition. 
Incremental processes 
Hybrid marketing strategy making processes with a significant 
component of incremental processes were common in this study, 
although incrementalism was always a secondary component of the 
hybrid marketing strategy making process. As such, it is significant 
that the findings indicate a number of cultural artefacts that appear 
necessary to support or hinder this component of the process. 
• Overskilling 
In most cases of microcongruent incremental processes (see, 
for example, Cases A, D and L) there was a common cultural 
artefact of overskilling in the key implementation roles. This 
was the human resource policy of recruiting, retaining and 
training staff for roles such as sales team and product 
management who were significantly better qualified and 
experienced than the norm for the sector. This was cited as an 
important supporting factor in enabling effective 
incrementalism, allowing better gathering of market data, 
design of revised strategies and implementation of revised 
targeting or propositions. By comparison, cases in which 
human resource policies were typical of the industry (see, for 
instance, F and G) cited issues such as skill levels and staff 
turnover as constraints on incrementalism. 
• Openness in communication 
Characteristic of many cases in which incremental processes 
were dominant, was the importance placed upon openness in 
internal communication. Sometimes, deliberate steps were 
taken to enable openness in communication (see Case D), such 
as rewarding ideas or setting up channels to supplement line-
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 management communication. Other examples were more 
implicit, with cultural artefacts like stories used to improve self 
expression and, importantly, to reduce fear of blame (see, for 
example, Case D). In other cases, freedom of expression was 
curtailed by cultural habits (see Cases B, K, O and R). 
Respondents cited openness in communication as an adjunct 
to overskilling (see above) and, in cases where it was 
insufficient (Case F, for example) cited it as a barrier to 
incrementalism. 
• Bureaucracy reduction 
The third significant cultural artefact in the support or 
hindrance of incremental processes was the absence or 
presence of bureaucratic barriers to incrementalism. 
Bureaucratic cultures presented numerous barriers to 
incrementalism, some of which were explicit and formal, and 
others of which were implicit and unofficial. Among the former 
were low sign-off limits for expenditure approval and rigid 
formal processes for the approval of management decisions (see 
Cases M and O). The latter, more implicit, hindrances included 
flat structures and a belief in the primacy of hard data. A flat 
structure meant that incremental changes required multiple 
peer approvals (rather than a single superior approval in 
hierarchal structures), which slowed down implementation (see 
Case G). The second factor, belief in the primacy of hard data, 
related to the point made above concerning attitudes to non-
traditional data, where the implication was that the burden of 
proof for incremental changes lay in the hands of the initiator 
and required numerical proof (Cases F, G and R for example). 
The absence of this proof meant that no action could be taken. 
These observations of cultural support or hindrance for the three 
sub-processes of a hybrid marketing strategy making process imply a 
mechanism for microcongruence in terms of the fit between the 
process and the cultural assumptions of the organisation. 
Summarised in  (page 224), three pairs of contrasting 
cultural assumptions are suggested as responsible for 
microcongruence: 
Table 13
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 • Cultural homogeneity and acceptance vs. cultural heterogeneity 
and rebellion 
The degree of cultural homogeneity is important to the support 
of visionary command processes. Homogenous cultures with 
widely shared fundamental assumptions appear to be 
necessary to the acceptance of centrally originated commands. 
By contrast, the different core assumptions held within 
heterogeneous cultures imply levels of intraorganisational 
conflict that hinder visionary processes.  
• Cultural sophistication and openness vs. cultural rigidity and 
conflict 
The degree to which organisations value sophisticated 
processes and cross-functional working is important to the 
functioning of rational planning processes. By contrast, 
organisations in which sophistication of approach is devalued 
and simplicity valued lead to cultural artefacts that hinder 
rational planning.  
• Cultural generosity vs. cultural pettiness 
The degree to which organisations value flexibility and loose 
control is important to the functioning of incremental 
processes. By contrast, organisational cultures which value 
rigid processes or bureaucratic controls hinder incremental 
processes.  
When taken as a snapshot of the cases studied, at a single point in 
time, these cases suggest a clear, albeit partial,  underlying 
mechanism for the congruency hypotheses. Their illustration of a 
mechanism by which microcongruence moderates marketing strategy 
quality is complementary to that partial explanation given above in 
terms of macrocongruence. 
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 Table 13:  Mechanisms of Microcongruence 
 Visionary command  Rational planning  Incrementalism 
Microcongruent 
cultures  
Mechanism: cultural homogeneity 
and acceptance 
Visionary command processes 
are enabled by strong, 
homogenous cultures that 
include widely held assumptions 
about the primacy of the 
visionary command process. 
Mechanism: cultural 
sophistication and openness  
Rational planning processes are 
enabled by cultures in which 
process sophistication is valued 
and cross functional working 
encouraged. 
Mechanism: cultural 
generosity  
Incremental processes are 
enabled by cultures in 
which resources are not 
strictly controlled and 
experimentation is 
condoned. 
Microincongruent 
cultures   
Mechanism: cultural 
heterogeneity and rebellion 
Visionary command processes 
are hindered by weak, 
fragmented cultures in which 
assumptions about the primacy 
of the visionary command 
process is questioned.  
Mechanism: cultural rigidity and 
conflict 
Rational planning processes are 
hindered by cultures in which 
process sophistication is 
countered by process rigidity 
and cross functional working 
hindered by control measures. 
Mechanism: cultural 
pettiness 
Incremental processes are 
hindered by cultures in 
which resources are 
bureaucratically controlled 
and experimentation is 
feared. 
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Indications of cultural lag 
As in the above discussion of macrocongruence, a more detailed 
consideration of the findings indicates a longitudinal aspect to many 
of the cases. In many cases, respondents reported a lack of 
microcongruence between a hybrid marketing strategy making 
process that had been recently modified, or was in the process of 
modification, and the organisational culture (see Cases B, E, F, G, M, 
and Q). In many cases, this took the form of a process that had 
become more rational planning in its nature, typically from a 
command or command and incrementalism process. More 
particularly, the microcongruence described was consistent with a 
rational planning process operating in an organisational culture that 
had previously been supportive of a command or command and 
incrementalism process. 
Although this study was not longitudinal, this interpretation of the 
findings does imply a time related phenomenon. The findings would 
seem to suggest that organisations develop an organisational culture 
that is appropriate to the particular situation in which they exist. If 
this is not the case then they do not survive. Consequently, surviving 
(and therefore observable) organisations have an organisational 
culture that is appropriate to the market situation in which the 
culture developed. Further, a hybrid marketing strategy making 
process develops that is microcongruent to that culture. Frequently, 
this is a relatively simple market context, a hybrid marketing strategy 
making process that has a strong element of visionary command and 
an organisational culture that supports that process. 
Over time, the market conditions develop, frequently becoming either 
more complex or more turbulent. If the hybrid marketing strategy 
making process is adapted to the new market conditions and the 
organisational culture remains relatively unchanged, then a lower 
level of microcongruence and a weaker strategy ensue. These findings 
would support this explanation of the development of low levels of 
microcongruence, albeit with significant qualifications concerning the 
limitations of the methodology in this respect. As in the case of 
macrocongruence, this would seem to be complementary to the 
concept of strategic drift. 
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6.2.3 The Combined Underlying Mechanisms of 
Macrocongruence and Microcongruence 
Taken together, the underlying mechanisms of macrocongruence 
(Section 6.2.1) and microcongruence (Section 6.2.2) describe a 
mechanism through which the congruency hypotheses operate. In 
short, macrocongruence (the result of using a process with a blend of 
the three components appropriate to the market conditions), allows 
the process to adequately understand the market. Microcongruence 
(the result of a supportive culture) allows that understanding to be 
translated into a strong strategy. 
This evidence of an underlying mechanism by which organisational 
culture, market conditions and strategy process interact to determine 
the properties of a marketing strategy is important to the 
substantiation of the hypotheses and the model. In addition, this 
examination of the underlying mechanism of microcongruence and 
macrocongruence moves the combined congruency model from a 
“black box” model to one that might more usefully inform 
management practice. Finally, the indications of strategic drift and 
cultural lag suggested by the findings offer an interesting connection 
with the idea of strategic drift and a possible explanation for why 
once effective organisations now have weak marketing strategies. The 
implications of these points for practitioners are described in 
Section 6.3. 
6.3 Implications of these Findings for Practitioners 
The aim of this work is to improve management practice by 
contributing to the knowledge available to practising managers. To 
this end, Sections 6.1 and 6.2 describe a contribution to knowledge 
via the testing and development of an extant theory, namely Burrell 
and Morgan’s congruency hypotheses. By extension, this section of 
the thesis sets out the implications of the work for management 
practice. 
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All senior marketers face the task of making marketing strategy, 
explicitly or otherwise. There is a large body of published literature to 
 support the practitioner in this task, the vast majority advocating 
rational planning processes in the form of strategic marketing 
planning. Amongst academics, upon whom practitioners rely for 
guidance, a debate continues about the value or otherwise of rational 
planning processes. Hence there is a need amongst practitioners for 
clarification or qualification of the advice they are routinely given.  
The findings of this work imply that the existing literature has two 
shortcomings: 
• It is prescriptive, making little allowance for the context of the 
strategy making process. 
• It is simplistic, viewing the process choice in terms of a single 
dimension of planning versus non-planning. 
By contrast, this work suggests that a more effective marketing 
strategy process would be:  
• Context specific, contingent upon the external and internal 
environment in which the marketing strategy making process 
works. 
• Complex, a hybrid marketing strategy making process 
assembled from the three component processes. 
The congruency hypotheses and the associated combined congruency 
model suggest that the prescriptive approach of attempting to apply 
strategic marketing planning to any context is flawed. The same 
would be true for any other prescriptive approach. The congruency 
hypotheses imply that any prescriptive process risks 
macroincongruence with the market situation and 
microincongruence with the organisational culture. Instead, it 
suggests the deliberate construction of a hybrid marketing strategy 
making process that is appropriate to the particular business context 
under consideration. Given a small number of simple and reasonable  
assumptions, it is possible to extrapolate the congruency hypotheses 
into a process by which to do this. This process would contain the 
following four stages: 
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 a) An evaluation of the market situation in terms of market 
complexity and market turbulence. 
This stage assumes that the complexity and turbulence of the 
market are outside the control of the organisation and hence 
that the organisation must design its strategy making process 
to fit the market conditions. This assumption seems 
reasonable, with the caveat that it may be possible practically 
to simplify the market by means of divisionalisation of the 
organisation, as seen in some of the case studies. Such 
divisionalisation effectively simplifies the market to which the 
hybrid marketing strategy making process is to apply. In any 
event, the findings of this work suggest market characteristics 
that might be used as factors in the assessment of the market 
conditions. 
b) Design a hybrid marketing strategy making process that is 
macrocongruent to the external market situation. 
This stage builds on the findings of this work which suggest 
that market complexity implies a need for rational planning, 
turbulence implies a need for visionary command processes, 
whilst all market conditions require an element of 
incrementalism. These implications are summarised in 
 (page 230). 
Figure 
7
c) Make such amendments to the organisational culture as are 
necessary to achieve microcongruence with the hybrid 
marketing strategy making process. 
This stage builds on the findings of this work which indicate 
the nature of cultural artefacts needed to support each process 
component. Note that this does not suggest a wholesale 
revision of organisational culture, which the literature review 
suggests may be difficult and counterproductive. 
d) Implement the hybrid marketing strategy making process and 
evaluate the outputs against the properties of a strong strategy. 
This stage builds on the findings from both the literature 
review and the empirical work that characterise the properties 
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 of a strong strategy. By applying these properties as tests prior 
to execution, the strategy quality is improved. 
Clearly, the above four-stage process is illustrative and is not 
intended to be a comprehensive, prescriptive approach to marketing 
strategy making. Rather, it is intended to demonstrate the 
implications of these findings to practitioners, that marketing 
strategy making effectiveness arises from a tailored, context specific 
process. When compared to the normative literature, this is a 
valuable contribution to practice. 
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 Figure 7: Hybrid Marketing Strategy Making Process Fit with Market Conditions 
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6.4 The Contribution to Knowledge Made by this 
Work  
This work makes contributions to knowledge in three areas: 
• To theory, this work confirms the Burrell and Morgan 
congruency hypotheses, extends them into the domain of 
marketing strategy making processes and contributes to the 
characterisation of macrocongruence and microcongruence, 
concepts undeveloped by previous work.  
• To methodology, this work confirms the value of multiple 
informant case studies in the field of marketing strategy 
process research, extends the contingency approach to 
consider both internal and external environments 
simultaneously and addresses the previous criticisms of 
organisational effectiveness measures by the use of strategy 
diagnostics. 
• To practice, this work confirms that rational planning 
processes such as strategic marketing planning are appropriate 
to complex markets, extends the concept of a “requisite” 
planning process and gives guidance on the requisite hybrid 
marketing strategy making process in different market 
conditions. Further, this work makes a new contribution to 
practice by giving guidelines for the deliberate management of 
process and culture to fit the market situation. 
The contributions are explained in Sections 6.4.1 to 6.4.3, and 
summarised in Table 14 (page 237). 
6.4.1 Contribution to Theory 
This work contributes to theory at three levels, confirming, developing 
and expounding the ideas Burrell and Morgan developed from the 
work of Lawrence and Lorsch and earlier writers in the contingency 
school.  The contribution to this area of theory is useful in the 
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 explanation of the effectiveness of marketing strategy making 
processes. The contribution can be described at three levels:  
Confirmation of theory 
Despite their ubiquity, the Burrell and Morgan congruency 
hypotheses have not been extensively tested. The literature search for 
this work found frequent mention of the work but no attempt to test 
the hypotheses. As such, their work remains untested despite its 
potential application to a very wide range of domains.  This work set 
out to test the hypotheses, albeit with a recognition that early 
attempts at theory testing inevitably involve a degree of theory 
building and construct development. This work, by supporting the 
congruency  hypotheses, confirms the Burrell and Morgan work and 
suggests its wider applicability to other domains.  
Development of theory 
Concomitant with the lack of empirical testing of the congruency 
hypotheses, they have not been previously applied to the marketing 
strategy making area. The literature search in this area found no 
mention of the Burrell and Morgan work in the field of marketing 
strategy making processes, nor in the related fields of strategy 
process more generally.  This work, by synthesising the congruency 
hypotheses with previous work in the areas of hybrid marketing 
strategy making process, marketing strategy content, and internal 
and external mediators of strategy process, develops the congruency 
hypotheses into this field. By developing the theory into the combined 
congruency model of marketing strategy making process 
effectiveness, and testing the model empirically, this work extends 
the theory into a new area and provides an approach for similar 
application in other domains.  
New or unique contribution to theory 
The lack of empirical exploration or testing of the congruency 
hypotheses has resulted in a lack of development of the important 
constructs of macrocongruence and microcongruence. This is true 
generally, but especially in relation to the domain of marketing 
strategy making processes. Without such characterisation, the 
congruency hypotheses remain as high level explanations of the 
effectiveness of management processes such as marketing strategy 
making. This work expounds the nature of macrocongruence and 
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 microcongruence. The former is elucidated in terms of the ability of 
the hybrid marketing strategy making process to comprehend market 
complexity and react to market turbulence. The latter is explicated in 
terms of the capacity of the organisational culture, via its observable 
artefacts, to support or hinder the three sub-processes of the hybrid 
marketing strategy making process. Whilst the characterisation of 
macrocongruence and microcongruence cannot be said to be 
complete, this work advances greatly from the outline descriptions 
given by Burrell and Morgan. It therefore makes a significant 
contribution to this area of theory. 
6.4.2 Contribution to Methodology 
This work contributes to methodology at three levels, confirming the 
uses of multiple respondent case studies in the area of marketing 
strategy process, extending previous work in this area by considering 
both internal and external mediators of process effectiveness and 
contributing new methods by the use of strategy diagnostics.  The 
contribution to methodology is therefore useful to the understanding 
of the effectiveness of marketing strategy making processes. The 
contribution can be described at three levels: 
Confirmation of methodology 
Whilst much previous work has used and recommended case studies 
in strategy process research, there remains much debate amongst 
researchers as to the most appropriate method to employ in order to 
explicate and understand  strategy making process. This is evidenced 
by the wide variety of approaches, from the strongly quantitative to 
the single case qualitative, described in the strategy process 
literature. This work confirms multiple respondent case studies as an 
appropriate method, especially in the light of the failure of the earlier, 
survey based, approaches. This work suggests that a multiple 
respondent case study approach, using a moderately sized sample,  
offers some of the generalisability of a survey and the sensitivity of an 
in-depth case. IT does not preclude the use of other methods, but 
does confirm the applicability of this approach, as suggested by 
previous workers.  
Development of method 
This work does not attempt to make significant new contributions in 
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 terms of the detail of the execution of the method employed. On the 
contrary, its use of accepted and well tested methods was a deliberate 
choice in order to maximise the trustworthiness of the results. 
However, the work does contribute to the development of 
methodology by bringing together two areas of research that have 
previously occupied different areas of the literature. Whilst 
recognising the importance of both internal and external mediators, 
previous researchers have restricted their work to considering effects 
of only one or the other on the effectiveness of strategy making 
processes. Even with well executed methodology, this would allow 
only a  partial or contingent explanation of strategy making process 
effectiveness. This work develops and builds upon the work of 
previous researchers (notably Mintzberg, Eisenhardt and 
Fredrickson)  to consider the mediating effects upon marketing 
strategy making processes of both internal contingencies and 
external contingencies. In doing so, it develops the method so as to 
allow a fuller and less contingent understanding of the effectiveness 
of marketing strategy making processes.  
New or unique contribution to methodology 
This work largely follows the methodological recommendations of 
many previous workers in using the multiple respondent case study 
method. Further, it follows their recommendations as to the design, 
execution and analysis of the method. However, a critical 
consideration of the previous work and criticisms made of it 
suggested two areas in which the previous work was flawed and 
where new and useful contributions to method might be made. The 
first of these was the criticism made of the use of organisational 
effectiveness measures in studying the effectiveness of marketing 
strategy making processes. Whilst the more recent work in this area 
has attempted to accommodate these criticisms to some degree, the 
complexity of the linkage between marketing strategy making process 
and organisational outputs, compared to the relative simplicity of the 
research, remains a point of criticism. This work attempts to resolve 
this problem by replacing organisational outputs with marketing 
strategy making process outputs, in the form of consensually 
developed marketing strategy properties, abbreviated as strategy 
diagnostics. The development and application of these intermediate 
dependent variables is a useful contribution to knowledge in the area 
of marketing strategy making process effectiveness.  The second 
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 unresolved criticism of research in this area is that voiced by 
Pettigrew concerning the true level of understanding gained by 
researchers in the context of industry jargon and complexity. To 
address this issue, the use of a single industry sector and an 
industry knowledgeable researcher was made. Whilst not unique in 
management research generally, this approach has not been cited in 
previous research into marketing strategy making process 
effectiveness and is therefore a useful new contribution to method. 
6.4.3 Contribution to Practice 
This work contributes to practice at three levels, by confirming the 
appropriateness of planning-based hybrid marketing strategy making 
processes in complex, stable markets, by developing the concept of 
requisite processes in different contexts, as first suggested by 
McDonald, and by making a new contribution by suggesting steps for 
the deliberate creation of a context-requisite marketing strategy 
making process. The contribution can be described at three levels:  
Confirmation of practice 
The large majority of the prescriptive literature advocates a rational 
planning approach to marketing strategy making. This prescriptive 
process varies little between authors, except in terminology and 
detail. These prescriptive processes make little or no allowance for 
different market contexts and virtually none for different 
organisational culture context. Such prescription takes little account 
of the now extensive knowledge concerning the mediation of 
marketing strategy making processes by internal and external 
factors. This work confirms the appropriateness of planning-based 
approaches in cases where the market is stable and complex. 
However, it qualifies the use of planning as the dominant sub-process 
within a hybrid marketing strategy making process. Further, it 
suggests that this process is not necessary in simple markets and not 
appropriate in turbulent markets. Hence this work develops the 
concept of a “requisite” marketing strategy making process as first 
suggested by McDonald (McDonald1982) by indicating the broad 
nature of the most appropriate hybrid marketing strategy making 
process for a range of market conditions.  
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 New contributions to practice 
Whilst the prescribed rational planning approach to marketing 
strategy making forms the basis of many organisation’s espoused 
strategy making process, it is observed that many practitioners 
attempt to adapt the process to suit their environment. Much of the 
current literature provides very little guidance as to how to carry out 
such adaptation. Neither the contingent conditions, nor the 
component parts of the process to be varied, nor the manner of 
assessing the result are well specified in the practitioner literature. 
The research literature, although limited in its use by practitioners, is 
more helpful in this respect, but is fragmented and disjointed. This 
work makes a new contribution to practice by giving clear guidelines 
by which  to deliberately create a hybrid marketing strategy making 
process that is both macrocongruent and microcongruent. These 
guidelines cover the assessment of market conditions, the design of a 
requisite, macrocongruent, process, the adaptation of the 
organisational culture to create microcongruence and the assessment 
of the resultant marketing strategy in terms of its properties, 
compared to a literature derived ideal. Hence this work makes a new 
contribution to practice 
Hence this work makes valuable contributions to theory, method and 
practice at the confirmatory, development and novel contribution 
levels, as summarised in  (page 237). Table 14
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 Table 14: Contribution to Knowledge Made by this Work 
 Theory Methodology Practice 
Confirmation This work provides a valuable 
empirical test of the Burrell 
and Morgan congruency 
hypotheses, supporting their 
validity and value to both 
researchers and practitioners. 
This work replicates and 
confirms the usefulness of 
multiple informant case 
studies in marketing strategy 
process research. 
This work confirms that 
rational planning processes 
such as strategic marketing 
planning are appropriate to 
complex markets. 
Development This work develops and 
extends the congruency 
hypotheses into the combined 
congruency model of 
marketing strategy making 
process effectiveness. 
This work extends the 
contingency approach by 
considering both internal and 
external contingencies 
simultaneously. 
This work extends the 
concept of a “requisite” 
planning process and gives 
guidance on the requisite 
hybrid marketing strategy 
making process in different 
market conditions. 
New or unique 
contribution 
This work, has made a new 
contribution by  illuminating 
the underlying mechanisms of 
macro- and microcongruence. 
This work contributes a new 
methodological construct of 
strategy quality and  
demonstrates the value of a 
single industry sector sample 
with an industry-
knowledgeable researcher.  
This work makes a new 
contribution to practice by 
giving guidelines for the 
deliberate management of 
process and culture to fit 
the market situation. 
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 6.5 A Critique of this Work and 
Recommendations for Further Research 
6.5.1 A Critique of this Work 
As with any piece of empirical work, this research is open to criticism 
at a number of levels. The ontological and epistemological 
assumptions that underlie the choice of method are clearly not the 
only ones that could be made, and the qualitative, case study 
interview, methodology is open to criticism from those of a different 
philosophical persuasion. However, the purpose of this section is to 
inform those who might wish to duplicate or extend this work. For 
that practical reason, the lessons learned from this research and 
listed below have assumed agreement with the pragmatist 
philosophical position. The criticisms to be made of this work fall into 
three categories: 
Methodological criticisms 
The strengths of the methodology lay in the depth of insight it made 
possible. As a qualitative study, it allowed exploration of untested 
constructs of macrocongruence, microcongruence, strategy quality 
and hybrid marketing strategy making processes. The operational-
isation of each of these constructs, described in Section 4 (page 54) 
was successful. The data gathering stage worked reasonably well, 
although some improvements are suggested later. The analysis 
process was unusual, by current practice, in choosing to use a 
“manual” method (employing only word processing software) rather 
than NUD:IST or NVIVO. The analysis worked well, despite being 
rather time consuming, fulfilling the motivating objective of gaining 
deep insight without interference by software. Most importantly, the 
decision to carry out the study in an industry sector with which the 
researcher was very familiar was important to the success of the 
work. The researcher’s specialist knowledge allowed greater 
understanding of this complex industry, and time-effective use of the 
research interviews. 
Two weaknesses were found in the methodology which might be 
addressed by future researchers. Firstly, the sampling did not provide 
sufficient variety of cases to fully address the research objectives. 
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 Partly, this was an artefact of the industry sector choice. The 
availability of turbulent market cases in the medical sector is very 
restricted, due simply to the characteristics of the industry. The more 
significant omission however was the absence of cases which were 
macrocongruent but not microcongruent. The shortfall in the sample 
leaves open a small possibility that macrocongruence alone may be 
the determinant of strategy process effectiveness, as expressed in 
proposition P4.  
The second, minor, weakness in the methodology lay in the use of an 
interview guide. In hindsight, more testing of this might have 
uncovered the subjective reaction to some terms (for instance, ‘stable’ 
and ‘simple’). These issues were addressed in the interviews, but later 
researchers may wish to note the lessons learned. It may also be 
worth considering the use of diagrams to help communicate some of 
the concepts used, such as McDonald’s three process model. 
Generalisability criticisms 
As with all research, the applicability of these findings and 
conclusions beyond this work is questionable. Although the medical 
sector was selected for methodological reasons, there are no aspects 
of this sample which make it unique in terms of marketing strategy 
making and hence limit the generalisability. Similarly, the range of 
cases supports claims for generalisability of these findings. Against 
this are those features of the industry that may bias the nature of 
marketing strategy making processes. The industry is heavily 
regulated, capital intensive and mostly mature. It is a reasonable 
criticism that this work is not wholly generalisable into industries 
that are less mature and less constrained by regulation or product 
development timescales. 
Criticism concerning the role of the researcher 
In any research, “Hawthorne Effects” of the researcher in some way 
influencing the research are important. Assessment of any impact of 
the researcher is therefore important, even though the methods of 
data gathering and analysis were designed to counter this as much 
as practically possible.  
The most significant comment that can be made regarding the role of 
the researcher is that his presence may have distorted the 
 
The Effectiveness of Marketing Strategy Making Processes in Medical Markets 
 (2003)  Page 239 
 phenomena observed. This is possible and very difficult to identify. 
However, the consistency of this research with previous research 
supports the belief that the role of the researcher was not harmful to 
the research. The findings support Burrell and Morgan’s congruency 
hypotheses. Further, they are consistent with the literature on 
internal and external contingencies on strategy process. 
6.5.2 Recommendations for Further Research 
This  work was the first of its type that could be uncovered from 
extensive literature searching. No other work using the Burrell and 
Morgan congruency hypotheses has been found in the area of 
marketing strategy making processes or in related fields. As such, the 
work was required to create and operationalise four new constructs 
(hybrid marketing strategy making process, macrocongruence, 
microcongruence  and  strategy quality). The research was therefore 
designed to both develop these constructs as well as to examine the 
relationship between them. Work that attempts both theory building 
and theory testing at the same time is necessarily compromised to 
some degree in the way in which it addresses both needs. Whilst the 
methodology of this work was intended to limit the extent of that 
compromise, neither the theory building nor the theory testing 
aspects of this work can be said to conclusive and not amenable to 
further testing or building. 
There are innumerable ways in which this work suggests possibilities 
for further work. Perhaps the most straightforward way to consider 
these possibilities is in terms of the levels of contribution 
(confirmatory, development or new contributions) that such work 
might make.  The findings in this research suggest a number of 
avenues for future work at each of these three levels. Whilst no listing 
of these can be complete, it is hoped that the following provide some 
guidance to other researchers: 
Replication or confirmatory research 
Much scope exists for confirming the findings of this work. 
Replication of the work, perhaps incorporating the lessons learned in 
this work, would be a valuable first step. Confirmation of the 
congruency hypotheses by other methodologies would also be 
valuable. The partial elucidation of the mechanisms of 
 
The Effectiveness of Marketing Strategy Making Processes in Medical Markets 
 (2003)  Page 240 
 macrocongruence and microcongruence makes possible the 
improvement of methods for the confirmation of this work. Two 
methodological directions are most obvious: the development of more 
positivistic, quantitative methods and the development of deeper, 
qualitative methods. Each of these two approaches would represent a 
divergence from the mid-range method used in this work. The 
quantitative approach might lay greater claim to the external validity 
and generalisability of the theory, whilst the deeper qualitative 
approach might claim greater internal validity and add greater depth 
to the theory. Hence both approaches would have value and are 
considerable possible avenues for future researchers, in addition to 
straightforward replication of this work.  
Development or extending research 
There are numerous ways in which this work might be usefully 
extended from its focus on marketing strategy making in medical 
markets. This focus was deliberate and clearly aided the execution of 
the research, but development of the combined congruency model 
outside this focus would be a useful contribution to both theory and 
practice. There are two obvious dimensions in which this work might 
be extended. Firstly, the work could be extended, relatively simply, 
into other, non-medical industry sectors. Not only would this extend 
the theory, but it would also give it greater claims to generalisability, 
particularly if the industry were characteristically different from the 
medical industry in some way. For instance, extension into sectors 
that are less mature, less regulated, less technical or involve different 
types of transaction would add to our understanding of the 
congruency hypotheses. Secondly, the work could be extended 
beyond the marketing strategy making process into other 
management processes. Such an extension would require the 
development of equivalents to the constructs of hybrid marketing 
strategy making process and marketing strategy quality and would 
probably result in different mechanisms of macrocongruence and 
microcongruence. The extension of the congruency hypotheses in this 
way might range from areas closely related to marketing strategy 
making (such as strategy for other functional areas) to very different 
management processes (such as new product development or supply 
chain management). The two possible directions (medical or other 
market sectors, marketing strategy making or other management 
process for extending this work) suggest four broad categories of 
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 work for future researchers to consider. When considered with 
possible methodological developments into more quantitative or 
qualitative approaches, the number of research directions is large.  
New or unique research 
In addition to confirming (by replication or by methodological 
divergence) or extending (to different sectors or different management 
processes) this work, it is possible to suggest work that might be 
inspired by these findings that is neither confirmatory nor extensive, 
and would instead make a novel contribution to knowledge.  
This work concerns itself, in part, with the linkages between artefacts 
of organisational culture and marketing strategy making process 
effectiveness. These can be seen as part of a chain of linkages 
between the underlying assumptions of organisational culture and 
the overall effectiveness of the organisation. The current work 
considers only a part of that chain. It does not concern itself with the 
“downstream” connectivity between the properties of marketing 
strategy and organisational effectiveness. Instead, this work has 
assumed a positive connection between those properties of marketing 
strategy and the performance of the organisation, based on the 
strong consensus about “ideal”  strategy properties observed in the 
strategy content literature. Similarly, the current work does not 
concern itself with the “upstream” connectivity of organisational 
culture artefacts to the underlying assumptions of the organisational 
culture.  
Each of these two, unexplored, areas suggest directions for future 
research that would make new contributions to knowledge. Firstly, 
understanding of the association between the properties of marketing 
strategy (target definition, proposition tailoring, SWOT alignment and 
strategy uniqueness) and organisational effectiveness would not only 
be useful in its own right; it would also complement our 
understanding of how to create strategies with those properties. 
Hence a coherent understanding of how market conditions, 
organisational culture, marketing strategy properties and 
organisational effectiveness are linked could be developed.  Secondly, 
an understanding of the way in which organisational culture 
artefacts (particularly those that impact upon marketing strategy 
making processes) are derived from the underlying cultural 
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 assumptions of the organisation would be useful in informing how we 
might more fundamentally manage the artefacts and therefore the 
effectiveness of marketing strategy making process. Taking both of 
these directions together might allow us to develop an understanding 
of the way in which the underlying assumptions of the organisational 
culture are connected to organisational effectiveness by way of 
microcongruence and marketing strategy making process 
effectiveness. 
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 7 Appendices 
Appendix 1: Recruitment Correspondence for Case Companies 
 
 
Understanding and Improving the Effectiveness of 
Strategic Marketing Planning in Medical Markets: 
A Proposal to Potential Case Study Companies 
Executive Summary 
You are asked to take part in a piece of industry specific management research that requires 
minimal commitment from you and gives valuable independent benchmarking of your 
strategy making process. 
What is This Research About?  
This research is aimed at improving the effectiveness of strategic marketing planning in 
medical markets such as pharmaceuticals, diagnostics and devices. In particular, the work 
seeks to understand how strategy-making processes can be improved in the light of increased 
market turbulence and complexity. The intended results are practical suggestions to 
companies in those markets for the improvement of their own marketing strategy making.  
What is Required of Case Study Companies? 
No financial expenditure whatsoever is required. All that is required is that three managers 
submit to an interview of less than one hour each. The managers must be directly involved in 
the marketing strategy development process. The interviews will be carried out at a time and 
place convenient to the managers involved, sometime in the first half of 2002. No other 
commitment is necessary. 
What Are the Benefits to Case Study Companies? 
Companies that take part in this work will obtain three benefits: 
♦ Direct comparison of their strategy making process with other leading companies in the 
same and closely related markets. This will include practical suggestions for how their 
process might be improved in the face of the specific conditions of their market.  
♦ Early and privileged access to the results of this work, its recommendations and 
conclusions. 
♦ Personal feedback from the researcher covering the result of the work and what that might 
imply for the company. 
What About Issues Such as Confidentiality?  
All interviews will be made anonymous and will remain strictly confidential. No mention of 
company or individual names will be made in any reporting of the data. If required, 
confidentiality agreements will be signed.  
How Might We Proceed? 
If you have any further questions, or wish to take part in this research, please call Brian Smith on 01438 712441 or 
b.smith@cranfield.ac.uk 
 
 
 
 
The Effectiveness of Marketing Strategy Making Processes in Medical Markets 
 (2003)  Page 244 
 Appendix 2: Interview Guide Notes 
Phase 2 Interview Script; Version 3.  
Introduction: 
The aim of this research is to better understand the way in which companies in this market 
develop their marketing strategies. By marketing strategies, I mean the set of decisions about 
which customers to address and what overall proposition to offer to them.  
I’d like to ask you a few questions about your business and record the answers for 
transcription and analysis. The whole interview should take about an hour. 
Do you have any questions at this stage, or may I proceed? 
(Check for understanding, concerns about confidentiality etc.)  
1. Please tell me about the customer groups you address  
1.1. How would you differentiate between those customers that you focus upon, as 
opposed to those you do not focus upon? 
1.2. How alike are the customers within your target customer groups in terms of what 
benefits they seek and how they buy? 
2. Can you describe the total offering that these customers see coming from your 
company? 
2.1. What are the most important benefits of the overall propositions you offer your 
customers? 
2.2. How do these benefits address the particular needs of the customers you have chosen 
to focus on?  
2.3. In what way do these propositions differ from those of your competitors?  
2.4. In what way are the overall propositions designed to use the distinctive strengths or 
minimise any weaknesses of your company? 
3. Theory suggests that strategy is made by a mixture of rational, command and 
incremental processes. Using these terms, please describe to me the process by which 
you and your colleagues decide upon which customers to target and what to offer them  
3.1. How much of the target and offer decision is determined at a level above you and 
your peers? 
3.2. How much of the target and offer decision is determined by formal, rational planning 
processes? 
3.3. How much of the target and offer decision is made during the course of 
implementation, in reaction to events in the market place? 
4. I’m interested in understanding the nature of your market. In particular, I’m interested 
in knowing how complex and turbulent it is. Please describe to me how you perceive the 
level of complexity and turbulence in your market. 
4.1. How quickly do the customers, propositions, competitors, channels and decision 
making process in your market change? 
4.2. How complex is your market in terms of complexity of customers, propositions, 
competitors, channels and decision?  
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 5. How well does your process for making target and proposition decisions cope with the 
turbulence and complexity of the market? 
5.1 Are there any examples of the process coping particularly well or badly with the 
complexity of the market? 
5.2 Are there any examples of the process coping particularly well or badly with the 
turbulence of the market?  
6. How would you describe the organisational culture in which you develop the target 
customer and proposition decisions?  
6.1 Does the organisational culture support or hinder rational planning (Prompts: 
Data, Skills, Resources, and Structures)? 
6.2 Does the organisational culture support or hinder a visionary command process? 
(Prompts: Articulations, Directions etc.) 
6.3 Does the organisational culture support or hinder incremental decision making? 
(Prompts: Autonomy, Feedback, Experiments?)  
 
Thank you. That completes the questions I have, but I would be very interested to hear any 
other thoughts you have on your marketing strategy, how that strategy is developed and the 
organisational culture in which that development takes place.  
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 Appendix 3: Coding Analysis Template 
Analysis Table for 2nd Phase PhD Case Study Interviews 
Case Company:  
Individual:  
Date & Location of Interview:  
Interview Code:  
Mark Allocation Case Characteristic 
-2 -1    0 +1 +2
1. The target markets 
are clearly defined 
in terms of 
reasonably 
homogeneous 
customer segments 
rather than product 
categories or broad 
descriptor groups. 
Statement indicates 
heterogeneous 
indistinct target 
groups in a clear and 
unqualified manner. 
Statement indicates 
heterogeneous 
indistinct target 
groups in a qualified 
or compromised 
manner. 
Statement neither 
indicates nor refutes 
homogeneous & 
distinct target 
groups. 
Statement suggests 
homogeneous & 
distinct target groups 
in a qualified or 
compromised 
manner. 
Statement indicates 
homogeneous & 
distinct target groups 
in a clear and 
unqualified manner.  
2. The overall value 
propositions are 
clearly aligned to 
the needs of the 
target segments 
across the breadth 
of the marketing 
mix. 
Statement indicates 
non-segment specific 
propositions in a 
clear and unqualified 
manner. 
Statement indicates 
non-segment specific 
propositions in a 
qualified or 
compromised 
manner. 
Statement neither 
indicates nor refutes 
segment specific 
propositions. 
Statement suggests 
segment specific 
propositions in a 
qualified or 
compromised 
manner. 
Statement indicates 
segment specific 
propositions in a 
clear and unqualified 
manner.  
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 Mark Allocation Case Characteristic 
-2 -1 0 +1 +2 
3. The combination 
of target segments 
and value 
propositions is 
clearly distinct 
from that of the 
competition. 
Statement indicates 
competitor similar 
strategies in a clear 
and unqualified 
manner. 
Statement indicates 
competitor similar 
strategies in a 
qualified or 
compromised 
manner. 
Statement neither 
indicates nor refutes 
competitor distinct 
strategies. 
Statement suggests 
competitor distinct 
strategies in a 
qualified or 
compromised 
manner. 
Statement indicates 
competitor distinct 
strategies in a clear 
and unqualified 
manner.  
4. The combination 
of target segments 
and value 
propositions is 
clearly aligned to 
internal strengths 
and weaknesses. 
Statement indicates 
SWOT mis-
alignment in a clear 
and unqualified 
manner. 
Statement indicates 
SWOT mis-
alignment in a 
qualified or 
compromised 
manner. 
Statement neither 
indicates nor refutes 
SWOT alignment. 
Statement suggests 
SWOT alignment in 
a qualified or 
compromised 
manner. 
Statement indicates 
SWOT alignment in 
a clear and 
unqualified manner.  
5. The process for 
making the target 
market and 
offering decisions 
is based on rational 
planning. 
Statement contradicts 
use of rational 
planning in a clear 
and unqualified 
manner. 
Statement contradicts 
use of rational 
planning in a 
qualified or 
compromised 
manner. 
Statement neither 
indicates nor refutes 
use of rational 
planning. 
Statement indicates 
use of rational 
planning a qualified 
or compromised 
manner. 
Statement indicates 
use of rational 
planning in a clear 
and unqualified 
manner.  
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 Mark Allocation Case Characteristic 
-2 -1 0 +1 +2 
6. The process for 
making the target 
market and 
offering decisions 
is based on 
visionary 
leadership. 
Statement contradicts 
use of visionary 
command process in 
a clear and 
unqualified manner.  
Statement contradicts 
use of visionary 
command process in 
a qualified or 
compromised 
manner. 
Statement neither 
indicates nor refutes 
use of visionary 
command process. 
Statement indicates 
use of visionary 
command process in 
a qualified or 
compromised 
manner. 
Statement indicates 
use of visionary 
command process in 
a clear and 
unqualified manner.  
7. The process for 
making the target 
market and 
offering decisions 
is based 
incremental 
development. 
Statement contradicts 
use of incremental 
process in a clear and 
unqualified manner.  
Statement contradicts 
use of incremental 
process in a qualified 
or compromised 
manner. 
Statement neither 
indicates nor refutes 
use of incremental 
process. 
Statement indicates 
use of incremental 
process in a qualified 
or compromised 
manner. 
Statement indicates 
use of incremental 
process in a clear and 
unqualified manner.  
8. The market is 
relatively complex. 
Statement contradicts 
complexity in market 
factors in a clear and 
unqualified manner. 
Statement contradicts 
complexity in market 
factors in a qualified 
or compromised 
manner. 
Statement neither 
indicates nor refutes 
complexity in 
market factors. 
Statement indicates 
complexity in market 
factors in a qualified 
or compromised 
manner. 
Statement indicates 
complexity in market 
factors in a clear and 
unqualified manner. 
9. The market is 
relatively 
turbulent.  
Statement contradicts 
turbulence in market 
factors in a clear and 
unqualified manner. 
Statement contradicts 
turbulence in market 
factors in a qualified 
or compromised 
manner. 
Statement neither 
indicates nor refutes 
turbulence in 
market factors. 
Statement indicates 
turbulence in market 
factors in a qualified 
or compromised 
manner. 
Statement indicates 
turbulence in market 
factors in a clear and 
unqualified manner. 
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-2 -1 0 +1 +2 
10. The process for 
making the target 
market and 
offering decisions 
accommodates the 
complexity of the 
market 
environment. 
Statement contradicts 
the process 
accommodates 
complexity in market 
factors in a clear and 
unqualified manner. 
Statement contradicts 
the process 
accommodates 
complexity in market 
factors in a qualified 
or compromised 
manner. 
Statement neither 
indicates nor refutes 
that the process 
accommodates 
complexity. 
Statement indicates 
the process 
accommodates 
complexity in market 
factors in a qualified 
or compromised 
manner. 
Statement indicates 
the process 
accommodates 
complexity in market 
factors in a clear and 
unqualified manner. 
11. The process for 
making the target 
market and 
offering decisions 
accommodates the 
turbulence of the 
market 
environment. 
 
Statement contradicts 
the process 
accommodates 
turbulence in market 
factors in a clear and 
unqualified manner. 
Statement contradicts 
the process 
accommodates 
turbulence in market 
factors in a qualified 
or compromised 
manner. 
Statement neither 
indicates nor refutes 
that the process 
accommodates 
turbulence in 
market.  
Statement indicates 
the process 
accommodates 
turbulence in market 
factors in a qualified 
or compromised 
manner. 
Statement indicates 
the process 
accommodates 
turbulence in market 
factors in a clear and 
unqualified manner. 
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-2 -1 0 +1 +2 
12. The rational 
planning process 
for making the 
target market and 
offering decisions 
is supported rather 
than hindered by 
the organisational 
culture. 
 
Statement indicates 
that the 
organisational 
culture hinders the 
rational planning 
process in a clear and 
unqualified manner.  
Statement indicates 
that the 
organisational culture 
hinders the rational 
planning process in a 
qualified or 
compromised 
manner. 
Statement neither 
indicates nor refutes 
that the process 
hinders or supports 
the rational 
planning. 
Statement indicates 
that the 
organisational culture 
supports the rational 
planning process in a 
qualified or 
compromised 
manner. 
Statement indicates 
that the 
organisational 
culture supports the 
rational planning 
process in a clear and 
unqualified manner.  
13. The visionary 
leadership process 
for making the 
target market and 
offering decisions 
is supported rather 
than hindered by 
the organisational 
culture. 
Statement indicates 
that the 
organisational 
culture hinders the 
visionary command 
process in a clear and 
unqualified manner.  
Statement indicates 
that the 
organisational culture 
hinders the visionary 
command process in 
a qualified or 
compromised 
manner. 
Statement neither 
indicates nor refutes 
that the process 
hinders or supports 
the visionary 
command process. 
Statement indicates 
that the 
organisational culture 
supports the 
visionary command 
process in a qualified 
or compromised 
manner. 
Statement indicates 
that the 
organisational 
culture supports the 
visionary command 
process in a clear and 
unqualified manner.  
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-2 -1 0 +1 +2 
14. The incremental 
process for making 
the target market 
and offering 
decisions is 
supported rather 
than hindered by 
the organisational 
culture. 
Statement indicates 
that the 
organisational 
culture hinders the 
incremental process 
in a clear and 
unqualified manner.  
Statement indicates 
that the 
organisational culture 
hinders the 
incremental process 
in a qualified or 
compromised 
manner. 
Statement neither 
indicates nor refutes 
that the process 
hinders or supports 
the incremental 
process. 
Statement indicates 
that the 
organisational culture 
supports the 
incremental process 
in a qualified or 
compromised 
manner. 
Statement indicates 
that the 
organisational 
culture supports the 
incremental process 
in a clear and 
unqualified manner.  
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 Results Summation for this Interview 
Mark Distribution Case Characteristic 
-2      -1 0 +1 +2 Total
Strategy quality (1-4)       
Rational (5)        
Visionary (6)        
Marketing strategy 
process 
 
Incremental (7)        
Complexity (8)        Market characteristics 
Turbulence (9)         
With Complexity       Macro-congruence 
(characteristics 10-11)  
With Turbulence       
 
Rational       
Visionary       
Micro-congruence 
(characteristics 12-14) 
Incremental       
 
 
Other Comments: 
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